|
Top 10 proteins (for # mutations) |
Top 10 proteins
| Uniprot AC
| Muts
| Diseases
| Ints
|
F8 |
P00451 |
468 |
1 |
16 |
SCN1A |
P35498 |
381 |
3 |
6 |
FBN1 |
P35555 |
352 |
6 |
20 |
PAH |
P00439 |
206 |
2 |
4 |
MYH7 |
P12883 |
197 |
4 |
21 |
ABCA4 |
P78363 |
190 |
4 |
5 |
GJB1 |
P08034 |
188 |
2 |
48 |
ATP7B |
P35670 |
181 |
1 |
7 |
GLA |
P06280 |
180 |
1 |
9 |
GBA1 |
P04062 |
162 |
1 |
11 |
|
Diseases with potential edgetic perturbations |
Disease | Phenotype | Relevant proteins |
3-methylglutaconic aciduria |
3-methylglutaconic aciduria 7A (MGCA7A) [MIM:619835] |
CLPB |
3-methylglutaconic aciduria 7B (MGCA7B) [MIM:616271] |
CLPB |
3M syndrome |
3M syndrome 1 (3M1) [MIM:273750] |
CUL7 |
3MC syndrome |
3MC syndrome 2 (3MC2) [MIM:265050] |
COLEC11 |
ADULT syndrome |
Acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) [MIM:103285] |
TP63 |
ARTS syndrome |
ARTS syndrome (ARTS) [MIM:301835] |
PRPS1 |
Achondrogenesis |
Achondrogenesis 2 (ACG2) [MIM:200610] |
COL2A1 |
Achondroplasia |
Achondroplasia (ACH) [MIM:100800] |
FGFR3 |
Achondroplasia, severe, with developmental delay and acanthosis nigricans (SADDAN) [MIM:616482] |
FGFR3 |
Achromatopsia |
Achromatopsia 5 (ACHM5) [MIM:613093] |
PDE6C |
Acne |
Acne inversa, familial, 1 (ACNINV1) [MIM:142690] |
NCSTN |
Acrodysostosis |
Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800] |
PRKAR1A |
Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613] |
PDE4D |
Acrofacial dysostosis, Cincinnati type (AFDCIN) [MIM:616462] |
Acrofacial dysostosis, Cincinnati type (AFDCIN) [MIM:616462] |
POLR1A |
Acromesomelic dysplasia |
Acromesomelic dysplasia 1 (AMD1) [MIM:602875] |
NPR2 |
Acromesomelic dysplasia 2B (AMD2B) [MIM:228900] |
GDF5 |
Acyl-CoA dehydrogenase deficiency |
Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
ACADM |
Adrenal hyperplasia |
ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080] |
GNAS |
Adrenal hypoplasia, congenital (AHC) [MIM:300200] |
NR0B1 |
Adrenal insufficiency, NR5A1-related |
Adrenal insufficiency, NR5A1-related (AINR) [MIM:612964] |
NR5A1 |
Afibrinogenemia |
Congenital afibrinogenemia (CAFBN) [MIM:202400] |
FGA, FGG, FGB |
Agammaglobulinemia |
Agammaglobulinemia 2, autosomal recessive (AGM2) [MIM:613500] |
IGLL1 |
Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692] |
CD79B |
X-linked agammaglobulinemia (XLA) [MIM:300755] |
BTK |
Age-related macular degeneration |
Macular degeneration, age-related, 15 (ARMD15) [MIM:615591] |
C9 |
Macular degeneration, age-related, 3 (ARMD3) [MIM:608895] |
FBLN5 |
Macular degeneration, age-related, 4 (ARMD4) [MIM:610698] |
CFH |
Macular degeneration, age-related, 9 (ARMD9) [MIM:611378] |
C3 |
Aicardi-Goutieres syndrome |
Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181] |
RNASEH2B |
Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333] |
RNASEH2A |
Aicardi-Goutieres syndrome 5 (AGS5) [MIM:612952] |
SAMHD1 |
Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010] |
ADAR |
Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846] |
IFIH1 |
Alagille syndrome |
Alagille syndrome 1 (ALGS1) [MIM:118450] |
JAG1 |
Alazami-Yuan syndrome |
Alazami-Yuan syndrome (ALYUS) [MIM:617126] |
TAF6 |
Alexander disease |
Alexander disease (ALXDRD) [MIM:203450] |
GFAP |
Alpha-methylacetoacetic aciduria |
3-ketothiolase deficiency (3KTD) [MIM:203750] |
ACAT1 |
Alpha-thalassemia/impaired intellectual development syndrome, X-linked |
Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040] |
ATRX |
Alzheimer disease |
Alzheimer disease 1 (AD1) [MIM:104300] |
APP |
Alzheimer disease 2 (AD2) [MIM:104310] |
APOE |
Alzheimer disease mitochondrial (AD-MT) [MIM:502500] |
MT-ND2, MT-ND1 |
Alzheimer disease 4 (AD4) [MIM:606889] |
Alzheimer disease 4 (AD4) [MIM:606889] |
PSEN2 |
Amelogenesis imperfecta |
Amelogenesis imperfecta 1H (AI1H) [MIM:616221] |
ITGB6 |
Amyloidosis |
Amyloidosis, hereditary systemic 4, Finnish type (AMYLD4) [MIM:105120] |
GSN |
Amyloidosis, hereditary systemic 6 (AMYLD6) [MIM:620659] |
B2M |
Amyloidosis, hereditary systemic 3 (AMYLD3) [MIM:620657] |
Amyloidosis, hereditary systemic 3 (AMYLD3) [MIM:620657] |
APOA1 |
Amyotrophic lateral sclerosis |
Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069] |
TARDBP |
Amyotrophic lateral sclerosis 18 (ALS18) [MIM:614808] |
PFN1 |
Amyotrophic lateral sclerosis 19 (ALS19) [MIM:615515] |
ERBB4 |
Amyotrophic lateral sclerosis 23 (ALS23) [MIM:617839] |
ANXA11 |
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030] |
FUS |
Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895] |
ANG |
Amyotrophic lateral sclerosis (ALS) [MIM:105400] |
Amyotrophic lateral sclerosis (ALS) [MIM:105400] |
DCTN1 |
Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426] |
Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426] |
HNRNPA1 |
Aniridia |
Aniridia 1 (AN1) [MIM:106210] |
PAX6 |
Antley-Bixler syndrome |
Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410] |
FGFR2 |
Aortic aneurysm |
Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788] |
ACTA2 |
Apert syndrome |
Apert syndrome (APRS) [MIM:101200] |
FGFR2 |
Arrhythmogenic right ventricular dysplasia |
Arrhythmogenic right ventricular dysplasia, familial, 13 (ARVD13) [MIM:615616] |
CTNNA3 |
Arthrogryposis |
Arthrogryposis, distal, 11 (DA11) [MIM:620019] |
MET |
Asplenia |
Asplenia, isolated congenital (ICAS) [MIM:271400] |
RPSA |
Ataxia telangiectasia |
Ataxia-telangiectasia-like disorder 1 (ATLD1) [MIM:604391] |
MRE11 |
Ataxia telangiectasia (AT) [MIM:208900] |
Ataxia telangiectasia (AT) [MIM:208900] |
ATM |
Atrial fibrillation, familial, 16 (ATFB16) [MIM:613120] |
Atrial fibrillation, familial, 16 (ATFB16) [MIM:613120] |
SCN3B |
Atrial septal defect |
Atrial fibrillation, familial, 13 (ATFB13) [MIM:615377] |
SCN1B |
Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378] |
SCN2B |
Atrial fibrillation, familial, 3 (ATFB3) [MIM:607554] |
KCNQ1 |
Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980] |
KCNJ2 |
Atrial septal defect 2 (ASD2) [MIM:607941] |
GATA4 |
Atrial standstill |
Atrial standstill 2 (ATRST2) [MIM:615745] |
NPPA |
Auriculocondylar syndrome |
Auriculocondylar syndrome 1 (ARCND1) [MIM:602483] |
GNAI3 |
Autism |
Diaphragmatic hernia 5, X-linked (DIH5) [MIM:306950] |
PLS3 |
Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features (EPILX2) [MIM:301091] |
GABRA3 |
Autoimmune disease, multisystem, infantile-onset, |
Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952] |
STAT3 |
Autoimmune disease, multisystem, infantile-onset, 2 (ADMIO2) [MIM:617006] |
ZAP70 |
Coffin-Siris syndrome 3 (CSS3) [MIM:614608] |
SMARCB1 |
Coffin-Siris syndrome 4 (CSS4) [MIM:614609] |
SMARCA4 |
Autoimmune lymphoproliferative syndrome |
Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859] |
FAS |
Autoimmune polyendocrine syndrome |
Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300] |
AIRE |
Autoinflammation, antibody deficiency, and immune dysregulation |
Autoinflammation, antibody deficiency, and immune dysregulation (APLAID) [MIM:614878] |
PLCG2 |
Autoinflammation, immune dysregulation, and eosinophilia |
Autoinflammation, immune dysregulation, and eosinophilia (AIIDE) [MIM:618999] |
JAK1 |
Axenfeld-Rieger syndrome |
Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500] |
PITX2 |
Baraitser-Winter syndrome |
Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310] |
ACTB |
Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583] |
ACTG1 |
Bardet-Biedl syndrome |
Bardet-Biedl syndrome 1 (BBS1) [MIM:209900] |
BBS1 |
Bardet-Biedl syndrome 4 (BBS4) [MIM:615982] |
BBS4 |
Bardet-Biedl syndrome 6 (BBS6) [MIM:605231] |
MKKS |
Bardet-Biedl syndrome 7 (BBS7) [MIM:615984] |
BBS7 |
Bardet-Biedl syndrome 12 (BBS12) [MIM:615989] |
Bardet-Biedl syndrome 12 (BBS12) [MIM:615989] |
BBS12 |
Basal cell nevus syndrome |
Becker nevus syndrome (BNS) [MIM:604919] |
ACTB |
Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550] |
NRAS |
Bernard-Soulier syndrome |
Bernard-Soulier syndrome (BSS) [MIM:231200] |
GP1BB |
Bethlem myopathy |
Inclusion body myopathy and brain white matter abnormalities (IBMWMA) [MIM:619733] |
ANXA11 |
Myopathy, scapulohumeroperoneal (SHPM) [MIM:616852] |
ACTA1 |
Visceral myopathy 1 (VSCM1) [MIM:155310] |
ACTG2 |
Bladder cancer |
Bladder cancer (BLC) [MIM:109800] |
FGFR3 |
Bleeding disorder |
Bleeding disorder, platelet-type, 11 (BDPLT11) [MIM:614201] |
GP6 |
Bleeding disorder, platelet-type, 13 (BDPLT13) [MIM:614009] |
TBXA2R |
Bleeding disorder, platelet-type, 16 (BDPLT16) [MIM:187800] |
ITGA2B |
Bleeding disorder, platelet-type, 24 (BDPLT24) [MIM:619271] |
ITGB3 |
Bleeding disorder, platelet-type, 8 (BDPLT8) [MIM:609821] |
P2RY12 |
Blepharocheilodontic syndrome |
Blepharocheilodontic syndrome 1 (BCDS1) [MIM:119580] |
CDH1 |
Blepharophimosis-impaired intellectual development syndrome |
Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293] |
SMARCA2 |
Bosch-Boonstra-Schaaf optic atrophy syndrome |
Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722] |
NR2F1 |
Brachycephaly, trichomegaly, and developmental delay |
Brachycephaly, trichomegaly, and developmental delay (BTDD) [MIM:617412] |
RPS23 |
Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) [MIM:617744] |
NFE2L2 |
Brachydactyly |
Brachydactyly A1, C (BDA1C) [MIM:615072] |
GDF5 |
Brachydactyly A2 (BDA2) [MIM:112600] |
GDF5 |
Brachydactyly C (BDC) [MIM:113100] |
GDF5 |
Brachydactyly E2 (BDE2) [MIM:613382] |
PTHLH |
Brachyolmia |
Brachyolmia 3 (BCYM3) [MIM:113500] |
TRPV4 |
Branchiootic syndrome |
Branchiootic syndrome 3 (BOS3) [MIM:608389] |
SIX1 |
Breast cancer |
Breast cancer (BC) [MIM:114480] |
BRCA2, BRCA1, PIK3CA, CHEK2 |
Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370] |
BRCA1 |
Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399] |
RAD51C |
Bronchiectasis |
Bronchiectasis with or without elevated sweat chloride 2 (BESC2) [MIM:613021] |
SCNN1A |
Brugada syndrome |
Brugada syndrome 1 (BRGDA1) [MIM:601144] |
SCN5A |
Bryant-Li-Bhoj neurodevelopmental syndrome |
Bryant-Li-Bhoj neurodevelopmental syndrome 2 (BRYLIB2) [MIM:619721] |
H3-3B |
Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720] |
Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720] |
H3-3B |
Buratti-Harel syndrome |
Buratti-Harel syndrome (BURHAS) [MIM:619314] |
SIAH1 |
CIMDAG syndrome |
CIMDAG syndrome (CIMDAG) [MIM:619273] |
VPS4A |
CLAPO syndrome |
CLAPO syndrome (CLAPO) [MIM:613089] |
PIK3CA |
CLOVE syndrome |
Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) [MIM:612918] |
PIK3CA |
Camptodactyly tall stature and hearing loss syndrome |
Camptodactyly, tall stature, and hearing loss syndrome (CATSHLS) [MIM:610474] |
FGFR3 |
Cardiospondylocarpofacial syndrome (CSCF) [MIM:157800] |
MAP3K7 |
Camurati-Engelmann disease |
Camurati-Engelmann disease (CAEND) [MIM:131300] |
TGFB1 |
Candidiasis |
Candidiasis, familial, 6 (CANDF6) [MIM:613956] |
IL17F |
Cardiac valvular defect, developmental |
Cardiac, facial, and digital anomalies with developmental delay (CAFDADD) [MIM:618164] |
TRAF7 |
Cardiofaciocutaneous syndrome |
Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150] |
BRAF |
Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278] |
KRAS |
Cardiofaciocutaneous syndrome 3 (CFC3) [MIM:615279] |
MAP2K1 |
Cardiomyopathy |
Cardiomyopathy, dilated, 1A (CMD1A) [MIM:115200] |
LMNA |
Cardiomyopathy, dilated, 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158] |
ACTN2 |
Cardiomyopathy, dilated, 1D (CMD1D) [MIM:601494] |
TNNT2 |
Cardiomyopathy, dilated, 1FF (CMD1FF) [MIM:613286] |
TNNI3 |
Cardiomyopathy, dilated, 1GG (CMD1GG) [MIM:613642] |
SDHA |
Cardiomyopathy, dilated, 1II (CMD1II) [MIM:615184] |
CRYAB |
Cardiomyopathy, dilated, 1NN (CMD1NN) [MIM:615916] |
RAF1 |
Cardiomyopathy, dilated, 1R (CMD1R) [MIM:613424] |
ACTC1 |
Cardiomyopathy, dilated, 1S (CMD1S) [MIM:613426] |
MYH7 |
Cardiomyopathy, dilated, 1W (CMD1W) [MIM:611407] |
VCL |
Cardiomyopathy, dilated, 1Y (CMD1Y) [MIM:611878] |
TPM1 |
Cardiomyopathy, dilated, 1Z (CMD1Z) [MIM:611879] |
TNNC1 |
Cardiomyopathy, dilated, 2H (CMD2H) [MIM:620203] |
GET3 |
Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112] |
LMNA |
Cardiomyopathy, familial hypertrophic, 10 (CMH10) [MIM:608758] |
MYL2 |
Cardiomyopathy, familial hypertrophic, 11 (CMH11) [MIM:612098] |
ACTC1 |
Cardiomyopathy, familial hypertrophic, 13 (CMH13) [MIM:613243] |
TNNC1 |
Cardiomyopathy, familial hypertrophic, 23, with or without left ventricular non-compaction (CMH23) [MIM:612158] |
ACTN2 |
Cardiomyopathy, familial hypertrophic, 3 (CMH3) [MIM:115196] |
TPM1 |
Cardiomyopathy, familial hypertrophic, 6 (CMH6) [MIM:600858] |
PRKAG2 |
Cardiomyopathy, familial hypertrophic, 7 (CMH7) [MIM:613690] |
TNNI3 |
Cardiomyopathy, familial hypertrophic, 8 (CMH8) [MIM:608751] |
MYL3 |
Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210] |
TNNI3 |
Cardiomyopathy, familial hypertrophic, 1 (CMH1) [MIM:192600] |
Cardiomyopathy, familial hypertrophic, 1 (CMH1) [MIM:192600] |
MYH7 |
Cardiomyopathy, familial hypertrophic, 4 (CMH4) [MIM:115197] |
Cardiomyopathy, familial hypertrophic, 4 (CMH4) [MIM:115197] |
MYBPC3 |
Carney complex |
Carney complex 1 (CNC1) [MIM:160980] |
PRKAR1A |
Cataract |
Cataract 23, multiple types (CTRCT23) [MIM:610425] |
CRYBA4 |
Cataract 30, multiple types (CTRCT30) [MIM:116300] |
VIM |
Cataract 31, multiple types (CTRCT31) [MIM:605387] |
CHMP4B |
Cataract 6, multiple types (CTRCT6) [MIM:116600] |
EPHA2 |
Cataract 17, multiple types (CTRCT17) [MIM:611544] |
Cataract 17, multiple types (CTRCT17) [MIM:611544] |
CRYBB1 |
Cerebellar ataxia and hypogonadotropic hypogonadism |
Gordon Holmes syndrome (GDHS) [MIM:212840] |
RNF216 |
Cerebellar atrophy, visual impairment, and psychomotor retardation |
Cerebellar ataxia, brain abnormalities, and cardiac conduction defects (CABAC) [MIM:619576] |
EXOSC5 |
Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures (NEDHCAS) [MIM:618879] |
PIGK |
Spastic paraplegia 88, autosomal dominant (SPG88) [MIM:620106] |
KPNA3 |
Spastic paraplegia 90A, autosomal dominant (SPG90A) [MIM:620416] |
SPTSSA |
Cerebellar atrophy, visual impairment, and psychomotor retardation (CAVIPMR) [MIM:616875] |
Cerebellar atrophy, visual impairment, and psychomotor retardation (CAVIPMR) [MIM:616875] |
EMC1 |
Cerebral amyloid angiopathy |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
APP |
Cerebral arteriopathy |
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310] |
NOTCH3 |
Cerebral cavernous malformations |
Cerebral cavernous malformations 1 (CCM1) [MIM:116860] |
KRIT1 |
Cerebral cavernous malformations 2 (CCM2) [MIM:603284] |
CCM2 |
Cerebral cavernous malformations 4 (CCM4) [MIM:619538] |
PIK3CA |
Cerebrocostomandibular syndrome |
Cerebrocostomandibular syndrome (CCMS) [MIM:117650] |
SNRPB |
Cerebrooculofacioskeletal syndrome |
Cerebro-oculo-facio-skeletal syndrome 2 (COFS2) [MIM:610756] |
ERCC2 |
Cerebro-oculo-facio-skeletal syndrome 4 (COFS4) [MIM:610758] |
ERCC1 |
Cerebroretinal microangiopathy with calcifications and cysts |
Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199] |
CTC1 |
Cerebroretinal microangiopathy with calcifications and cysts 2 (CRMCC2) [MIM:617341] |
STN1 |
Cervical cancer |
Cervical cancer (CERCA) [MIM:603956] |
FGFR3 |
Charcot-Marie-Tooth disease |
Charcot-Marie-Tooth disease, X-linked recessive, 5 (CMTX5) [MIM:311070] |
PRPS1 |
Charcot-Marie-Tooth disease, demyelinating, 1H (CMT1H) [MIM:619764] |
FBLN5 |
Charcot-Marie-Tooth disease, demyelinating, 1I (CMT1I) [MIM:619742] |
POLR3B |
Charcot-Marie-Tooth disease, demyelinating, 1J (CMT1J) [MIM:620111] |
ITPR3 |
Charcot-Marie-Tooth disease, dominant intermediate G (CMTDIG) [MIM:617882] |
NEFL |
Cherubism |
Cherubism (CRBM) [MIM:118400] |
SH3BP2 |
Childhood cancer retinoblastoma (RB) [MIM:180200] |
Childhood cancer retinoblastoma (RB) [MIM:180200] |
RB1 |
Chronic granulomatous disease |
Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400] |
CYBB |
Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710] |
NCF2 |
Chronic infantile neurologic cutaneous and articular syndrome |
Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
NLRP3 |
Chronic recurrent multifocal osteomyelitis 3 |
Chronic recurrent multifocal osteomyelitis 3 (CRMO3) [MIM:259680] |
IL1R1 |
Cirrhosis |
Cirrhosis (CIRRH) [MIM:215600] |
KRT8 |
Coagulation factor deficiency |
Factor II deficiency (FA2D) [MIM:613679] |
F2 |
Factor XII deficiency (FA12D) [MIM:234000] |
F12 |
Cockayne syndrome |
Cockayne syndrome A (CSA) [MIM:216400] |
ERCC8 |
Cockayne syndrome B (CSB) [MIM:133540] |
ERCC6 |
Coffin-Lowry syndrome |
Coffin-Lowry syndrome (CLS) [MIM:303600] |
RPS6KA3 |
Coffin-Siris syndrome 10 |
Coffin-Siris syndrome 11 (CSS11) [MIM:618779] |
SMARCD1 |
Coffin-Siris syndrome 8 (CSS8) [MIM:618362] |
Coffin-Siris syndrome 8 (CSS8) [MIM:618362] |
SMARCC2 |
Cohen-Gibson syndrome |
Cohen-Gibson syndrome (COGIS) [MIM:617561] |
EED |
Cold-induced sweating syndrome |
Crisponi/Cold-induced sweating syndrome 1 (CISS1) [MIM:272430] |
CRLF1 |
Crisponi/Cold-induced sweating syndrome 2 (CISS2) [MIM:610313] |
CLCF1 |
Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness |
Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness (COMMAD) [MIM:617306] |
MITF |
Colorectal cancer |
Hereditary non-polyposis colorectal cancer 6 (HNPCC6) [MIM:614331] |
TGFBR2 |
Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470] |
NRAS, HRAS |
Colorectal cancer (CRC) [MIM:114500] |
Colorectal cancer (CRC) [MIM:114500] |
BRAF, CTNNB1, MLH1, MT-CO1, PIK3CA |
Combined immunodeficiency |
Immunodeficiency 107, susceptibility to invasive Staphylococcus aureus infection (IMD107) [MIM:619986] |
OTULIN |
Immunodeficiency 120 (IMD120) [MIM:620836] |
POLD1 |
Immunodeficiency 84 (IMD84) [MIM:619437] |
IKZF3 |
Immunodeficiency 85 (IMD85) [MIM:619510] |
TOM1 |
Immunodeficiency 97 with autoinflammation (IMD97) [MIM:619802] |
PIK3CG |
Immunodeficiency 98 with autoinflammation, X-linked (IMD98) [MIM:301078] |
TLR8 |
Combined oxidative phosphorylation |
Combined oxidative phosphorylation deficiency 30 (COXPD30) [MIM:616974] |
TRMT10C |
Combined oxidative phosphorylation deficiency 33 (COXPD33) [MIM:617713] |
C1QBP |
Combined oxidative phosphorylation deficiency |
Combined oxidative phosphorylation deficiency 19 (COXPD19) [MIM:615595] |
LYRM4 |
Combined oxidative phosphorylation deficiency 36 (COXPD36) [MIM:617950] |
MRPS2 |
Combined oxidative phosphorylation deficiency 38 (COXPD38) [MIM:618378] |
MRPS14 |
Combined oxidative phosphorylation deficiency 5 (COXPD5) [MIM:611719] |
MRPS22 |
Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 (HUMOP2) [MIM:620085] |
ATP5F1B |
Combined oxidative phosphorylation deficiency 54 (COXPD54) [MIM:619737] |
Combined oxidative phosphorylation deficiency 54 (COXPD54) [MIM:619737] |
PRORP |
Combined oxidative phosphorylation deficiency 55 (COXPD55) [MIM:619743] |
Combined oxidative phosphorylation deficiency 55 (COXPD55) [MIM:619743] |
POLRMT |
Combined oxidative phosphorylation deficiency 58 (COXPD58) [MIM:620451] |
Combined oxidative phosphorylation deficiency 58 (COXPD58) [MIM:620451] |
TEFM |
Combined oxidative phosphorylation deficiency II |
Combined oxidative phosphorylation deficiency 43 (COXPD43) [MIM:618851] |
TIMM22 |
Combined oxidative phosphorylation deficiency 46 (COXPD46) [MIM:618952] |
MRPS23 |
Combined oxidative phosphorylation deficiency 47 (COXPD47) [MIM:618958] |
MRPS28 |
Combined oxidative phosphorylation deficiency 50 (COXPD50) [MIM:619025] |
MRPS25 |
Combined oxidative phosphorylation deficiency 52 (COXPD52) [MIM:619386] |
NFS1 |
Complement component deficiency |
C1q deficiency 2 (C1QD2) [MIM:620321] |
C1QB |
C1q deficiency 3 (C1QD3) [MIM:620322] |
C1QC |
Complement component 7 deficiency (C7D) [MIM:610102] |
C7 |
MHC class II deficiency 2 (MHC2D2) [MIM:620815] |
RFXANK |
Complement factors deficiency |
Complement factor I deficiency (CFI deficiency) [MIM:610984] |
CFI |
Cone-rod dystrophy |
Cone dystrophy 4 (COD4) [MIM:613093] |
PDE6C |
Corneal dystrophy, punctiform and polychromatic pre-Descemet (PPPCD) [MIM:619871] |
PRDX3 |
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 (MRCS1) [MIM:619082] |
ARL2 |
Congenital bilateral absence of the vas deferens |
Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
CFTR |
Congenital clubfoot |
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly (CCF) [MIM:119800] |
PITX1 |
Congenital heart defects |
Congenital heart defects and skeletal malformations syndrome (CHDSKM) [MIM:617602] |
ABL1 |
Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159] |
CHD4 |
Takenouchi-Kosaki syndrome (TKS) [MIM:616737] |
CDC42 |
Congenital heart defects and ectodermal dysplasia |
Congenital heart defects and ectodermal dysplasia (CHDED) [MIM:617364] |
PRKD1 |
Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder |
Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) [MIM:617360] |
CDK13 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
ACTB |
Congenital stationary night blindness |
Night blindness, congenital stationary, 1E (CSNB1E) [MIM:614565] |
GPR179 |
Corneal dystrophy |
Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200] |
TGFBI |
Corneal dystrophy, lattice type 3A (CDL3A) [MIM:608471] |
TGFBI |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
KRT12 |
Cornelia de Lange syndrome |
Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470] |
NIPBL |
Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590] |
SMC1A |
Cornelia de Lange syndrome 4 with or without midline brain defects (CDLS4) [MIM:614701] |
RAD21 |
Cortical dysplasia complex with other brain malformations |
Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039] |
TUBB3 |
Cortical dysplasia, complex, with other brain malformations 4 (CDCBM4) [MIM:615412] |
TUBG1 |
Cortical dysplasia, complex, with other brain malformations 5 (CDCBM5) [MIM:615763] |
TUBB2A |
Cortical dysplasia, complex, with other brain malformations 6 (CDCBM6) [MIM:615771] |
TUBB |
Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031] |
TUBB2B |
Cowden disease |
Cowden syndrome 1 (CWS1) [MIM:158350] |
PTEN |
Cowden syndrome 5 (CWS5) [MIM:615108] |
PIK3CA |
Cowden syndrome 6 (CWS6) [MIM:615109] |
AKT1 |
Craniosynostosis |
Craniosynostosis 2 (CRS2) [MIM:604757] |
MSX2 |
Craniosynostosis 3 (CRS3) [MIM:615314] |
TCF12 |
Craniosynostosis and dental anomalies (CRSDA) [MIM:614188] |
IL11RA |
Trigonocephaly 1 (TRIGNO1) [MIM:190440] |
FGFR1 |
Crouzon syndrome |
Crouzon syndrome (CS) [MIM:123500] |
FGFR2 |
Crouzon syndrome with acanthosis nigricans (CAN) [MIM:612247] |
FGFR3 |
Cutis laxa |
Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100] |
FBLN5 |
Cutis laxa, autosomal recessive, 2C (ARCL2C) [MIM:617402] |
ATP6V1E1 |
Cutis laxa, autosomal recessive, 2D (ARCL2D) [MIM:617403] |
ATP6V1A |
Cyanosis |
Cyanosis transient neonatal (TNCY) [MIM:613977] |
HBG2 |
Cystic fibrosis (CF) [MIM:219700] |
Cystic fibrosis (CF) [MIM:219700] |
CFTR |
D-2-hydroxyglutaric aciduria |
D-2-hydroxyglutaric aciduria 2 (D2HGA2) [MIM:613657] |
IDH2 |
Deafness |
Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717] |
ACTG1 |
Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101] |
KCNQ4 |
Deafness, autosomal dominant, 64 (DFNA64) [MIM:614152] |
DIABLO |
Deafness, autosomal dominant, 70 (DFNA70) [MIM:616968] |
MCM2 |
Deafness, autosomal recessive, 35 (DFNB35) [MIM:608565] |
ESRRB |
Deafness, autosomal recessive, 68 (DFNB68) [MIM:610419] |
S1PR2 |
Deafness, autosomal recessive, 89 (DFNB89) [MIM:613916] |
KARS1 |
Deafness, congenital, and adult-onset progressive leukoencephalopathy (DEAPLE) [MIM:619196] |
KARS1 |
Leukodystrophy, hypomyelinating, 21 (HLD21) [MIM:619310] |
POLR3K |
Leukoencephalopathy, progressive, infantile-onset, with or without deafness (LEPID) [MIM:619147] |
KARS1 |
Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities (NEDSPLB) [MIM:616531] |
PI4KA |
Dehydrated hereditary stomatocytosis 2 |
Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema (DHS1) [MIM:194380] |
PIEZO1 |
Dejerine-Sottas syndrome |
Leber-like hereditary optic neuropathy, autosomal recessive 2 (LHONAR2) [MIM:620569] |
NDUFS2 |
Visceral neuropathy, familial, 1, autosomal recessive (VSCN1) [MIM:243180] |
ERBB3 |
Visceral neuropathy, familial, 2, autosomal recessive (VSCN2) [MIM:619465] |
ERBB2 |
Dementia |
Dementia, Lewy body (DLB) [MIM:127750] |
SNCA |
Frontotemporal dementia (FTD) [MIM:600274] |
PSEN1, MAPT |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437] |
SQSTM1 |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439] |
TBK1 |
Parkinsonism with polyneuropathy (PKNPY) [MIM:619279] |
UQCRC1 |
Denys-Drash syndrome |
Denys-Drash syndrome (DDS) [MIM:194080] |
WT1 |
Developmental and epileptic encephalopathy 108 (DEE108) [MIM:620115] |
Developmental and epileptic encephalopathy 108 (DEE108) [MIM:620115] |
MAST3 |
Diabetes insipidus |
Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800] |
AVPR2 |
Diabetes mellitus |
Bone marrow failure syndrome 6 (BMFS6) [MIM:618849] |
MDM4 |
Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858] |
INS |
Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
INSR |
Maturity-onset diabetes of the young 13 (MODY13) [MIM:616329] |
KCNJ11 |
Pulmonary fibrosis, and/or bone marrow failure syndrome, telomere-related, 1 (PFBMFT1) [MIM:614742] |
TERT |
Pulmonary fibrosis, and/or bone marrow failure syndrome, telomere-related, 5 (PFBMFT5) [MIM:618674] |
ZCCHC8 |
Type 1 diabetes mellitus 2 (T1D2) [MIM:125852] |
INS |
Type 2 diabetes mellitus (T2D) [MIM:125853] |
INSR |
Diamond-Blackfan anemia |
Diamond-Blackfan anemia 13 (DBA13) [MIM:615909] |
RPS29 |
Digital arthropathy-brachydactyly |
Digital arthropathy-brachydactyly, familial (FDAB) [MIM:606835] |
TRPV4 |
Dihydrolipoamide dehydrogenase deficiency |
Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900] |
DLD |
Disabling pansclerotic morphea of childhood |
Disabling pansclerotic morphea of childhood (DPMC) [MIM:620443] |
STAT4 |
Dysfibrinogenemia |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
FGA, FGG, FGB |
Dyskeratosis congenita |
Autoinflammation with arthritis and dyskeratosis (AIADK) [MIM:617388] |
NLRP1 |
Dyskeratosis congenita, X-linked (DKCX) [MIM:305000] |
DKC1 |
Dyskeratosis congenita, autosomal recessive, 3 (DKCB3) [MIM:613988] |
WRAP53 |
Dystonia |
Dystonia 2, torsion, autosomal recessive (DYT2) [MIM:224500] |
HPCA |
Dystonia 4, torsion, autosomal dominant (DYT4) [MIM:128101] |
TUBB4A |
Epilepsy, progressive myoclonic 9 (EPM9) [MIM:616540] |
LMNB2 |
Hypermanganesemia with dystonia 1 (HMNDYT1) [MIM:613280] |
SLC30A10 |
Dystonia-deafness syndrome 1 |
Dystonia-deafness syndrome 1 (DDS1) [MIM:607371] |
ACTB |
Ectodermal dysplasia |
Ectodermal dysplasia 7, hair/nail type (ECTD7) [MIM:614929] |
KRT74 |
Ectodermal dysplasia and immunodeficiency 1 (EDAID1) [MIM:300291] |
IKBKG |
Ectodermal dysplasia and immunodeficiency 2 (EDAID2) [MIM:612132] |
NFKBIA |
Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies (EDFAOB) [MIM:618727] |
RHOA |
Ectrodactyly-ectodermal dysplasia |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292] |
TP63 |
Ehlers-Danlos syndrome |
Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050] |
COL3A1 |
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome (PMGEDSV) [MIM:618343] |
COL3A1 |
Elliptocytosis |
Elliptocytosis 2 (EL2) [MIM:130600] |
SPTA1 |
Elliptocytosis 3 (EL3) [MIM:617948] |
SPTB |
Emery-Dreifuss muscular dystrophy |
Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516] |
LMNA |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350] |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350] |
LMNA |
Encephalitis, acute, infection-induced, 12 (IIAE12) [MIM:620461] |
Encephalitis, acute, infection-induced, 12 (IIAE12) [MIM:620461] |
RNH1 |
Encephalocraniocutaneous lipomatosis |
Encephalocraniocutaneous lipomatosis (ECCL) [MIM:613001] |
FGFR1 |
Enhanced S cone syndrome |
Enhanced S cone syndrome (ESCS) [MIM:268100] |
NR2E3 |
Epidermolysis bullosa |
Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760] |
KRT14 |
Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900] |
KRT14 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
KRT14 |
Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive (EBS1D) [MIM:601001] |
KRT14 |
Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555] |
KRT5 |
Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588] |
KRT5 |
Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594] |
KRT5 |
Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive (EBS2D) [MIM:619599] |
KRT5 |
Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) [MIM:226730] |
ITGB4 |
Epidermolytic hyperkeratosis |
Epidermolytic hyperkeratosis 1 (EHK1) [MIM:113800] |
KRT1 |
Epidermolytic hyperkeratosis 2A (EHK2A) [MIM:620150] |
KRT10 |
Epilepsy |
Developmental and epileptic encephalopathy 104 (DEE104) [MIM:619970] |
ATP6V0A1 |
Developmental and epileptic encephalopathy 109 (DEE109) [MIM:620145] |
FZR1 |
Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721] |
SCN2A |
Developmental and epileptic encephalopathy 111 (DEE111) [MIM:620504] |
DEPDC5 |
Developmental and epileptic encephalopathy 17 (DEE17) [MIM:615473] |
GNAO1 |
Developmental and epileptic encephalopathy 19 (DEE19) [MIM:615744] |
GABRA1 |
Developmental and epileptic encephalopathy 2 (DEE2) [MIM:300672] |
CDKL5 |
Developmental and epileptic encephalopathy 26 (DEE26) [MIM:616056] |
KCNB1 |
Developmental and epileptic encephalopathy 27 (DEE27) [MIM:616139] |
GRIN2B |
Developmental and epileptic encephalopathy 31A (DEE31A) [MIM:616346] |
DNM1 |
Developmental and epileptic encephalopathy 33 (DEE33) [MIM:616409] |
EEF1A2 |
Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164] |
STXBP1 |
Developmental and epileptic encephalopathy 44 (DEE44) [MIM:617132] |
UBA5 |
Developmental and epileptic encephalopathy 46 (DEE46) [MIM:617162] |
GRIN2D |
Developmental and epileptic encephalopathy 5 (DEE5) [MIM:613477] |
SPTAN1 |
Developmental and epileptic encephalopathy 56 (DEE56) [MIM:617665] |
YWHAG |
Developmental and epileptic encephalopathy 59 (DEE59) [MIM:617904] |
GABBR2 |
Developmental and epileptic encephalopathy 65 (DEE65) [MIM:618008] |
CYFIP2 |
Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396] |
GABRG2 |
Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557] |
GABRA2 |
Developmental and epileptic encephalopathy 99 (DEE99) [MIM:619606] |
ATP1A3 |
Epilepsy, childhood absence 2 (ECA2) [MIM:607681] |
GABRG2 |
Epilepsy, childhood absence 5 (ECA5) [MIM:612269] |
GABRB3 |
Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364] |
DEPDC5 |
Epilepsy, idiopathic generalized 13 (EIG13) [MIM:611136] |
GABRA1 |
Epilepsy, idiopathic generalized 17 (EIG17) [MIM:602477] |
HCN2 |
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions (EPM3) [MIM:611726] |
KCTD7 |
Epilepsy, progressive myoclonic 7 (EPM7) [MIM:616187] |
KCNC1 |
Generalized epilepsy with febrile seizures plus 10 (GEFSP10) [MIM:618482] |
HCN1 |
Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403] |
SCN1A |
Generalized epilepsy with febrile seizures plus 3 (GEFSP3) [MIM:607681] |
GABRG2 |
Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172] |
STX1B |
Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
SCN1A |
Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136] |
GABRA1 |
Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy (PNKD3) [MIM:609446] |
KCNMA1 |
Epilepsy, early-onset, 3, with or without developmental delay (EPEO3) [MIM:620465] |
Epilepsy, early-onset, 3, with or without developmental delay (EPEO3) [MIM:620465] |
ATP6V0C |
Epileptic encephalopathy |
Epileptic encephalopathy, infantile or early childhood, 2 (IECEE2) [MIM:617829] |
GABRB2 |
Epiphyseal chondrodysplasia, Miura type |
Epiphyseal chondrodysplasia, Miura type (ECDM) [MIM:615923] |
NPR2 |
Episodic ataxia |
Episodic ataxia 2 (EA2) [MIM:108500] |
CACNA1A |
Episodic pain syndrome |
Episodic pain syndrome, familial, 1 (FEPS1) [MIM:615040] |
TRPA1 |
Erythermalgia |
Primary erythermalgia (PERYTHM) [MIM:133020] |
SCN9A |
Erythrocytosis |
Erythrocytosis, familial, 2 (ECYT2) [MIM:263400] |
VHL |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
EPAS1 |
Estrogen resistance |
Estrogen resistance (ESTRR) [MIM:615363] |
ESR1 |
Exudative vitreoretinopathy |
Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780] |
FZD4 |
FG syndrome |
FG syndrome 4 (FGS4) [MIM:300422] |
CASK |
Facial paresis |
Facial paresis, hereditary congenital, 3 (HCFP3) [MIM:614744] |
HOXB1 |
Faciocutaneoskeletal syndrome |
Costello syndrome (CSTLO) [MIM:218040] |
HRAS |
Factor X deficiency (FA10D) [MIM:227600] |
Factor X deficiency (FA10D) [MIM:227600] |
F10 |
Factor XIII subunit B deficiency (FA13BD) [MIM:613235] |
Factor XIII subunit B deficiency (FA13BD) [MIM:613235] |
F13B |
Familial Mediterranean fever |
Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100] |
MEFV |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
APC |
Familial advanced sleep-phase syndrome |
Advanced sleep phase syndrome, familial, 2 (FASPS2) [MIM:615224] |
CSNK1D |
Familial cold autoinflammatory syndrome |
Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100] |
NLRP3 |
Proteasome-associated autoinflammatory syndrome 6 (PRAAS6) [MIM:620796] |
PSMB9 |
Familial hyperproinsulinemia |
Hyperproinsulinemia (HPRI) [MIM:616214] |
INS |
Fanconi anemia |
Fanconi anemia complementation group D1 (FANCD1) [MIM:605724] |
BRCA2 |
Fanconi anemia complementation group I (FANCI) [MIM:609053] |
FANCI |
Fanconi anemia complementation group Q (FANCQ) [MIM:615272] |
ERCC4 |
Fanconi anemia complementation group T (FANCT) [MIM:616435] |
UBE2T |
Fanconi anemia, complementation group R (FANCR) [MIM:617244] |
RAD51 |
Fanconi anemia, complementation group S (FANCS) [MIM:617883] |
BRCA1 |
Faundes-Banka syndrome |
Faundes-Banka syndrome (FABAS) [MIM:619376] |
EIF5A |
Feingold syndrome |
Feingold syndrome 1 (FGLDS1) [MIM:164280] |
MYCN |
Fibrodysplasia ossificans progressiva |
Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
ACVR1 |
Fibrosis of extraocular muscles |
Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700] |
KIF21A |
Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638] |
TUBB3 |
Focal cortical dysplasia 2 (FCORD2) [MIM:607341] |
Focal cortical dysplasia 2 (FCORD2) [MIM:607341] |
TSC1 |
Focal segmental glomerulosclerosis |
Focal segmental glomerulosclerosis 2 (FSGS2) [MIM:603965] |
TRPC6 |
Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278] |
Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278] |
ACTN4 |
Fragile X syndrome |
Fragile X syndrome (FXS) [MIM:300624] |
FMR1 |
Frontometaphyseal dysplasia |
Frontometaphyseal dysplasia 2 (FMD2) [MIM:617137] |
MAP3K7 |
Frontotemporal |
Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia (ALS12) [MIM:613435] |
OPTN |
Amyotrophic lateral sclerosis 27, juvenile (ALS27) [MIM:620285] |
SPTLC1 |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 (FTDALS6) [MIM:613954] |
VCP |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 (FTDALS7) [MIM:600795] |
CHMP2B |
GM1/2-gangliosidosis |
GM1-gangliosidosis 1 (GM1G1) [MIM:230500] |
GLB1 |
GM1-gangliosidosis 2 (GM1G2) [MIM:230600] |
GLB1 |
Gabriele-de Vries syndrome |
Gabriele-de Vries syndrome (GADEVS) [MIM:617557] |
YY1 |
Galactosialidosis |
Galactosialidosis (GSL) [MIM:256540] |
CTSA |
Galloway-Mowat syndrome |
Galloway-Mowat syndrome 2, X-linked (GAMOS2) [MIM:301006] |
LAGE3 |
Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729] |
OSGEP |
Galloway-Mowat syndrome 4 (GAMOS4) [MIM:617730] |
TP53RK |
Gastric cancer |
Diffuse gastric and lobular breast cancer syndrome (DGLBC) [MIM:137215] |
CDH1 |
Gastric cancer (GASC) [MIM:613659] |
KRAS |
Gaucher disease |
Gaucher disease, atypical, due to saposin C deficiency (GDSAPC) [MIM:610539] |
PSAP |
Germ cell tumor |
Testicular germ cell tumor (TGCT) [MIM:273300] |
FGFR3, STK11 |
Glanzmann thrombasthenia |
Glanzmann thrombasthenia 1 (GT1) [MIM:273800] |
ITGA2B |
Glanzmann thrombasthenia 2 (GT2) [MIM:619267] |
ITGB3 |
Glaucoma 1, open angle, E (GLC1E) [MIM:137760] |
Glaucoma 1, open angle, E (GLC1E) [MIM:137760] |
OPTN |
Glioma (GLM) [MIM:137800] |
Glioma (GLM) [MIM:137800] |
H3-3B, H3C12, IDH2 |
Glomerulopathy |
Lipoprotein glomerulopathy (LPG) [MIM:611771] |
APOE |
Glucocorticoid deficiency |
Glucocorticoid deficiency 1 (GCCD1) [MIM:202200] |
MC2R |
Glucocorticoid resistance, generalized (GCCR) [MIM:615962] |
Glucocorticoid resistance, generalized (GCCR) [MIM:615962] |
NR3C1 |
Glutaric aciduria |
Glutaric aciduria 2B (GA2B) [MIM:231680] |
ETFB |
Glycine encephalopathy |
Encephalopathy, acute, infection-induced, 7, herpes-specific (IIAE7) [MIM:616532] |
IRF3 |
Encephalopathy, acute, infection-induced, 8, herpes-specific (IIAE8) [MIM:617900] |
TBK1 |
Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis (PEERB) [MIM:618331] |
TRAPPC2L |
Glycogen storage disease of heart |
Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740] |
PRKAG2 |
Glycosylphosphatidylinositol biosynthesis defect |
Glycosylphosphatidylinositol biosynthesis defect 15 (GPIBD15) [MIM:617810] |
GPAA1 |
Glycosylphosphatidylinositol biosynthesis defect 18 (GPIBD18) [MIM:618143] |
PIGS |
Growth hormone deficiency |
Growth hormone deficiency, isolated partial (GHDP) [MIM:615925] |
GHSR |
Growth hormone deficiency, isolated, 2 (IGHD2) [MIM:173100] |
GH1 |
Growth hormone insensitivity |
Growth hormone insensitivity syndrome with immune dysregulation 1, autosomal recessive (GHISID1) [MIM:245590] |
STAT5B |
Growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant (GHISID2) [MIM:618985] |
STAT5B |
Growth hormone insensitivity, partial (GHIP) [MIM:604271] |
GHR |
Growth retardation |
Intellectual developmental disorder with persistence of fetal hemoglobin (IDPFH) [MIM:617101] |
BCL11A |
Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062] |
CSNK2A1 |
Hao-Fountain syndrome |
Hao-Fountain syndrome (HAFOUS) [MIM:616863] |
USP7 |
Hartnup disorder |
Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570] |
GRIN2A |
Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia (MICPCH) [MIM:300749] |
CASK |
Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures (NEDHSS) [MIM:620455] |
EIF4A2 |
Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures (NEDHCS) [MIM:614501] |
SNIP1 |
Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854] |
GNAI1 |
Neurodevelopmental disorder with or without variable movement or behavioral abnormalities (NEDMAB) [MIM:619725] |
KCNN2 |
Neurodevelopmental disorder with speech impairment and dysmorphic facies (NEDSID) [MIM:619056] |
SETD1A |
Hartsfield syndrome |
Hartsfield syndrome (HRTFDS) [MIM:615465] |
FGFR1 |
Hemangioma capillary infantile |
Hemangioma, capillary infantile (HCI) [MIM:602089] |
FLT4 |
Hemifacial myohyperplasia |
Hemifacial myohyperplasia (HFMH) [MIM:606773] |
PIK3CA |
Hemorrhagic telangiectasia |
Telangiectasia, hereditary hemorrhagic, 5 (HHT5) [MIM:615506] |
GDF2 |
Hepatocellular carcinoma |
Hepatocellular carcinoma (HCC) [MIM:114550] |
PIK3CA, MET |
Hermansky-Pudlak syndrome |
Hermansky-Pudlak syndrome 2 (HPS2) [MIM:608233] |
AP3B1 |
Hiatt-Neu-Cooper neurodevelopmental syndrome |
Hiatt-Neu-Cooper neurodevelopmental syndrome (HINCONS) [MIM:619311] |
RALA |
Hirschsprung disease |
Hirschsprung disease 1 (HSCR1) [MIM:142623] |
RET |
Hirschsprung disease 3 (HSCR3) [MIM:613711] |
GDNF |
Holt-Oram syndrome |
Holt-Oram syndrome (HOS) [MIM:142900] |
TBX5 |
Houge-Janssens syndrome |
Houge-Janssens syndrome 1 (HJS1) [MIM:616355] |
PPP2R5D |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
PPP2R1A |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
PPP2CA |
Hoyeraal-Hreidarsson syndrome |
Hoyeraal-Hreidarsson syndrome (HHS) [MIM:305000] |
DKC1 |
Humerofemoral hypoplasia with radiotibial ray deficiency |
Humerofemoral hypoplasia with radiotibial ray deficiency (HHRRD) [MIM:618022] |
RSPO2 |
Hutchinson-Gilford progeria syndrome |
Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
LMNA |
Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections (HIES1) [MIM:147060] |
Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections (HIES1) [MIM:147060] |
STAT3 |
Hypercholanemia |
Hypercholanemia, familial, 1 (FHCA1) [MIM:607748] |
TJP2 |
Hypercholesterolemia |
Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776] |
PCSK9 |
Hyperinsulinemic hypoglycemia |
Hyperinsulinemic hypoglycemia, familial, 5 (HHF5) [MIM:609968] |
INSR |
Hyperinsulinemic hypoglycemia, familial, 6 (HHF6) [MIM:606762] |
GLUD1 |
Hyperoxaluria |
Hyperoxaluria primary 1 (HP1) [MIM:259900] |
AGXT |
Hyperparathyroidism |
Hyperparathyroidism, neonatal severe (NSHPT) [MIM:239200] |
CASR |
Hyperparathyroidism, transient neonatal (HRPTTN) [MIM:618188] |
TRPV6 |
Hyperphenylalaninemia |
Hyperphenylalaninemia, BH4-deficient, B (HPABH4B) [MIM:233910] |
GCH1 |
Hyperthyroidism |
Familial gestational hyperthyroidism (HTFG) [MIM:603373] |
TSHR |
Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152] |
TSHR |
Hyperthyroxinemia, dystransthyretinemic |
Hyperthyroxinemia, dystransthyretinemic (DTTRH) [MIM:145680] |
TTR |
Hypocalcemia |
Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198] |
CASR |
Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361] |
GNA11 |
Hypochondroplasia |
Hypochondroplasia (HCH) [MIM:146000] |
FGFR3 |
Hypogonadotropic hypogonadism |
Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] |
FGFR1 |
Hypogonadotropic hypogonadism 24 with or without anosmia (HH24) [MIM:229070] |
FSHB |
Hypomagnesemia |
Hypomagnesemia 2 (HOMG2) [MIM:154020] |
FXYD2 |
Hypomagnesemia, seizures, and impaired intellectual development 2 (HOMGSMR2) [MIM:618314] |
ATP1A1 |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281] |
DARS1 |
Hypophosphataemic rickets |
Hypophosphatemic rickets, autosomal dominant (ADHR) [MIM:193100] |
FGF23 |
Hypothyroidism |
Hypothyroidism, congenital, non-goitrous, 4 (CHNG4) [MIM:275100] |
TSHB |
Hypothyroidism, congenital, non-goitrous, 5 (CHNG5) [MIM:225250] |
NKX2-5 |
Hypothyroidism, congenital, non-goitrous, 7 (CHNG7) [MIM:618573] |
TRHR |
Hypotonia, infantile, with psychomotor retardation |
Hypotonia, infantile, with psychomotor retardation and characteristic facies 2 (IHPRF2) [MIM:616801] |
UNC80 |
Hypotrichosis |
Hypotrichosis 11 (HYPT11) [MIM:615059] |
SNRPE |
Ichthyosis |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
KRT2 |
Ichthyosis, annular epidermolytic, 1 (AEI1) [MIM:607602] |
KRT10 |
Ichthyosis, annular epidermolytic, 2 (AEI2) [MIM:620148] |
KRT1 |
Ichthyosis, congenital, autosomal recessive 11 (ARCI11) [MIM:602400] |
ST14 |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
SUZ12 |
Immunodeficiency |
Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation (IDAIL) [MIM:616100] |
CTLA4 |
Immunodeficiency 10 (IMD10) [MIM:612783] |
STIM1 |
Immunodeficiency 11B with atopic dermatitis (IMD11B) [MIM:617638] |
CARD11 |
Immunodeficiency 16 (IMD16) [MIM:615593] |
TNFRSF4 |
Immunodeficiency 20 (IMD20) [MIM:615707] |
FCGR3A |
Immunodeficiency 26 with or without neurologic abnormalities (IMD26) [MIM:615966] |
PRKDC |
Immunodeficiency 27A (IMD27A) [MIM:209950] |
IFNGR1 |
Immunodeficiency 28 (IMD28) [MIM:614889] |
IFNGR2 |
Immunodeficiency 31A (IMD31A) [MIM:614892] |
STAT1 |
Immunodeficiency 31B (IMD31B) [MIM:613796] |
STAT1 |
Immunodeficiency 33 (IMD33) [MIM:300636] |
IKBKG |
Immunodeficiency 50 (IMD50) [MIM:300988] |
MSN |
Immunodeficiency 60 and autoimmunity (IMD60) [MIM:618394] |
BACH2 |
Immunodeficiency 67 (IMD67) [MIM:607676] |
IRAK4 |
Immunodeficiency 68 (IMD68) [MIM:612260] |
MYD88 |
Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia (IMD73B) [MIM:618986] |
RAC2 |
Immunodeficiency 82 with systemic inflammation (IMD82) [MIM:619381] |
SYK |
Immunodeficiency 9 (IMD9) [MIM:612782] |
ORAI1 |
Immunodeficiency 112 (IMD112) [MIM:620449] |
Immunodeficiency 112 (IMD112) [MIM:620449] |
MAP3K14 |
Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome |
Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790] |
FOXP3 |
Immunodeficiency-centromeric instability-facial anomalies syndrome |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1) [MIM:242860] |
DNMT3B |
Immunoglobulin kappa light chain deficiency |
Immunoglobulin kappa light chain deficiency (IGKCD) [MIM:614102] |
IGKC |
Inclusion body myopathy |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 (IBMPFD2) [MIM:615422] |
HNRNPA2B1 |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 (IBMPFD3) [MIM:615424] |
HNRNPA1 |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320] |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320] |
VCP |
Incontinentia pigmenti |
Incontinentia pigmenti (IP) [MIM:308300] |
IKBKG |
Infections recurrent associated with encephalopathy hepatic dysfunction and cardiovascular malformations |
Infections, recurrent, associated with encephalopathy, hepatic dysfunction and cardiovascular malformations (IEHDCM) [MIM:613759] |
FADD |
Inflammatory bowel disease |
Inflammatory bowel disease, immunodeficiency, and encephalopathy (IBDIMDE) [MIM:618213] |
TGFB1 |
Insensitivity to pain |
Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
NTRK1 |
Indifference to pain, congenital, autosomal recessive (CIP) [MIM:243000] |
SCN9A |
Insulin-like growth factor 1 resistance |
Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450] |
IGF1R |
Intellectual developmental disorder with dysmorphic facies and ptosis |
Intellectual developmental disorder with hypertelorism and distinctive facies (IDDHDF) [MIM:618147] |
CCNK |
Intellectual developmental disorder with macrocephaly, seizures, and speech delay (IDDMSSD) [MIM:618158] |
PAK1 |
Intellectual developmental disorder with hypotonia and behavioral abnormalities |
Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748] |
CDK8 |
Intellectual developmental disorder with impaired language and dysmorphic facies |
Intellectual developmental disorder with impaired language and dysmorphic facies (IDDILF) [MIM:618653] |
DDX6 |
Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism (IDLDP) [MIM:619911] |
Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism (IDLDP) [MIM:619911] |
NR4A2 |
Intellectual developmental disorder, X-linked, syndromic, |
Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type (MRXSSB) [MIM:300958] |
DDX3X |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
TRIO |
Intellectual developmental disorder, autosomal dominant 57 (MRD57) [MIM:618050] |
Intellectual developmental disorder, autosomal dominant 57 (MRD57) [MIM:618050] |
TLK2 |
Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970] |
Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970] |
GRIN2B |
Jackson-Weiss syndrome |
Jackson-Weiss syndrome (JWS) [MIM:123150] |
FGFR2, FGFR1 |
Jervell and Lange-Nielsen syndrome |
Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400] |
KCNQ1 |
Joubert syndrome |
Joubert syndrome 3 (JBTS3) [MIM:608629] |
AHI1 |
Juvenile polyposis |
Juvenile polyposis syndrome (JPS) [MIM:174900] |
BMPR1A, SMAD4 |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050] |
SMAD4 |
Kabuki syndrome 1 (KABUK1) [MIM:147920] |
Kabuki syndrome 1 (KABUK1) [MIM:147920] |
KMT2D |
Keratinocytic non-epidermolytic nevus |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
FGFR3, NRAS |
Keratoendothelitis fugax hereditaria |
Keratoendothelitis fugax hereditaria (KEFH) [MIM:148200] |
NLRP3 |
Keratosis |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
FGFR3, PIK3CA |
Kniest dysplasia |
Cardioacrofacial dysplasia 1 (CAFD1) [MIM:619142] |
PRKACA |
Cardioacrofacial dysplasia 2 (CAFD2) [MIM:619143] |
PRKACB |
Knobloch syndrome |
Knobloch syndrome 2 (KNO2) [MIM:618458] |
PAK2 |
Kury-Isidor syndrome |
Kury-Isidor syndrome (KURIS) [MIM:619762] |
BAP1 |
Lacrimo-auriculo-dento-digital syndrome II |
Lacrimo-auriculo-dento-digital syndrome 1 (LADD1) [MIM:149730] |
FGFR2 |
Laron syndrome |
Laron syndrome (LARS) [MIM:262500] |
GHR |
Leber congenital amaurosis |
Leber congenital amaurosis 11 (LCA11) [MIM:613837] |
IMPDH1 |
Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879] |
TUBB4B |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
MT-ND4L, MT-ND5, MT-ND6, MT-ND2, MT-CO3 |
Leber optic neuropathy |
Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
MT-ND6 |
Left ventricular non-compaction |
Congenital heart defects, multiple types, 8, with or without heterotaxy (CHTD8) [MIM:619657] |
SMAD2 |
Left ventricular non-compaction 7 (LVNC7) [MIM:615092] |
MIB1 |
Left ventricular non-compaction 9 (LVNC9) [MIM:611878] |
TPM1 |
Left ventricular non-compaction 5 (LVNC5) [MIM:613426] |
Left ventricular non-compaction 5 (LVNC5) [MIM:613426] |
MYH7 |
Leigh syndrome (LS) [MIM:256000] |
Leigh syndrome (LS) [MIM:256000] |
MT-ND6, SDHA, MT-ND3, MT-ATP6 |
Leopard syndrome |
LEOPARD syndrome 1 (LPRD1) [MIM:151100] |
PTPN11 |
LEOPARD syndrome 2 (LPRD2) [MIM:611554] |
RAF1 |
LEOPARD syndrome 3 (LPRD3) [MIM:613707] |
BRAF |
Leprechaunism |
Leprechaunism (LEPRCH) [MIM:246200] |
INSR |
Lethal congenital contracture syndrome |
Lethal congenital contracture syndrome 1 (LCCS1) [MIM:253310] |
GLE1 |
Leukemia |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
KRAS, PTPN11, NRAS |
Leukemia, acute myelogenous (AML) [MIM:601626] |
Leukemia, acute myelogenous (AML) [MIM:601626] |
JAK2, DNMT3A |
Leukocyte adhesion deficiency |
Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920] |
ITGB2 |
Leukodystrophy hypomyelinating |
Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494] |
POLR1C |
Leukodystrophy, hypomyelinating, 14 (HLD14) [MIM:617899] |
UFM1 |
Leukodystrophy, hypomyelinating, 6 (HLD6) [MIM:612438] |
TUBB4A |
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
POLR3A |
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381] |
POLR3B |
Leukodystrophy with vanishing white matter |
Leukoencephalopathy with vanishing white matter 1 (VWM1) [MIM:603896] |
EIF2B1 |
Leukoencephalopathy with vanishing white matter 2 (VWM2) [MIM:620312] |
EIF2B2 |
Leukoencephalopathy with vanishing white matter 3 (VWM3) [MIM:620313] |
EIF2B3 |
Leukoencephalopathy with vanishing white matter 4 (VWM4) [MIM:620314] |
EIF2B4 |
Leukoencephalopathy with vanishing white matter 5 (VWM5) [MIM:620315] |
EIF2B5 |
Leukodystrophy, hypomyelinating, 15 (HLD15) [MIM:617951] |
Leukodystrophy, hypomyelinating, 15 (HLD15) [MIM:617951] |
EPRS1 |
Li-Fraumeni syndrome |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
TP53 |
Tumor predisposition syndrome 3 (TPDS3) [MIM:615848] |
POT1 |
Tumor predisposition syndrome 4 (TPDS4) [MIM:609265] |
CHEK2 |
Liang-Wang syndrome |
Liang-Wang syndrome (LIWAS) [MIM:618729] |
KCNMA1 |
Limb pelvis hypoplasia aplasia syndrome (LPHAS) [MIM:276820] |
Limb pelvis hypoplasia aplasia syndrome (LPHAS) [MIM:276820] |
WNT7A |
Limb-girdle muscular dystrophy |
Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
LMNA |
Muscular dystrophy, limb-girdle, autosomal dominant 3 (LGMDD3) [MIM:609115] |
HNRNPDL |
Lipodystrophy |
Lipodystrophy, congenital generalized, 5 (CGL5) [MIM:620680] |
PCYT1A |
Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660] |
LMNA |
Lipodystrophy, familial partial, 3 (FPLD3) [MIM:604367] |
PPARG |
Partial acquired lipodystrophy (APLD) [MIM:608709] |
LMNB2 |
Lissencephaly |
Lissencephaly 1 (LIS1) [MIM:607432] |
PAFAH1B1 |
Lissencephaly 3 (LIS3) [MIM:611603] |
TUBA1A |
Lissencephaly with microcephaly |
Lissencephaly 6, with microcephaly (LIS6) [MIM:616212] |
KATNB1 |
Loeys-Dietz syndrome |
Loeys-Dietz syndrome 1 (LDS1) [MIM:609192] |
TGFBR1 |
Loeys-Dietz syndrome 2 (LDS2) [MIM:610168] |
TGFBR2 |
Loeys-Dietz syndrome 3 (LDS3) [MIM:613795] |
SMAD3 |
Loeys-Dietz syndrome 4 (LDS4) [MIM:614816] |
TGFB2 |
Loeys-Dietz syndrome 6 (LDS6) [MIM:619656] |
Loeys-Dietz syndrome 6 (LDS6) [MIM:619656] |
SMAD2 |
Long QT syndrome |
Long QT syndrome 14 (LQT14) [MIM:616247] |
CALM1 |
Long QT syndrome 15 (LQT15) [MIM:616249] |
CALM2 |
Long QT syndrome 16 (LQT16) [MIM:618782] |
CALM3 |
Long QT syndrome 7 (LQT7) [MIM:170390] |
KCNJ2 |
Long QT syndrome 6 (LQT6) [MIM:613693] |
Long QT syndrome 6 (LQT6) [MIM:613693] |
KCNE2 |
Long-Olsen-Distelmaier syndrome |
Long-Olsen-Distelmaier syndrome (LNGODS) [MIM:620609] |
RRAGC |
Lung cancer (LNCR) [MIM:211980] |
Lung cancer (LNCR) [MIM:211980] |
BRAF |
Luo-Schoch-Yamamoto syndrome |
Luo-Schoch-Yamamoto syndrome (LUSYAM) [MIM:619460] |
RNF2 |
Luteinizing hormone resistance |
Luteinizing hormone resistance (LHR) [MIM:238320] |
LHCGR |
Lymphedema |
Facial palsy, congenital, with ptosis and velopharyngeal dysfunction (FPVEPD) [MIM:617732] |
TUBB6 |
Lymphoma |
Lymphoproliferative syndrome, X-linked, 1 (XLP1) [MIM:308240] |
SH2D1A |
Lynch syndrome 2 (LYNCH2) [MIM:609310] |
Lynch syndrome 2 (LYNCH2) [MIM:609310] |
MLH1 |
MEHMO syndrome (MEHMO) [MIM:300148] |
MEHMO syndrome (MEHMO) [MIM:300148] |
EIF2S3 |
Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin |
Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin (MNDLFH) [MIM:619769] |
ZBTB7A |
Macrodactyly |
Macrodactyly (MADAC) [MIM:155500] |
PIK3CA |
Macrothrombocytopenia |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100] |
MYH9 |
Macular dystrophy |
Macular dystrophy, patterned, 2 (MDPT2) [MIM:608970] |
CTNNA1 |
Mandibuloacral dysplasia |
Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370] |
LMNA |
Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612] |
ZMPSTE24 |
Mandibulofacial dysostosis |
Mandibulofacial dysostosis with microcephaly (MFDM) [MIM:610536] |
EFTUD2 |
Marbach-Schaaf neurodevelopmental syndrome (MASNS) [MIM:619680] |
Marbach-Schaaf neurodevelopmental syndrome (MASNS) [MIM:619680] |
PRKAR1B |
Mastocytosis, cutaneous |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
KIT |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
KIT |
Maturity-onset diabetes of the young |
Maturity-onset diabetes of the young 1 (MODY1) [MIM:125850] |
HNF4A |
Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370] |
INS |
McCune-Albright syndrome |
McCune-Albright syndrome (MAS) [MIM:174800] |
GNAS |
Meacham syndrome |
Meacham syndrome (MEACHS) [MIM:608978] |
WT1 |
Medullary thyroid carcinoma |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
RET |
Medulloblastoma |
Medulloblastoma (MDB) [MIM:155255] |
APC, CTNNB1 |
Meesmann corneal dystrophy |
Corneal dystrophy, Meesmann 2 (MECD2) [MIM:618767] |
KRT3 |
Megacystis-microcolon-intestinal hypoperistalsis syndrome |
Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431] |
ACTG2 |
Megalencephaly-capillary malformation-polymicrogyria syndrome |
Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501] |
PIK3CA |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (MPPH2) [MIM:615937] |
AKT3 |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387] |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387] |
PIK3R2 |
Meier-Gorlin syndrome |
Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690] |
ORC1 |
Meier-Gorlin syndrome 2 (MGORS2) [MIM:613800] |
ORC4 |
Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804] |
CDT1 |
Meier-Gorlin syndrome 5 (MGORS5) [MIM:613805] |
CDC6 |
Meier-Gorlin syndrome 8 (MGORS8) [MIM:617564] |
MCM5 |
Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063] |
Meier-Gorlin syndrome 7 (MGORS7) [MIM:617063] |
CDC45 |
Melanoma |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
CDK4 |
Melanosis, neurocutaneous |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
NRAS |
Mental retardation |
Intellectual developmental disorder, X-linked 1 (XLID1) [MIM:309530] |
IQSEC2 |
Intellectual developmental disorder, X-linked, syndromic 14 (MRXS14) [MIM:300676] |
UPF3B |
Intellectual developmental disorder, X-linked, syndromic 33 (MRXS33) [MIM:300966] |
TAF1 |
Intellectual developmental disorder, X-linked, syndromic, Bain type (MRXSB) [MIM:300986] |
HNRNPH2 |
Intellectual developmental disorder, X-linked, syndromic, Nascimento-type (MRXSN) [MIM:300860] |
UBE2A |
Intellectual developmental disorder, X-linked, syndromic, Turner type (MRXST) [MIM:309590] |
HUWE1 |
Intellectual developmental disorder, autosomal dominant 38 (MRD38) [MIM:616393] |
EEF1A2 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
GNB1 |
Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635] |
STAG1 |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
RAC1 |
Intellectual developmental disorder, autosomal dominant 53 (MRD53) [MIM:617798] |
CAMK2A |
Intellectual developmental disorder, autosomal dominant 54 (MRD54) [MIM:617799] |
CAMK2B |
Intellectual developmental disorder, autosomal dominant 59 (MRD59) [MIM:618522] |
CAMK2G |
Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825] |
TRIO |
Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly (MRT34) [MIM:614499] |
CRADD |
Intellectual developmental disorder, autosomal recessive 60 (MRT60) [MIM:617432] |
TAF13 |
Intellectual developmental disorder, autosomal recessive 63 (MRT63) [MIM:618095] |
CAMK2A |
Intellectual developmental disorder, autosomal recessive 64 (MRT64) [MIM:618103] |
LINGO1 |
Intellectual developmental disorder, autosomal recessive 73 (MRT73) [MIM:619717] |
NAA20 |
Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly (MRT75) [MIM:619827] |
PIDD1 |
Metaphyseal chondrodysplasia |
Metaphyseal chondrodysplasia, Jansen type (MCDJ) [MIM:156400] |
PTH1R |
Metatropic dysplasia |
Metatropic dysplasia (MTD) [MIM:156530] |
TRPV4 |
Microcephaly |
Microcephaly 12, primary, autosomal recessive (MCPH12) [MIM:616080] |
CDK6 |
Microcephaly 26, primary, autosomal dominant (MCPH26) [MIM:619179] |
LMNB1 |
Microcephaly 27, primary, autosomal dominant (MCPH27) [MIM:619180] |
LMNB2 |
Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development (MCLMR) [MIM:152950] |
KIF11 |
Microcephaly, postnatal progressive, with seizures and brain atrophy (MCPHSBA) [MIM:613668] |
MED17 |
Neurodevelopmental disorder with microcephaly and structural brain anomalies (NEDMIBA) [MIM:618492] |
DYNC1I2 |
Microcephaly-capillary malformation syndrome |
Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261] |
STAMBP |
Microphthalmia |
Microphthalmia, syndromic, 12 (MCOPS12) [MIM:615524] |
RARB |
Mirror movements 1 (MRMV1) [MIM:157600] |
Mirror movements 1 (MRMV1) [MIM:157600] |
DCC |
Mitochondrial DNA depletion syndrome |
Mitochondrial DNA depletion syndrome 16, hepatic type (MTDPS16) [MIM:618528] |
POLG2 |
Mitochondrial complex |
Mitochondrial complex I deficiency, nuclear type 36 (MC1DN36) [MIM:619170] |
NDUFC2 |
Mitochondrial complex I deficiency, nuclear type 37 (MC1DN37) [MIM:619272] |
NDUFA8 |
Mitochondrial complex II deficiency, nuclear type 1 (MC2DN1) [MIM:252011] |
SDHA |
Mitochondrial complex II deficiency, nuclear type 4 (MC2DN4) [MIM:619224] |
SDHB |
Mitochondrial complex III deficiency, nuclear type 10 (MC3DN10) [MIM:618775] |
UQCRFS1 |
Mitochondrial complex III deficiency, nuclear type 5 (MC3DN5) [MIM:615160] |
UQCRC2 |
Mitochondrial complex III deficiency, nuclear type 6 (MC3DN6) [MIM:615453] |
CYC1 |
Mitochondrial complex IV deficiency, nuclear type 16 (MC4DN16) [MIM:619060] |
COX4I1 |
Mitochondrial complex IV deficiency, nuclear type 20 (MC4DN20) [MIM:619064] |
COX5A |
Mitochondrial complex IV deficiency, nuclear type 7 (MC4DN7) [MIM:619051] |
COX6B1 |
Mitochondrial complex V deficiency, nuclear type 4A (MC5DN4A) [MIM:620358] |
ATP5F1A |
Mitochondrial complex V deficiency, nuclear type 4B (MC5DN4B) [MIM:615228] |
ATP5F1A |
Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126] |
Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20) [MIM:611126] |
ACAD9 |
Mitochondrial complex deficiency |
Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014] |
MT-ND3 |
Mitochondrial complex I deficiency, nuclear type 1 (MC1DN1) [MIM:252010] |
NDUFS4 |
Mitochondrial complex I deficiency, nuclear type 12 (MC1DN12) [MIM:301020] |
NDUFA1 |
Mitochondrial complex I deficiency, nuclear type 2 (MC1DN2) [MIM:618222] |
NDUFS8 |
Mitochondrial complex I deficiency, nuclear type 24 (MC1DN24) [MIM:618245] |
NDUFB9 |
Mitochondrial complex I deficiency, nuclear type 25 (MC1DN25) [MIM:618246] |
NDUFB3 |
Mitochondrial complex I deficiency, nuclear type 26 (MC1DN26) [MIM:618247] |
NDUFA9 |
Mitochondrial complex I deficiency, nuclear type 28 (MC1DN28) [MIM:618249] |
NDUFA13 |
Mitochondrial complex I deficiency, nuclear type 30 (MC1DN30) [MIM:301021] |
NDUFB11 |
Mitochondrial complex I deficiency, nuclear type 32 (MC1DN32) [MIM:618252] |
NDUFB8 |
Mitochondrial complex I deficiency, nuclear type 33 (MC1DN33) [MIM:618253] |
NDUFA6 |
Mitochondrial complex I deficiency, nuclear type 4 (MC1DN4) [MIM:618225] |
NDUFV1 |
Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6) [MIM:618228] |
NDUFS2 |
Mitochondrial complex I deficiency, nuclear type 8 (MC1DN8) [MIM:618230] |
NDUFS3 |
Mitochondrial complex I deficiency, nuclear type 9 (MC1DN9) [MIM:618232] |
NDUFS6 |
Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
MT-CO2, MT-CO1 |
Mitochondrial complex V deficiency, nuclear type 3 (MC5DN3) [MIM:614053] |
ATP5F1E |
Mitochondrial complex V deficiency, nuclear type 5 (MC5DN5) [MIM:618120] |
ATP5F1D |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
MT-ND6, MT-ND5, MT-ND1 |
Miyoshi muscular dystrophy |
Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130] |
DYSF |
Monilethrix |
Monilethrix (MNLIX) [MIM:158000] |
KRT81, KRT83, KRT86 |
Mucopolysaccharidosis |
Mucopolysaccharidosis 4B (MPS4B) [MIM:253010] |
GLB1 |
Muenke syndrome |
Muenke syndrome (MNKS) [MIM:602849] |
FGFR3 |
Multicentric osteolysis, nodulosis, and arthropathy |
Multicentric osteolysis, nodulosis, and arthropathy (MONA) [MIM:259600] |
MMP2 |
Multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) [MIM:615398] |
Multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) [MIM:615398] |
PIGT |
Multiple mitochondrial dysfunctions syndrome |
Multiple mitochondrial dysfunctions syndrome 4 (MMDS4) [MIM:616370] |
ISCA2 |
Multiple neoplasia |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
RET |
Multiple neoplasia 2B (MEN2B) [MIM:162300] |
RET |
Multiple self-healing squamous epithelioma |
Multiple self-healing squamous epithelioma (MSSE) [MIM:132800] |
TGFBR1 |
Multiple synostoses syndrome |
Multiple synostoses syndrome 1 (SYNS1) [MIM:186500] |
NOG |
Muscular dystrophy, limb-girdle, autosomal recessive 28 (LGMDR28) [MIM:620375] |
Muscular dystrophy, limb-girdle, autosomal recessive 28 (LGMDR28) [MIM:620375] |
HMGCR |
Muscular dystrophy-dystroglycanopathy |
Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A14 (MDDGA14) [MIM:615350] |
GMPPB |
Myasthenic syndrome |
Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304] |
LRP4 |
Myasthenic syndrome, congenital, 18 (CMS18) [MIM:616330] |
SNAP25 |
Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9) [MIM:616325] |
MUSK |
Myeloperoxidase deficiency |
Myeloperoxidase deficiency (MPOD) [MIM:254600] |
MPO |
Myopathy |
Congenital myopathy 2B, severe infantile, autosomal recessive (CMYP2B) [MIM:620265] |
ACTA1 |
Congenital myopathy 2C, severe infantile, autosomal dominant (CMYP2C) [MIM:620278] |
ACTA1 |
Congenital myopathy 7A, myosin storage, autosomal dominant (CMYP7A) [MIM:608358] |
MYH7 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
HRAS |
Myopathy, centronuclear, 2 (CNM2) [MIM:255200] |
BIN1 |
Myopathy, distal, 1 (MPD1) [MIM:160500] |
MYH7 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
DES |
Myopathy, myofibrillar, 2 (MFM2) [MIM:608810] |
CRYAB |
Myopathy, tubular aggregate, 2 (TAM2) [MIM:615883] |
ORAI1 |
Myopathy with sideroblastic anemia |
Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy (MEOAL) [MIM:251900] |
FDX2 |
Myopathy, lactic acidosis, and sideroblastic anemia 3 (MLASA3) [MIM:500011] |
MT-ATP6 |
N-terminal acetyltransferase deficiency |
N-terminal acetyltransferase deficiency (NATD) [MIM:300855] |
NAA10 |
Nabais Sa-de Vries syndrome |
Nabais Sa-de Vries syndrome 1 (NSDVS1) [MIM:618828] |
SPOP |
Nabais Sa-de Vries syndrome 2 (NSDVS2) [MIM:618829] |
SPOP |
Narcolepsy |
Narcolepsy 1 (NRCLP1) [MIM:161400] |
HCRT |
Nemaline myopathy |
Congenital myopathy 2A, typical, autosomal dominant (CMYP2A) [MIM:161800] |
ACTA1 |
Nemaline myopathy 5B, autosomal recessive, childhood-onset (NEM5B) [MIM:620386] |
TNNT1 |
Nephrogenic syndrome |
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539] |
AVPR2 |
Nephrotic syndrome |
Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1 (CHINE1) [MIM:301108] |
DKC1 |
Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 2 (CHINE2) [MIM:620425] |
NOP10 |
Nephrotic syndrome 11 (NPHS11) [MIM:616730] |
NUP107 |
Nephrotic syndrome 12 (NPHS12) [MIM:616892] |
NUP93 |
Nephrotic syndrome 16 (NPHS16) [MIM:617783] |
KANK2 |
Nestor-Guillermo progeria syndrome |
Nestor-Guillermo progeria syndrome (NGPS) [MIM:614008] |
BANF1 |
Neural tube defects (NTD) [MIM:182940] |
Neural tube defects (NTD) [MIM:182940] |
VANGL2 |
Neuroblastoma |
Neuroblastoma 3 (NBLST3) [MIM:613014] |
ALK |
Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter |
Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (NDAGSCW) [MIM:617807] |
RAB11B |
Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia |
Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia (NEDBASH) [MIM:618718] |
NTNG2 |
Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis |
Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis (NEDBSS) [MIM:618590] |
PIGU |
Neurodevelopmental disorder with brain, liver, and lung abnormalities |
Neurodevelopmental disorder with or without variable brain abnormalities (NEDBA) [MIM:618443] |
MAPK8IP3 |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577] |
RAC3 |
Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities (NEDCASB) [MIM:619121] |
Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities (NEDCASB) [MIM:619121] |
SHMT2 |
Neurodevelopmental disorder with cerebellar hypoplasia and spasticity |
Neurodevelopmental disorder with cerebellar hypoplasia and spasticity (NEDCHS) [MIM:618572] |
INTS8 |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements (NEDHAHM) [MIM:618760] |
VAMP2 |
Neurodevelopmental disorder with hypotonia, seizures, and absent language |
Neurodevelopmental disorder with microcephaly, ataxia, and seizures (NEDMAS) [MIM:617709] |
SARS1 |
Neurodevelopmental disorder with involuntary movements |
Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493] |
GNAO1 |
Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures (NEDMHS) [MIM:619876] |
Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures (NEDMHS) [MIM:619876] |
CPSF3 |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
GRIN1 |
Neurodevelopmental, jaw, eye, and digital syndrome |
Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914] |
FBXW11 |
Neurofibromatosis |
Neurofibromatosis 1 (NF1) [MIM:162200] |
NF1 |
Schwannomatosis, vestibular (SWNV) [MIM:101000] |
NF2 |
Neurofibromatosis-Noonan syndrome |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
NF1 |
Neuropathy |
Leukodystrophy, hypomyelinating, 12 (HLD12) [MIM:616683] |
VPS11 |
Neuronopathy, distal hereditary motor, autosomal dominant 2 (HMND2) [MIM:158590] |
HSPB8 |
Neuronopathy, distal hereditary motor, autosomal dominant 8 (HMND8) [MIM:600175] |
TRPV4 |
Neuronopathy, distal hereditary motor, autosomal recessive 10 (HMNR10) [MIM:620542] |
VRK1 |
Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400] |
SPTLC1 |
Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640] |
SPTLC2 |
Neuropathy, hereditary sensory and autonomic, 3 (HSAN3) [MIM:223900] |
ELP1 |
Neuropathy, hereditary sensory and autonomic, 5 (HSAN5) [MIM:608654] |
NGF |
Neuropathy, hereditary motor and sensory |
Neuropathy, hereditary motor and sensory, Okinawa type (HMSNO) [MIM:604484] |
TFG |
Neutropenia |
Neutropenia, severe congenital 2, autosomal dominant (SCN2) [MIM:613107] |
GFI1 |
Neutropenia, severe congenital 8, autosomal dominant (SCN8) [MIM:618752] |
SRP54 |
Neutropenia, severe congenital 9, autosomal dominant (SCN9) [MIM:619813] |
CLPB |
Neutrophil immunodeficiency syndrome |
Immunodeficiency 73A with defective neutrophil chemotaxis and leukocytosis (IMD73A) [MIM:608203] |
RAC2 |
Immunodeficiency, common variable, 13 (CVID13) [MIM:616873] |
IKZF1 |
Niemann-Pick disease |
Niemann-Pick disease C1 (NPC1) [MIM:257220] |
NPC1 |
Non-Hodgkin lymphoma |
Familial non-Hodgkin lymphoma (NHL) [MIM:605027] |
BRAF, CASP10 |
Noonan syndrome |
Noonan syndrome 1 (NS1) [MIM:163950] |
PTPN11 |
Noonan syndrome 11 (NS11) [MIM:618499] |
MRAS |
Noonan syndrome 12 (NS12) [MIM:618624] |
RRAS2 |
Noonan syndrome 13 (NS13) [MIM:619087] |
MAPK1 |
Noonan syndrome 3 (NS3) [MIM:609942] |
KRAS |
Noonan syndrome 4 (NS4) [MIM:610733] |
SOS1 |
Noonan syndrome 5 (NS5) [MIM:611553] |
RAF1 |
Noonan syndrome 6 (NS6) [MIM:613224] |
NRAS |
Noonan syndrome 7 (NS7) [MIM:613706] |
BRAF |
Noonan syndrome 8 (NS8) [MIM:615355] |
RIT1 |
Noonan syndrome-like disorder with loose anagen hair 1 (NSLH1) [MIM:607721] |
SHOC2 |
Noonan syndrome-like disorder with loose anagen hair 2 (NSLH2) [MIM:617506] |
PPP1CB |
Noonan syndrome 2 (NS2) [MIM:605275] |
Noonan syndrome 2 (NS2) [MIM:605275] |
LZTR1 |
Noonan-like syndrome |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
CBL |
Obesity |
Developmental delay, dysmorphic facies, and brain anomalies (DEVDFB) [MIM:620535] |
U2AF2 |
Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012] |
FBXW7 |
Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475] |
SPTBN1 |
Developmental delay, language impairment, and ocular abnormalities (DEVLO) [MIM:620141] |
ARPC4 |
Intellectual developmental disorder with language impairment and with or without autistic features (MRLIAF) [MIM:613670] |
FOXP1 |
Leptin deficiency (LEPD) [MIM:614962] |
LEP |
Thrombocytopenia 8, with dysmorphic features and developmental delay (THC8) [MIM:620475] |
ACTB |
Obesity, hyperphagia, and developmental delay (OBHD) [MIM:613886] |
Obesity, hyperphagia, and developmental delay (OBHD) [MIM:613886] |
NTRK2 |
Oculoectodermal syndrome |
Oculoectodermal syndrome (OES) [MIM:600268] |
KRAS |
Ohdo syndrome |
Ohdo syndrome, X-linked (OHDOX) [MIM:300895] |
MED12 |
Olmsted syndrome 1 |
Olmsted syndrome 1 (OLMS1) [MIM:614594] |
TRPV3 |
Oocyte/zygote/embryo maturation arrest |
Oocyte/zygote/embryo maturation arrest 16 (OZEMA16) [MIM:617234] |
PADI6 |
Oocyte/zygote/embryo maturation arrest 20 (OZEMA20) [MIM:620383] |
MOS |
Oocyte/zygote/embryo maturation arrest 21 (OZEMA21) [MIM:620610] |
CHEK1 |
Oocyte/zygote/embryo maturation arrest 14 (OZEMA14) [MIM:620276] |
Oocyte/zygote/embryo maturation arrest 14 (OZEMA14) [MIM:620276] |
CDC20 |
Ophthalmoplegia, external, with rib and vertebral anomalies |
Ophthalmoplegia, external, with rib and vertebral anomalies (EORVA) [MIM:618155] |
MYF5 |
Orofacial cleft |
Cleft palate with or without ankyloglossia, X-linked (CPX) [MIM:303400] |
TBX22 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
KDM1A |
Dyskinesia with orofacial involvement, autosomal recessive (DSKOR) [MIM:619647] |
ADCY5 |
Non-syndromic orofacial cleft 11 (OFC11) [MIM:600625] |
BMP4 |
Osseous heteroplasia |
Progressive osseous heteroplasia (POH) [MIM:166350] |
GNAS |
Osteogenesis imperfecta |
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115] |
COL1A1 |
Osteogenesis imperfecta 1 (OI1) [MIM:166200] |
COL1A1 |
Osteogenesis imperfecta 17 (OI17) [MIM:616507] |
SPARC |
Osteogenesis imperfecta 2 (OI2) [MIM:166210] |
COL1A1, COL1A2 |
Osteogenesis imperfecta 3 (OI3) [MIM:259420] |
COL1A1, COL1A2 |
Osteogenesis imperfecta 4 (OI4) [MIM:166220] |
COL1A1 |
Osteoglophonic dysplasia |
Osteoglophonic dysplasia (OGD) [MIM:166250] |
FGFR1 |
Osteopetrosis autosomal |
Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301] |
TNFRSF11A |
Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600] |
Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600] |
CLCN7 |
Otopalatodigital syndrome |
Otopalatodigital syndrome 2 (OPD2) [MIM:304120] |
FLNA |
Ovarian cancer |
Ovarian cancer (OC) [MIM:167000] |
CTNNB1, BRCA1, PIK3CA |
Ovarian dysgenesis |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
ESR2 |
PAPA syndrome |
PAPA syndrome (PAPAS) [MIM:604416] |
PSTPIP1 |
PHOAR2-enteropathy syndrome |
PHOAR2-enteropathy syndrome (PHOAR2E) [MIM:614441] |
SLCO2A1 |
Pachyonychia congenita |
Pachyonychia congenita 1 (PC1) [MIM:167200] |
KRT16 |
Pachyonychia congenita 2 (PC2) [MIM:167210] |
KRT17 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
KRT6A |
Pachyonychia congenita 4 (PC4) [MIM:615728] |
KRT6B |
Paget disease of bone |
Paget disease of bone 3 (PDB3) [MIM:167250] |
SQSTM1 |
Palmoplantar keratoderma |
Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350] |
GJB2 |
Palmoplantar keratoderma, non-epidermolytic, focal or diffuse (PPKNEFD) [MIM:615735] |
KRT6C |
Woolly hair autosomal recessive 3 (ARWH3) [MIM:616760] |
KRT25 |
Pancreatic cancer |
Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719] |
CDKN2A |
Paraganglioma |
Pheochromocytoma/paraganglioma syndrome 2 (PPGL2) [MIM:601650] |
SDHAF2 |
Parietal foramina |
Parietal foramina 1 (PFM1) [MIM:168500] |
MSX2 |
Parkinson disease |
Parkinson disease (PARK) [MIM:168600] |
PRKN |
Parkinson disease 1, autosomal dominant (PARK1) [MIM:168601] |
SNCA |
Parkinson disease 17 (PARK17) [MIM:614203] |
VPS35 |
Parkinson disease 2 (PARK2) [MIM:600116] |
PRKN |
Parkinson disease 24, autosomal dominant (PARK24) [MIM:619491] |
PSAP |
Parkinson disease 8 (PARK8) [MIM:607060] |
LRRK2 |
Paroxysmal extreme pain disorder |
Paroxysmal extreme pain disorder (PEXPD) [MIM:167400] |
SCN9A |
Periodic fever, familial, autosomal dominant (FPF) [MIM:142680] |
Periodic fever, familial, autosomal dominant (FPF) [MIM:142680] |
TNFRSF1A |
Periventricular heterotopia |
Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201] |
NEDD4L |
Periventricular nodular heterotopia 8 (PVNH8) [MIM:618185] |
Periventricular nodular heterotopia 8 (PVNH8) [MIM:618185] |
ARF1 |
Peroxisome biogenesis disorder |
Peroxisome biogenesis disorder 2B (PBD2B) [MIM:202370] |
PEX5 |
Perrault syndrome |
Perrault syndrome 3 (PRLTS3) [MIM:614129] |
CLPP |
Perry syndrome |
Perry syndrome (PERRYS) [MIM:168605] |
DCTN1 |
Peutz-Jeghers syndrome |
Peutz-Jeghers syndrome (PJS) [MIM:175200] |
STK11 |
Pfeiffer syndrome |
Pfeiffer syndrome (PS) [MIM:101600] |
FGFR2, FGFR1 |
Pheochromocytoma (PCC) [MIM:171300] |
Pheochromocytoma (PCC) [MIM:171300] |
VHL, RET, MAX |
Phosphoribosylpyrophosphate synthetase superactivity |
Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661] |
PRPS1 |
Pick disease of the brain (PIDB) [MIM:172700] |
Pick disease of the brain (PIDB) [MIM:172700] |
MAPT |
Piebaldism |
Piebald trait (PBT) [MIM:172800] |
KIT |
Pigmented adrenocortical disease |
Primary pigmented nodular adrenocortical disease 4 (PPNAD4) [MIM:615830] |
PRKACA |
Pilomatrixoma |
Pilomatrixoma (PTR) [MIM:132600] |
CTNNB1 |
Pitt-Hopkins syndrome |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
TCF4 |
Pituitary adenoma 1, multiple types (PITA1) [MIM:102200] |
Pituitary adenoma 1, multiple types (PITA1) [MIM:102200] |
AIP |
Pituitary hormone deficiency |
Pituitary hormone deficiency, combined, 4 (CPHD4) [MIM:262700] |
LHX4 |
Plasminogen deficiency |
Plasminogen deficiency (PLGD) [MIM:217090] |
PLG |
Pneumothorax |
Primary spontaneous pneumothorax (PSP) [MIM:173600] |
FLCN |
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732] |
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732] |
CSNK2B |
Polycystic kidney disease |
Polycystic kidney disease 2 with or without polycystic liver disease (PKD2) [MIM:613095] |
PKD2 |
Tubulointerstitial kidney disease, autosomal dominant, 5 (ADTKD5) [MIM:617056] |
SEC61A1 |
Polycythemia vera |
Polycythemia vera (PV) [MIM:263300] |
JAK2 |
Polydactyly-macrocephaly syndrome |
Polydactyly-macrocephaly syndrome (PDMCS) [MIM:620712] |
MAX |
Polymicrogyria |
Cortical dysplasia, complex, with other brain malformations 13 (CDCBM13) [MIM:614563] |
DYNC1H1 |
Pontocerebellar hypoplasia |
Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678] |
EXOSC3 |
Pontocerebellar hypoplasia 1C (PCH1C) [MIM:616081] |
EXOSC8 |
Pontocerebellar hypoplasia 1D (PCH1D) [MIM:618065] |
EXOSC9 |
Pontocerebellar hypoplasia 2A (PCH2A) [MIM:277470] |
TSEN54 |
Pontocerebellar hypoplasia 2B (PCH2B) [MIM:612389] |
TSEN2 |
Pontocerebellar hypoplasia 2F (PCH2F) [MIM:617026] |
TSEN15 |
Pontocerebellar hypoplasia 9 (PCH9) [MIM:615809] |
AMPD2 |
Pontocerebellar hypoplasia 14 (PCH14) [MIM:619301] |
Pontocerebellar hypoplasia 14 (PCH14) [MIM:619301] |
PPIL1 |
Premature chromatid separation trait |
Premature chromatid separation trait (PCS) [MIM:176430] |
BUB1B |
Premature ovarian failure |
Premature ovarian failure 7 (POF7) [MIM:612964] |
NR5A1 |
Primary ciliary dyskinesia |
Ciliary dyskinesia, primary, 24 (CILD24) [MIM:615481] |
RSPH1 |
Progressive external ophthalmoplegia |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4) [MIM:610131] |
POLG2 |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 (PEOB4) [MIM:617070] |
DGUOK |
Properdin deficiency |
Properdin deficiency (PFD) [MIM:312060] |
CFP |
Propionic acidemia |
Propionic acidemia type I (PA-1) [MIM:606054] |
PCCA |
Prostate cancer |
Prostate cancer (PC) [MIM:176807] |
EPHB2, CHEK2 |
Pseudohypoaldosteronism |
Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735] |
NR3C2 |
Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491] |
WNK4 |
Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496] |
CUL3 |
Pseudohypoparathyroidism |
Albright hereditary osteodystrophy (AHO) [MIM:103580] |
GNAS |
Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580] |
GNAS |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
GNAS |
Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600] |
Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600] |
BMPR2 |
Pyropoikilocytosis |
Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
SPTA1 |
RAS-associated autoimmune leukoproliferative disorder |
RAS-associated autoimmune leukoproliferative disorder (RALD) [MIM:614470] |
NRAS |
Rabson-Mendenhall syndrome |
Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
INSR |
Radioulnar synostosis with amegakaryocytic thrombocytopenia |
Thrombocytopenia 6 (THC6) [MIM:616937] |
SRC |
Rapp-Hodgkin syndrome |
Rapp-Hodgkin syndrome (RHS) [MIM:129400] |
TP63 |
Refsum disease |
Autoinflammatory disease, systemic, with vasculitis (SAIDV) [MIM:620376] |
LYN |
Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) [MIM:600882] |
RAB7A |
Charcot-Marie-Tooth disease, axonal, 2B1 (CMT2B1) [MIM:605588] |
LMNA |
Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071] |
TRPV4 |
Charcot-Marie-Tooth disease, axonal, 2E (CMT2E) [MIM:607684] |
NEFL |
Charcot-Marie-Tooth disease, axonal, 2F (CMT2F) [MIM:606595] |
HSPB1 |
Charcot-Marie-Tooth disease, axonal, 2O (CMT2O) [MIM:614228] |
DYNC1H1 |
Charcot-Marie-Tooth disease, axonal, 2R (CMT2R) [MIM:615490] |
TRIM2 |
Charcot-Marie-Tooth disease, axonal, 2W (CMT2W) [MIM:616625] |
HARS1 |
Charcot-Marie-Tooth disease, axonal, 2Y (CMT2Y) [MIM:616687] |
VCP |
Inflammatory bowel disease 28, autosomal recessive (IBD28) [MIM:613148] |
IL10RA |
Mahvash disease (MVAH) [MIM:619290] |
GCGR |
Pyrin-associated autoinflammatory disease (PAAND) [MIM:608068] |
MEFV |
Rajab interstitial lung disease with brain calcifications 1 (RILDBC1) [MIM:613658] |
FARSB |
Sickle cell disease (SKCA) [MIM:603903] |
HBB |
Von Willebrand disease, platelet-type (VWDP) [MIM:177820] |
GP1BA |
Renal cell carcinoma |
Renal cell carcinoma (RCC) [MIM:144700] |
VHL |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
MET |
Renal tubular acidosis |
Renal tubular acidosis, distal, 4, with hemolytic anemia (DRTA4) [MIM:611590] |
SLC4A1 |
Renal tubular dysgenesis |
Renal tubular dysgenesis (RTD) [MIM:267430] |
AGTR1 |
Retinitis pigmentosa |
Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections (HIES6) [MIM:620532] |
STAT6 |
Retinitis pigmentosa 10 (RP10) [MIM:180105] |
IMPDH1 |
Retinitis pigmentosa 13 (RP13) [MIM:600059] |
PRPF8 |
Retinitis pigmentosa 18 (RP18) [MIM:601414] |
PRPF3 |
Retinitis pigmentosa 45 (RP45) [MIM:613767] |
CNGB1 |
Retinitis pigmentosa 62 (RP62) [MIM:614181] |
MAK |
Retinitis pigmentosa 70 (RP70) [MIM:615922] |
PRPF4 |
Retinitis pigmentosa 72 (RP72) [MIM:616469] |
ZNF408 |
Retinitis pigmentosa 74 (RP74) [MIM:616562] |
BBS2 |
Short stature, hearing loss, retinitis pigmentosa, and distinctive facies (SHRF) [MIM:617763] |
EXOSC2 |
Retinitis pigmentosa 33 (RP33) [MIM:610359] |
Retinitis pigmentosa 33 (RP33) [MIM:610359] |
SNRNP200 |
Richieri-Costa-Pereira syndrome |
Richieri-Costa-Pereira syndrome (RCPS) [MIM:268305] |
EIF4A3 |
Rickets |
Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440] |
VDR |
Ring dermoid of cornea |
Ring dermoid of cornea (RDC) [MIM:180550] |
PITX2 |
Ritscher-Schinzel syndrome |
Ritscher-Schinzel syndrome 3 (RTSC3) [MIM:619135] |
VPS35L |
Robinow syndrome, autosomal dominant 1 (DRS1) [MIM:180700] |
Robinow syndrome, autosomal dominant 1 (DRS1) [MIM:180700] |
WNT5A |
Rothmund-Thomson syndrome |
Rothmund-Thomson syndrome 3 (RTS3) [MIM:615789] |
CRIPT |
Rubinstein-Taybi syndrome |
Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849] |
CREBBP |
SHORT syndrome |
SHORT syndrome (SHORTS) [MIM:269880] |
PIK3R1 |
Skin creases, congenital symmetric circumferential, 1 (CSCSC1) [MIM:156610] |
TUBB |
Skin creases, congenital symmetric circumferential, 2 (CSCSC2) [MIM:616734] |
MAPRE2 |
STING-associated vasculopathy |
STING-associated vasculopathy, infantile-onset (SAVI) [MIM:615934] |
STING1 |
Saethre-Chotzen syndrome |
Saethre-Chotzen syndrome (SCS) [MIM:101400] |
TWIST1 |
Scaphocephaly syndrome |
Familial scaphocephaly syndrome (FSPC) [MIM:609579] |
FGFR2 |
Schimmelpenning-Feuerstein-Mims syndrome |
Schimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM:163200] |
KRAS, HRAS |
Sclerosteosis |
Sclerosteosis 2 (SOST2) [MIM:614305] |
LRP4 |
Segawa syndrome |
Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
TH |
Seizures |
Febrile seizures, familial, 8 (FEB8) [MIM:607681] |
GABRG2 |
Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745] |
SCN2A |
Senior-Loken syndrome |
Senior-Loken syndrome 8 (SLSN8) [MIM:616307] |
WDR19 |
Severe combined immunodeficiency |
Immunodeficiency 15A (IMD15A) [MIM:618204] |
IKBKB |
Immunodeficiency 43 (IMD43) [MIM:241600] |
B2M |
Immunodeficiency 47 (IMD47) [MIM:300972] |
ATP6AP1 |
Immunodeficiency 48 (IMD48) [MIM:269840] |
ZAP70 |
Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
IL2RG |
Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation (RSSCID) [MIM:602450] |
DCLRE1C |
Short QT syndrome |
Short QT syndrome 2 (SQT2) [MIM:609621] |
KCNQ1 |
Short QT syndrome 3 (SQT3) [MIM:609622] |
KCNJ2 |
Short stature |
Hemolytic uremic syndrome, atypical, 1 (AHUS1) [MIM:235400] |
CFH |
Hemolytic uremic syndrome, atypical, 3 (AHUS3) [MIM:612923] |
CFI |
Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925] |
C3 |
Short stature, microcephaly, and endocrine dysfunction (SSMED) [MIM:616541] |
XRCC4 |
Short-rib thoracic dysplasia |
Short-rib thoracic dysplasia 18 with polydactyly (SRTD18) [MIM:617866] |
IFT43 |
Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091] |
DYNC2H1 |
Short-rib thoracic dysplasia 6 with or without polydactyly (SRTD6) [MIM:263520] |
NEK1 |
Shprintzen-Goldberg craniosynostosis syndrome |
Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212] |
SKI |
Sick sinus syndrome |
Sick sinus syndrome 1 (SSS1) [MIM:608567] |
SCN5A |
Sick sinus syndrome 2 (SSS2) [MIM:163800] |
HCN4 |
Singleton-Merten syndrome |
Singleton-Merten syndrome 2 (SGMRT2) [MIM:616298] |
RIGI |
Snijders Blok-Campeau syndrome |
Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205] |
CHD3 |
Solitary median maxillary central incisor |
Solitary median maxillary central incisor (SMMCI) [MIM:147250] |
SHH |
Spastic ataxia |
Spastic ataxia 2, autosomal recessive (SPAX2) [MIM:611302] |
KIF1C |
Spastic paraplegia |
Spastic paraplegia 30 (SPG30) [MIM:610357] |
KIF1A |
Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601] |
Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601] |
SPAST |
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (SPG91) [MIM:620538] |
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (SPG91) [MIM:620538] |
SPTAN1 |
Speech-language disorder 1 |
Speech-language disorder 1 (SPCH1) [MIM:602081] |
FOXP2 |
Spherocytosis |
Spherocytosis 4 (SPH4) [MIM:612653] |
SLC4A1 |
Spinal muscular atrophy |
Neurodegeneration with ataxia and late-onset optic atrophy (NDAXOA) [MIM:619259] |
SDHA |
Neurodevelopmental disorder plus optic atrophy (NEDOA) [MIM:620784] |
SNF8 |
Scapuloperoneal spinal muscular atrophy (SPSMA) [MIM:181405] |
TRPV4 |
Spinal muscular atrophy 1 (SMA1) [MIM:253300] |
SMN2 |
Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600] |
DYNC1H1 |
Spinal muscular atrophy, lower extremity-predominant 2A, childhood onset, autosomal dominant (SMALED2A) [MIM:615290] |
BICD2 |
Spinal muscular atrophy, proximal, adult, autosomal dominant (SMAPAD) [MIM:182980] |
VAPB |
Spinocerebellar ataxia |
Spinocerebellar ataxia 19 (SCA19) [MIM:607346] |
KCND3 |
Spinocerebellar ataxia 41 (SCA41) [MIM:616410] |
TRPC3 |
Spinocerebellar ataxia 5 (SCA5) [MIM:600224] |
SPTBN2 |
Spinocerebellar ataxia, autosomal recessive, 31 (SCAR31) [MIM:619422] |
ATG7 |
Split-hand/foot malformation |
Split-hand/foot malformation 4 (SHFM4) [MIM:605289] |
TP63 |
Spondyloepimetaphyseal dysplasia |
Spondyloepimetaphyseal dysplasia, Krakow type (SEMDK) [MIM:618162] |
SIK3 |
Spondyloepimetaphyseal dysplasia, short limb-hand type (SEMD-SL) [MIM:271665] |
DDR2 |
Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
COL2A1 |
Spondylometaphyseal dysplasia |
Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
TRPV4 |
Stormorken syndrome |
Stormorken syndrome (STRMK) [MIM:185070] |
STIM1 |
Striatonigral degeneration |
Mitochondrial infantile bilateral striatal necrosis (MIBSN) [MIM:500003] |
MT-ATP6 |
Sturge-Weber syndrome |
Sturge-Weber syndrome (SWS) [MIM:185300] |
GNAQ |
Supranuclear palsy |
Progressive supranuclear palsy 1 (PSNP1) [MIM:601104] |
MAPT |
Sveinsson chorioretinal atrophy |
Sveinsson chorioretinal atrophy (SCRA) [MIM:108985] |
TEAD1 |
Symphalangism |
Symphalangism, proximal 1B (SYM1B) [MIM:615298] |
GDF5 |
Systemic lupus erythematosus |
Systemic lupus erythematosus 17 (SLEB17) [MIM:301080] |
TLR7 |
Tarsal-carpal coalition syndrome |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
NOG |
Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879] |
Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879] |
DNMT3A |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 1 (TEBIVANED1) [MIM:619758] |
H4C16 |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950] |
H4C16 |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 4 (TEBIVANED4) [MIM:619951] |
H4C16 |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 2 (TEBIVANED2) [MIM:619759] |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 2 (TEBIVANED2) [MIM:619759] |
H4C16 |
Thalassemia |
Beta-thalassemia (B-THAL) [MIM:613985] |
HBB |
Thanatophoric dysplasia |
Thanatophoric dysplasia 1 (TD1) [MIM:187600] |
FGFR3 |
Thanatophoric dysplasia 2 (TD2) [MIM:187601] |
FGFR3 |
Thrombocythemia |
Thrombocythemia 3 (THCYT3) [MIM:614521] |
JAK2 |
Thrombocytopenia |
Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies (THC11) [MIM:620654] |
RAP1B |
Thrombophilia |
Thrombophilia due to activated protein C resistance (THPH2) [MIM:188055] |
F5 |
Thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:612356] |
SERPIND1 |
Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860] |
PROC |
Thrombophilia due to protein C deficiency, autosomal recessive (THPH4) [MIM:612304] |
PROC |
Thrombophilia, X-linked, due to factor IX defect (THPH8) [MIM:300807] |
F9 |
Thyroid dyshormonogenesis |
Selective pituitary thyroid hormone resistance (PRTH) [MIM:145650] |
THRB |
Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570] |
THRB |
Tonne-Kalscheuer syndrome |
Tonne-Kalscheuer syndrome (TOKAS) [MIM:300978] |
RLIM |
Treacher Collins syndrome |
Treacher Collins syndrome 2 (TCS2) [MIM:613717] |
POLR1D |
Treacher Collins syndrome 3 (TCS3) [MIM:248390] |
POLR1C |
Trichothiodystrophy |
Autoinflammation, panniculitis, and dermatosis syndrome (AIPDS) [MIM:617099] |
OTULIN |
Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675] |
ERCC2 |
Trichothiodystrophy 3, photosensitive (TTD3) [MIM:616395] |
GTF2H5 |
Triosephosphate isomerase deficiency |
Triosephosphate isomerase deficiency (TPID) [MIM:615512] |
TPI1 |
Tuberous sclerosis |
Tuberous sclerosis 2 (TSC2) [MIM:613254] |
TSC2 |
Tuberous sclerosis 1 (TSC1) [MIM:191100] |
Tuberous sclerosis 1 (TSC1) [MIM:191100] |
TSC1 |
UV-sensitive syndrome |
UV-sensitive syndrome 3 (UVSS3) [MIM:614640] |
UVSSA |
Usher syndrome |
Usher syndrome 1G (USH1G) [MIM:606943] |
USH1G |
Usmani-Riazuddin syndrome, autosomal |
Usmani-Riazuddin syndrome, autosomal dominant (USRISD) [MIM:619467] |
AP1G1 |
Usmani-Riazuddin syndrome, autosomal recessive (USRISR) [MIM:619548] |
AP1G1 |
Van Esch-O'Driscoll syndrome |
Van Esch-O'Driscoll syndrome (VEODS) [MIM:301030] |
POLA1 |
Ventricular tachycardia |
Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916] |
CALM1 |
Ventricular tachycardia, catecholaminergic polymorphic, 6 (CPVT6) [MIM:618782] |
CALM3 |
Verheij syndrome |
Verheij syndrome (VRJS) [MIM:615583] |
PUF60 |
Vissers-Bodmer syndrome (VIBOS) [MIM:619033] |
Vissers-Bodmer syndrome (VIBOS) [MIM:619033] |
CNOT1 |
Vohwinkel syndrome |
Vohwinkel syndrome (VOWNKL) [MIM:124500] |
GJB2 |
Von Hippel-Lindau disease |
Von Hippel-Lindau disease (VHLD) [MIM:193300] |
VHL |
Von Willebrand disease |
Von Willebrand disease 3 (VWD3) [MIM:277480] |
VWF |
Waardenburg syndrome |
Waardenburg syndrome 1 (WS1) [MIM:193500] |
PAX3 |
Waardenburg syndrome 2A (WS2A) [MIM:193510] |
MITF |
Waardenburg syndrome 2E (WS2E) [MIM:611584] |
SOX10 |
Waardenburg syndrome 3 (WS3) [MIM:148820] |
PAX3 |
Warburg-Cinotti syndrome |
Warburg-Cinotti syndrome (WRCN) [MIM:618175] |
DDR2 |
Weaver syndrome |
Weaver syndrome (WVS) [MIM:277590] |
EZH2 |
White sponge nevus |
White sponge nevus 1 (WSN1) [MIM:193900] |
KRT4 |
White-Kernohan syndrome |
White-Kernohan syndrome (WHIKERS) [MIM:619426] |
DDB1 |
Wilms tumor |
Global developmental delay, lung cysts, overgrowth, and Wilms tumor (GLOW) [MIM:618272] |
DICER1 |
Wilms tumor 1 (WT1) [MIM:194070] |
WT1 |
Wolff-Parkinson-White syndrome |
Wolff-Parkinson-White syndrome (WPW) [MIM:194200] |
PRKAG2 |
Xeroderma pigmentosum |
Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700] |
XPA |
Xeroderma pigmentosum complementation group B (XP-B) [MIM:610651] |
ERCC3 |
Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
ERCC2 |
Xeroderma pigmentosum complementation group E (XP-E) [MIM:278740] |
DDB2 |
Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
ERCC4 |
Xeroderma pigmentosum variant type (XPV) [MIM:278750] |
POLH |
Zimmermann-Laband syndrome |
Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500] |
KCNH1 |
Zinc deficiency |
Zinc deficiency, transient neonatal (TNZD) [MIM:608118] |
SLC30A2 |
[Show all]
|
Diseases with mutations on the two sides of the same interaction |
Disease | Phenotype | Relevant interactions |
---|
3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200] |
3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200] |
(MCCC1,MCCC2) |
3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210] |
3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210] |
(MCCC1,MCCC2) |
ADULT syndrome |
Acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) [MIM:103285] |
(TP53,TP63) |
Achondroplasia |
Achondroplasia (ACH) [MIM:100800] |
(FGFR2,FGFR3) |
Achondroplasia, severe, with developmental delay and acanthosis nigricans (SADDAN) [MIM:616482] |
(FGFR2,FGFR3) |
Achromatopsia |
Achromatopsia 2 (ACHM2) [MIM:216900] |
(CNGA3,CNGB3) |
Achromatopsia 3 (ACHM3) [MIM:262300] |
Achromatopsia 3 (ACHM3) [MIM:262300] |
(CNGA3,CNGB3) |
Acrodysostosis |
Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800] |
(PRKAR1A,PRKACB), (PRKAR1A,PRKACA) |
Acromesomelic dysplasia |
Acromesomelic dysplasia 2B (AMD2B) [MIM:228900] |
(GDF5,NOG), (GDF5,HJV) |
Adenosine monophosphate deaminase deficiency |
Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
(AMPD3,AMPD2) |
Adrenal hyperplasia |
ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080] |
(GNB1,GNAS), (AVPR2,GNAS) |
Adrenal hypoplasia, congenital (AHC) [MIM:300200] |
(NR0B1,NR5A1) |
Afibrinogenemia |
Congenital afibrinogenemia (CAFBN) [MIM:202400] |
(FGA,FGG), (FGB,FGG), (FGA,FGB), (F2,FGA) |
Agammaglobulinemia |
X-linked agammaglobulinemia (XLA) [MIM:300755] |
(MET,BTK) |
Age-related macular degeneration |
Macular degeneration, age-related, 3 (ARMD3) [MIM:608895] |
(EFEMP2,FBLN5) |
Macular degeneration, age-related, 4 (ARMD4) [MIM:610698] |
(C3,CFH) |
Aicardi-Goutieres syndrome |
Aicardi-Goutieres syndrome 2 (AGS2) [MIM:610181] |
(RNASEH2A,RNASEH2B), (RNASEH2B,RNASEH2C) |
Aicardi-Goutieres syndrome 3 (AGS3) [MIM:610329] |
(RNASEH2A,RNASEH2C), (RNASEH2B,RNASEH2C) |
Aicardi-Goutieres syndrome 4 (AGS4) [MIM:610333] |
(RNASEH2A,RNASEH2B), (RNASEH2A,RNASEH2C) |
Alacrima, achalasia, and impaired intellectual development syndrome |
Alacrima, achalasia, and impaired intellectual development syndrome (AAMR) [MIM:615510] |
(GMPPA,GMPPB) |
Alagille syndrome |
Alagille syndrome 1 (ALGS1) [MIM:118450] |
(JAG1,NOTCH3) |
Alexander disease |
Alexander disease (ALXDRD) [MIM:203450] |
(GFAP,DES), (VIM,GFAP) |
Alpha-thalassemia/impaired intellectual development syndrome, X-linked |
Alpha-thalassemia/impaired intellectual development syndrome, X-linked (ATRX) [MIM:301040] |
(ATRX,H3-3B) |
Alzheimer disease |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP,PSEN1), (APP,PSEN2) |
Alzheimer disease mitochondrial (AD-MT) [MIM:502500] |
(NDUFS8,MT-ND1), (NDUFS2,MT-ND1) |
Alzheimer disease 3 (AD3) [MIM:607822] |
Alzheimer disease 3 (AD3) [MIM:607822] |
(APP,PSEN1) |
Alzheimer disease 4 (AD4) [MIM:606889] |
Alzheimer disease 4 (AD4) [MIM:606889] |
(APP,PSEN2) |
Amyotrophic lateral sclerosis |
Amyotrophic lateral sclerosis 18 (ALS18) [MIM:614808] |
(PFN1,ACTB) |
Antithrombin III deficiency (AT3D) [MIM:613118] |
Antithrombin III deficiency (AT3D) [MIM:613118] |
(F9,SERPINC1), (F10,SERPINC1), (F2,SERPINC1) |
Aortic aneurysm |
Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788] |
(ACTA2,ACTA1), (ACTA2,ACTG2), (ACTA2,ACTC1) |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
(CALM1,MYLK) |
Apert syndrome |
Apert syndrome (APRS) [MIM:101200] |
(FGF10,FGFR2) |
Arthrogryposis |
Arthrogryposis, distal, 11 (DA11) [MIM:620019] |
(MET,BTK) |
Arthrogryposis, distal, 1A (DA1A) [MIM:108120] |
(TPM2,TPM1) |
Arthrogryposis, distal, 2B4 (DA2B4) [MIM:108120] |
(TPM2,TPM1) |
Atrial septal defect |
Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378] |
(SCN2B,SCN2A) |
Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980] |
(KCNJ18,KCNJ2) |
Autism |
Diaphragmatic hernia 5, X-linked (DIH5) [MIM:306950] |
(PLS3,ACTB) |
Autoimmune disease, multisystem, infantile-onset, |
Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952] |
(STAT3,STAT1), (RET,STAT3) |
Coffin-Siris syndrome 4 (CSS4) [MIM:614609] |
(SMARCA4,CHD4) |
Autoimmune lymphoproliferative syndrome |
Autoimmune lymphoproliferative syndrome 1A (ALPS1A) [MIM:601859] |
(CALM1,FAS), (FAS,FADD) |
Baraitser-Winter syndrome |
Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310] |
(ACTB,ACTA1) |
Bardet-Biedl syndrome |
Bardet-Biedl syndrome 1 (BBS1) [MIM:209900] |
(BBS1,BBS4) |
Bardet-Biedl syndrome 10 (BBS10) [MIM:615987] |
(BBS10,MKKS) |
Bardet-Biedl syndrome 2 (BBS2) [MIM:615981] |
(BBS7,BBS2) |
Bardet-Biedl syndrome 4 (BBS4) [MIM:615982] |
(BBS1,BBS4) |
Bardet-Biedl syndrome 6 (BBS6) [MIM:605231] |
(BBS10,MKKS) |
Bardet-Biedl syndrome 7 (BBS7) [MIM:615984] |
(BBS7,BBS2) |
Bart-Pumphrey syndrome |
Bart-Pumphrey syndrome (BAPS) [MIM:149200] |
(GJB2,GJA8), (GJB1,GJB2) |
Basal cell nevus syndrome |
Becker nevus syndrome (BNS) [MIM:604919] |
(ACTN2,ACTB), (PLS3,ACTB) |
Basal ganglia calcification, idiopathic, 8, autosomal recessive |
Basal ganglia calcification, idiopathic, 8, autosomal recessive (IBGC8) [MIM:618824] |
(JAM2,JAM3) |
Beckwith-Wiedemann syndrome (BWS) [MIM:130650] |
Beckwith-Wiedemann syndrome (BWS) [MIM:130650] |
(CDK4,CDKN1C) |
Bethlem myopathy |
Myopathy, scapulohumeroperoneal (SHPM) [MIM:616852] |
(ACTB,ACTA1) |
Visceral myopathy 1 (VSCM1) [MIM:155310] |
(ACTA2,ACTG2), (ACTG2,ACTC1), (ACTG2,ACTA1) |
Bladder cancer |
Bladder cancer (BLC) [MIM:109800] |
(FGFR2,FGFR3), (FGFR3,FGF9) |
Bleeding disorder |
Bleeding disorder, platelet-type, 11 (BDPLT11) [MIM:614201] |
(COL1A1,GP6) |
Bleeding disorder, platelet-type, 16 (BDPLT16) [MIM:187800] |
(ITGB3,ITGA2B) |
Bleeding disorder, platelet-type, 18 (BDPLT18) [MIM:615888] |
(RAP1B,RASGRP2) |
Bleeding disorder, platelet-type, 24 (BDPLT24) [MIM:619271] |
(ITGB3,ITGA2B) |
Brachydactyly |
Brachydactyly A1 (BDA1) [MIM:112500] |
(IHH,SHH) |
Brachydactyly A1, C (BDA1C) [MIM:615072] |
(GDF5,NOG), (GDF5,HJV) |
Brachydactyly B2 (BDB2) [MIM:611377] |
(GDF5,NOG) |
Brachydactyly C (BDC) [MIM:113100] |
(GDF5,BMPR2), (GDF5,NOG) |
Breast cancer |
Breast cancer (BC) [MIM:114480] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA) |
Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399] |
(RAD51C,RAD51) |
Brody myopathy |
Brody disease (BROD) [MIM:601003] |
(ATP2A1,ATP2A2) |
Bronchiectasis |
Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400] |
(SCNN1A,SCNN1B) |
Bronchiectasis with or without elevated sweat chloride 2 (BESC2) [MIM:613021] |
(SCNN1A,SCNN1B) |
Brugada syndrome |
Brugada syndrome 1 (BRGDA1) [MIM:601144] |
(CALM1,SCN5A) |
Bryant-Li-Bhoj neurodevelopmental syndrome |
Bryant-Li-Bhoj neurodevelopmental syndrome 2 (BRYLIB2) [MIM:619721] |
(ATRX,H3-3B), (H4C16,H3-3B), (H3-3B,DNMT3A) |
Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720] |
Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720] |
(ATRX,H3-3B), (H4C16,H3-3B), (H3-3B,DNMT3A) |
CLAPO syndrome |
CLAPO syndrome (CLAPO) [MIM:613089] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA) |
CLOVE syndrome |
Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) [MIM:612918] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA) |
Camptodactyly tall stature and hearing loss syndrome |
Camptodactyly, tall stature, and hearing loss syndrome (CATSHLS) [MIM:610474] |
(FGFR2,FGFR3) |
Cardiofaciocutaneous syndrome |
Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150] |
(NRAS,BRAF), (BRAF,YWHAG) |
Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278] |
(KRAS,SOS1), (KRAS,NF1) |
Cardiomyopathy |
Cardiomyopathy, dilated, 1A (CMD1A) [MIM:115200] |
(LMNA,LMNB2), (LMNA,LMNB1), (BANF1,LMNA), (KRT6A,LMNA) |
Cardiomyopathy, dilated, 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158] |
(ACTN2,ACTB) |
Cardiomyopathy, dilated, 1D (CMD1D) [MIM:601494] |
(TPM1,TNNT2) |
Cardiomyopathy, dilated, 1FF (CMD1FF) [MIM:613286] |
(TNNI3,TNNC1), (CALM2,TNNI3), (TNNI3,TNNT2) |
Cardiomyopathy, dilated, 1GG (CMD1GG) [MIM:613642] |
(SDHB,SDHA) |
Cardiomyopathy, dilated, 1II (CMD1II) [MIM:615184] |
(CRYAA,CRYAB) |
Cardiomyopathy, dilated, 1R (CMD1R) [MIM:613424] |
(ACTA2,ACTC1), (ACTC1,ACTA1), (ACTG2,ACTC1) |
Cardiomyopathy, dilated, 1S (CMD1S) [MIM:613426] |
(MYL3,MYH7), (MYH7,ACTC1) |
Cardiomyopathy, dilated, 1Z (CMD1Z) [MIM:611879] |
(TNNI3,TNNC1) |
Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112] |
(LMNA,LMNB2), (LMNA,LMNB1) |
Cardiomyopathy, familial hypertrophic, 10 (CMH10) [MIM:608758] |
(MYL2,MYH7) |
Cardiomyopathy, familial hypertrophic, 11 (CMH11) [MIM:612098] |
(ACTC1,ACTA1), (ACTA2,ACTC1), (ACTG2,ACTC1), (MYH7,ACTC1), (TPM1,ACTC1) |
Cardiomyopathy, familial hypertrophic, 13 (CMH13) [MIM:613243] |
(TNNI3,TNNC1), (TNNT2,TNNC1) |
Cardiomyopathy, familial hypertrophic, 2 (CMH2) [MIM:115195] |
(TPM1,TNNT2), (TNNT2,TNNC1), (TNNI3,TNNT2) |
Cardiomyopathy, familial hypertrophic, 23, with or without left ventricular non-compaction (CMH23) [MIM:612158] |
(ACTN2,ACTB) |
Cardiomyopathy, familial hypertrophic, 3 (CMH3) [MIM:115196] |
(TPM2,TPM1), (TPM1,ACTC1) |
Cardiomyopathy, familial hypertrophic, 7 (CMH7) [MIM:613690] |
(TNNI3,TNNC1), (CALM2,TNNI3), (TNNC2,TNNI3) |
Cardiomyopathy, familial hypertrophic, 8 (CMH8) [MIM:608751] |
(MYL3,MYH7) |
Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210] |
(TNNI3,TNNC1), (CALM2,TNNI3), (TNNC2,TNNI3) |
Cardiomyopathy, familial hypertrophic, 1 (CMH1) [MIM:192600] |
Cardiomyopathy, familial hypertrophic, 1 (CMH1) [MIM:192600] |
(MYH7,XRCC4), (MYL3,MYH7), (MYH7,ACTC1), (MYL2,MYH7) |
Cardiomyopathy, familial hypertrophic, 4 (CMH4) [MIM:115197] |
Cardiomyopathy, familial hypertrophic, 4 (CMH4) [MIM:115197] |
(ACTG1,MYBPC3) |
Carney complex |
Carney complex 1 (CNC1) [MIM:160980] |
(PRKAR1A,PRKAR1B) |
Cataract |
Cataract 30, multiple types (CTRCT30) [MIM:116300] |
(VIM,GFAP) |
Cataract 31, multiple types (CTRCT31) [MIM:605387] |
(CHMP4B,CHMP2B) |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450] |
(POLG,POLG2) |
Cataract 1, multiple types (CTRCT1) [MIM:116200] |
Cataract 1, multiple types (CTRCT1) [MIM:116200] |
(GJB2,GJA8) |
Cataract 9, multiple types (CTRCT9) [MIM:604219] |
Cataract 9, multiple types (CTRCT9) [MIM:604219] |
(CRYAA,HSPB1), (CRYAA,CRYAB) |
Cerebellar atrophy, visual impairment, and psychomotor retardation |
Cerebellar ataxia, brain abnormalities, and cardiac conduction defects (CABAC) [MIM:619576] |
(EXOSC5,EXOSC3) |
Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures (NEDHCAS) [MIM:618879] |
(GPAA1,PIGK) |
Cerebral amyloid angiopathy |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP,PSEN1), (APP,PSEN2) |
Cerebral arteriopathy |
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 (CADASIL1) [MIM:125310] |
(JAG1,NOTCH3) |
Cerebral cavernous malformations |
Cerebral cavernous malformations 4 (CCM4) [MIM:619538] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA) |
Cerebrooculofacioskeletal syndrome |
Cerebro-oculo-facio-skeletal syndrome 4 (COFS4) [MIM:610758] |
(ERCC1,ERCC4) |
Cerebroretinal microangiopathy with calcifications and cysts |
Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199] |
(CTC1,STN1) |
Cerebroretinal microangiopathy with calcifications and cysts 2 (CRMCC2) [MIM:617341] |
(CTC1,STN1) |
Cervical cancer |
Cervical cancer (CERCA) [MIM:603956] |
(FGFR3,FGF9) |
Charcot-Marie-Tooth disease |
Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800] |
(GJB1,GJB2) |
Charcot-Marie-Tooth disease, demyelinating, 1H (CMT1H) [MIM:619764] |
(EFEMP2,FBLN5) |
Charcot-Marie-Tooth disease, demyelinating, 1I (CMT1I) [MIM:619742] |
(POLR3A,POLR3B) |
Chronic granulomatous disease |
Granulomatous disease, chronic, X-linked (CGDX) [MIM:306400] |
(CYBB,RAC1), (CYBB,NCF2) |
Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710] |
(NCF2,RAC1), (CYBB,NCF2) |
Coagulation factor deficiency |
Factor II deficiency (FA2D) [MIM:613679] |
(F2,PROC), (F2,SERPIND1), (F2,SERPINC1), (F2,F5), (F2,GP1BA), (F2,FGB), (F2,FGA) |
Factor VII deficiency (FA7D) [MIM:227500] |
(F7,POGLUT1) |
Coffin-Lowry syndrome |
Coffin-Lowry syndrome (CLS) [MIM:303600] |
(MAPK1,RPS6KA3) |
Cohen-Gibson syndrome |
Cohen-Gibson syndrome (COGIS) [MIM:617561] |
(EED,EZH2) |
Colorectal cancer |
Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470] |
(HRAS,NF1), (HRAS,SOS1) |
Colorectal cancer (CRC) [MIM:114500] |
Colorectal cancer (CRC) [MIM:114500] |
(PIK3R1,PIK3CA), (BRAF,YWHAG), (PIK3R2,PIK3CA) |
Combined immunodeficiency |
Immunodeficiency 98 with autoinflammation, X-linked (IMD98) [MIM:301078] |
(TLR8,TLR7) |
Combined oxidative phosphorylation |
Combined oxidative phosphorylation deficiency 30 (COXPD30) [MIM:616974] |
(TRMT10C,HSD17B10) |
Combined oxidative phosphorylation deficiency |
Combined oxidative phosphorylation deficiency 19 (COXPD19) [MIM:615595] |
(LYRM4,NFS1) |
Combined oxidative phosphorylation deficiency 36 (COXPD36) [MIM:617950] |
(MRPS2,MRPS23), (MRPS28,MRPS2) |
Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 (HUMOP2) [MIM:620085] |
(ATP5F1B,ATP5F1A) |
Combined oxidative phosphorylation deficiency II |
Combined oxidative phosphorylation deficiency 46 (COXPD46) [MIM:618952] |
(MRPS2,MRPS23) |
Combined oxidative phosphorylation deficiency 47 (COXPD47) [MIM:618958] |
(MRPS28,MRPS2) |
Combined oxidative phosphorylation deficiency 52 (COXPD52) [MIM:619386] |
(LYRM4,NFS1), (FXN,NFS1) |
Complement component deficiency |
C1q deficiency 2 (C1QD2) [MIM:620321] |
(C1QB,C1QC) |
C1q deficiency 3 (C1QD3) [MIM:620322] |
(C1QB,C1QC) |
Metachromatic leukodystrophy due to saposin B deficiency (MLDSAPB) [MIM:249900] |
(GLA,PSAP) |
Complement factors deficiency |
Complement factor H deficiency (CFHD) [MIM:609814] |
(CFI,CFH), (C3,CFH) |
Cone-rod dystrophy |
Cone dystrophy retinal 3B (RCD3B) [MIM:610356] |
(KCNC1,KCNV2), (KCNB1,KCNV2) |
Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940] |
(PCYT1A,NMNAT1) |
Congenital clubfoot |
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly (CCF) [MIM:119800] |
(MSX2,PITX1) |
Congenital heart defects |
Sifrim-Hitz-Weiss syndrome (SIHIWES) [MIM:617159] |
(SMARCA4,CHD4) |
Takenouchi-Kosaki syndrome (TKS) [MIM:616737] |
(WAS,CDC42) |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTN2,ACTB), (PLS3,ACTB) |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
(KRT2,KRT12), (DES,KRT12), (KRT5,KRT12) |
Cornelia de Lange syndrome |
Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470] |
(SMC1A,NIPBL) |
Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590] |
(SMC1A,NIPBL) |
Cornelia de Lange syndrome 4 with or without midline brain defects (CDLS4) [MIM:614701] |
(RAD21,STAG2), (RAD21,STAG1) |
Cortical dysplasia complex with other brain malformations |
Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039] |
(TUBB3,TUBA1A) |
Cortical dysplasia, complex, with other brain malformations 5 (CDCBM5) [MIM:615763] |
(TUBB,TUBB2A) |
Cortical dysplasia, complex, with other brain malformations 6 (CDCBM6) [MIM:615771] |
(TUBB,TUBA1A), (TUBB,TUBB2B), (TUBB,TUBB4B), (TUBB,TUBB2A) |
Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031] |
(TUBB,TUBB2B) |
Cowden disease |
Cowden syndrome 5 (CWS5) [MIM:615108] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA) |
Cowden syndrome 6 (CWS6) [MIM:615109] |
(PRKACA,AKT1) |
Craniosynostosis |
Craniosynostosis 3 (CRS3) [MIM:615314] |
(MAX,TCF12) |
Crouzon syndrome |
Crouzon syndrome (CS) [MIM:123500] |
(FGFR2,FGFR3), (FGF10,FGFR2), (FGFR1,FGFR2) |
Cutis laxa |
Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100] |
(EFEMP2,FBLN5) |
Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437] |
(EFEMP2,FBLN5) |
Darier disease |
Darier disease (DD) [MIM:124200] |
(ATP2A1,ATP2A2) |
Deafness |
Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717] |
(ACTG1,MYBPC3) |
Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544] |
(GJB2,GJA8), (GJB1,GJB2) |
Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290] |
(GJB2,GJA8), (GJB1,GJB2) |
Hypokalemic tubulopathy and deafness (HKTD) [MIM:619406] |
(KCNJ10,KCNJ16) |
Leukodystrophy, hypomyelinating, 21 (HLD21) [MIM:619310] |
(POLR3A,POLR3K) |
Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance (SESAMES) [MIM:612780] |
(KCNJ10,KCNJ16) |
Dehydrated hereditary stomatocytosis 2 |
Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689] |
(KCNN4,CALM1) |
Dementia |
Frontotemporal dementia (FTD) [MIM:600274] |
(MAPT,TUBA1A), (APP,PSEN1), (MAPT,TUBB3) |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439] |
(OPTN,TBK1) |
Diabetes insipidus |
Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800] |
(AVPR2,GNB1), (AVP,AVPR2), (AVPR2,GNAS) |
Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700] |
(AVP,AVPR2) |
Diabetes mellitus |
Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856] |
(ABCC8,KCNJ11) |
Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857] |
(ABCC8,KCNJ11) |
Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858] |
(INS,INSR), (INS,IGF1R) |
Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
(INSR,IGF1R), (INS,INSR) |
Transient neonatal diabetes mellitus 3 (TNDM3) [MIM:610582] |
(ABCC8,KCNJ11) |
Dowling-Degos disease |
Dowling-Degos disease 4 (DDD4) [MIM:615696] |
(F7,POGLUT1) |
Dysfibrinogenemia |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
(FGA,FGG), (FGB,FGG), (FGA,FGB), (F2,FGB), (F2,FGA) |
Dyskeratosis congenita |
Dyskeratosis congenita, X-linked (DKCX) [MIM:305000] |
(DKC1,NOP10) |
Dyskeratosis congenita, autosomal recessive, 1 (DKCB1) [MIM:224230] |
(DKC1,NOP10) |
Dystonia |
Epilepsy, progressive myoclonic 9 (EPM9) [MIM:616540] |
(LMNB1,LMNB2) |
Dystonia-deafness syndrome 1 |
Dystonia-deafness syndrome 1 (DDS1) [MIM:607371] |
(ACTB,ACTA1) |
Ectodermal dysplasia |
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD10B) [MIM:224900] |
(EDA,EDAR) |
Ectodermal dysplasia and immunodeficiency 2 (EDAID2) [MIM:612132] |
(NFKBIA,FBXW11) |
Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100] |
Ectodermal dysplasia 1, hypohidrotic, X-linked (XHED) [MIM:305100] |
(EDA,EDAR) |
Ehlers-Danlos syndrome |
Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050] |
(COL3A1,SPARC) |
Elliptocytosis |
Elliptocytosis 2 (EL2) [MIM:130600] |
(SPTA1,SPTB) |
Elliptocytosis 3 (EL3) [MIM:617948] |
(SPTA1,SPTB), (SPTB,SPTAN1) |
Emery-Dreifuss muscular dystrophy |
Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516] |
(LMNA,LMNB2), (LMNA,LMNB1) |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350] |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350] |
(KRT6A,LMNA), (LMNA,LMNB1), (LMNA,LMNB2), (BANF1,LMNA) |
Encephalocraniocutaneous lipomatosis |
Encephalocraniocutaneous lipomatosis (ECCL) [MIM:613001] |
(FGFR1,FGFR2) |
Enhanced S cone syndrome |
Enhanced S cone syndrome (ESCS) [MIM:268100] |
(PPARG,NR2E3) |
Epidermolysis bullosa |
Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760] |
(KRT14,KRT2), (KRT14,DES), (KRT14,KRT5), (KRT14,KRT81), (KRT86,KRT14), (KRT14,KRT4), (KRT14,KRT6A), (KRT14,KRT3) |
Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900] |
(KRT14,KRT2), (KRT14,DES), (KRT14,KRT5), (KRT14,KRT81), (KRT86,KRT14), (KRT14,KRT4), (KRT14,KRT6A), (KRT14,KRT3) |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14,KRT2), (KRT14,DES), (KRT14,KRT5), (KRT14,KRT81), (KRT86,KRT14), (KRT14,KRT4), (KRT14,KRT6A), (KRT14,KRT3) |
Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive (EBS1D) [MIM:601001] |
(KRT14,KRT2), (KRT14,DES), (KRT14,KRT5), (KRT14,KRT81), (KRT86,KRT14), (KRT14,KRT4), (KRT14,KRT6A), (KRT14,KRT3) |
Epidermolysis bullosa simplex 2A, generalized severe (EBS2A) [MIM:619555] |
(KRT16,KRT5), (KRT14,KRT5), (KRT5,KRT12), (KRT5,KRT17), (KRT5,KRT25), (KRT5,DES) |
Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B) [MIM:619588] |
(KRT16,KRT5), (KRT14,KRT5), (KRT5,KRT12), (KRT5,KRT17), (KRT5,DES), (KRT5,KRT25) |
Epidermolysis bullosa simplex 2C, localized (EBS2C) [MIM:619594] |
(KRT16,KRT5), (KRT14,KRT5), (KRT5,KRT12), (KRT5,KRT17), (KRT5,KRT25), (KRT5,DES) |
Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive (EBS2D) [MIM:619599] |
(KRT16,KRT5), (KRT14,KRT5), (KRT5,KRT12), (KRT5,KRT17), (KRT5,DES), (KRT5,KRT25) |
Epidermolytic hyperkeratosis |
Epidermolytic hyperkeratosis 1 (EHK1) [MIM:113800] |
(KRT1,KRT10), (KRT1,DES) |
Epidermolytic hyperkeratosis 2A (EHK2A) [MIM:620150] |
(KRT1,KRT10) |
Epilepsy |
Developmental and epileptic encephalopathy 104 (DEE104) [MIM:619970] |
(ATP6V0C,ATP6V0A1) |
Developmental and epileptic encephalopathy 11 (DEE11) [MIM:613721] |
(SCN2B,SCN2A) |
Developmental and epileptic encephalopathy 19 (DEE19) [MIM:615744] |
(GABRA1,GABRB1), (GABRA1,GABRG2), (GABRA1,GABRB2), (GABRA1,GABRB3) |
Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871] |
(HCN1,HCN2) |
Developmental and epileptic encephalopathy 26 (DEE26) [MIM:616056] |
(KCNH1,KCNB1), (KCNB1,KCNV2) |
Developmental and epileptic encephalopathy 27 (DEE27) [MIM:616139] |
(GRIN1,GRIN2B) |
Developmental and epileptic encephalopathy 4 (DEE4) [MIM:612164] |
(STX1B,STXBP1) |
Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113] |
(GABRA1,GABRB3), (GABRB3,GABRA2), (GABRB3,GABRA5), (GABRG2,GABRB3) |
Developmental and epileptic encephalopathy 45 (DEE45) [MIM:617153] |
(GABRA1,GABRB1), (GABRB1,GABRA2), (GABRB1,GABRG2) |
Developmental and epileptic encephalopathy 46 (DEE46) [MIM:617162] |
(GRIN2D,GRIN1) |
Developmental and epileptic encephalopathy 47 (DEE47) [MIM:617166] |
(FGF12,SCN5A), (SCN1A,FGF12) |
Developmental and epileptic encephalopathy 5 (DEE5) [MIM:613477] |
(SPTBN1,SPTAN1), (SPTBN2,SPTAN1) |
Developmental and epileptic encephalopathy 56 (DEE56) [MIM:617665] |
(YWHAG,LRRK2), (RAF1,YWHAG), (BRAF,YWHAG), (MAPT,YWHAG) |
Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720] |
(KCNQ2,CALM1), (KCNQ2,CALM3) |
Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396] |
(GABRG2,GABRA5), (GABRA1,GABRG2), (GABRG2,GABRB2), (GABRG2,GABRB3), (GABRB1,GABRG2) |
Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557] |
(GABRA2,GABRB2), (GABRB1,GABRA2), (GABRB3,GABRA2) |
Developmental and epileptic encephalopathy 79 (DEE79) [MIM:618559] |
(GABRG2,GABRA5), (GABRB3,GABRA5) |
Dravet syndrome (DRVT) [MIM:607208] |
(SCN1A,FGF12) |
Epilepsy, childhood absence 2 (ECA2) [MIM:607681] |
(GABRG2,GABRA5), (GABRG2,GABRB2), (GABRB1,GABRG2), (GABRG2,GABRB3) |
Epilepsy, childhood absence 5 (ECA5) [MIM:612269] |
(GABRB3,GABRA2), (GABRG2,GABRB3) |
Epilepsy, idiopathic generalized 17 (EIG17) [MIM:602477] |
(HCN1,HCN2) |
Epilepsy, nocturnal frontal lobe, 1 (ENFL1) [MIM:600513] |
(CHRNB2,CHRNA4) |
Epilepsy, nocturnal frontal lobe, 3 (ENFL3) [MIM:605375] |
(CHRNB2,CHRNA4) |
Epilepsy, progressive myoclonic 7 (EPM7) [MIM:616187] |
(KCNC1,KCNV2) |
Generalized epilepsy with febrile seizures plus 10 (GEFSP10) [MIM:618482] |
(HCN1,HCN2) |
Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM:604403] |
(SCN1A,FGF12) |
Generalized epilepsy with febrile seizures plus 3 (GEFSP3) [MIM:607681] |
(GABRG2,GABRA5), (GABRG2,GABRB2), (GABRG2,GABRB3), (GABRB1,GABRG2) |
Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172] |
(STX1B,STXBP1) |
Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
(SCN1A,FGF12) |
Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136] |
(GABRA1,GABRG2), (GABRA1,GABRB2), (GABRA1,GABRB3) |
Epilepsy, early-onset, 3, with or without developmental delay (EPEO3) [MIM:620465] |
Epilepsy, early-onset, 3, with or without developmental delay (EPEO3) [MIM:620465] |
(ATP6V0C,ATP6V0A1) |
Epileptic encephalopathy |
Epileptic encephalopathy, infantile or early childhood, 2 (IECEE2) [MIM:617829] |
(GABRA2,GABRB2), (GABRG2,GABRB2), (GABRA1,GABRB2) |
Erythrocytosis |
Erythrocytosis, familial, 3 (ECYT3) [MIM:609820] |
(EPAS1,EGLN1) |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(EPAS1,EGLN1), (VHL,EPAS1) |
Exudative vitreoretinopathy |
Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780] |
(NDP,FZD4) |
Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390] |
(NDP,FZD4) |
Fabry disease |
Fabry disease (FD) [MIM:301500] |
(GLA,PSAP) |
Faciocutaneoskeletal syndrome |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS,NF1), (HRAS,SOS1) |
Factor X deficiency (FA10D) [MIM:227600] |
Factor X deficiency (FA10D) [MIM:227600] |
(F10,SERPINC1) |
Factor XIII subunit A deficiency (FA13AD) [MIM:613225] |
Factor XIII subunit A deficiency (FA13AD) [MIM:613225] |
(F13A1,F13B) |
Factor XIII subunit B deficiency (FA13BD) [MIM:613235] |
Factor XIII subunit B deficiency (FA13BD) [MIM:613235] |
(F13A1,F13B) |
Familial hyperproinsulinemia |
Hyperproinsulinemia (HPRI) [MIM:616214] |
(INS,INSR), (INS,IGF1R) |
Fanconi anemia |
Fanconi anemia complementation group Q (FANCQ) [MIM:615272] |
(ERCC1,ERCC4) |
Fanconi anemia, complementation group R (FANCR) [MIM:617244] |
(RAD51C,RAD51) |
Faundes-Banka syndrome |
Faundes-Banka syndrome (FABAS) [MIM:619376] |
(DHPS,EIF5A) |
Feingold syndrome |
Feingold syndrome 1 (FGLDS1) [MIM:164280] |
(MYCN,MAX) |
Fibrosis of extraocular muscles |
Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638] |
(MAPT,TUBB3) |
Focal cortical dysplasia 2 (FCORD2) [MIM:607341] |
Focal cortical dysplasia 2 (FCORD2) [MIM:607341] |
(TSC2,TSC1) |
Friedreich ataxia |
Friedreich ataxia (FRDA) [MIM:229300] |
(FXN,NFS1) |
Frontotemporal |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 (FTDALS7) [MIM:600795] |
(CHMP4B,CHMP2B) |
GM1/2-gangliosidosis |
GM1-gangliosidosis 1 (GM1G1) [MIM:230500] |
(CTSA,GLB1) |
GM1-gangliosidosis 2 (GM1G2) [MIM:230600] |
(CTSA,GLB1) |
GM2-gangliosidosis 1 (GM2G1) [MIM:272800] |
(HEXA,HEXB) |
GM2-gangliosidosis 2 (GM2G2) [MIM:268800] |
(HEXA,HEXB) |
Galactosialidosis |
Galactosialidosis (GSL) [MIM:256540] |
(CTSA,GLB1) |
Galloway-Mowat syndrome |
Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729] |
(TP53RK,OSGEP) |
Galloway-Mowat syndrome 4 (GAMOS4) [MIM:617730] |
(TP53RK,OSGEP) |
Gastric cancer |
Gastric cancer (GASC) [MIM:613659] |
(KRAS,NF1), (KRAS,SOS1) |
Germ cell tumor |
Testicular germ cell tumor (TGCT) [MIM:273300] |
(FGFR2,FGFR3) |
Glanzmann thrombasthenia |
Glanzmann thrombasthenia 1 (GT1) [MIM:273800] |
(ITGB3,ITGA2B) |
Glanzmann thrombasthenia 2 (GT2) [MIM:619267] |
(ITGB3,ITGA2B) |
Glaucoma 1, open angle, E (GLC1E) [MIM:137760] |
Glaucoma 1, open angle, E (GLC1E) [MIM:137760] |
(OPTN,TBK1) |
Glioma (GLM) [MIM:137800] |
Glioma (GLM) [MIM:137800] |
(H3C12,EZH2), (KDM6B,H3C12) |
Glomerulocystic kidney disease |
Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
(HNF1A,HNF1B) |
Glucocorticoid resistance, generalized (GCCR) [MIM:615962] |
Glucocorticoid resistance, generalized (GCCR) [MIM:615962] |
(NR3C1,NR3C2) |
Glutaric aciduria |
Glutaric aciduria 2A (GA2A) [MIM:231680] |
(ETFA,ETFB) |
Glutaric aciduria 2B (GA2B) [MIM:231680] |
(ETFA,ETFB) |
Glycosylphosphatidylinositol biosynthesis defect |
Glycosylphosphatidylinositol biosynthesis defect 15 (GPIBD15) [MIM:617810] |
(GPAA1,PIGU), (GPAA1,PIGK) |
Griscelli syndrome |
Griscelli syndrome 2 (GS2) [MIM:607624] |
(RAB27A,MLPH) |
Griscelli syndrome 3 (GS3) [MIM:609227] |
(RAB27A,MLPH) |
Growth hormone deficiency |
Growth hormone deficiency, isolated, 1B (IGHD1B) [MIM:612781] |
(GH1,PRLR), (GH1,GHR) |
Growth hormone deficiency, isolated, 2 (IGHD2) [MIM:173100] |
(GH1,PRLR), (GH1,GHR) |
Growth hormone insensitivity |
Growth hormone insensitivity, partial (GHIP) [MIM:604271] |
(GH1,GHR) |
Growth retardation |
Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062] |
(CSNK2B,CSNK2A1) |
HSD10 mitochondrial disease (HSD10MD) [MIM:300438] |
HSD10 mitochondrial disease (HSD10MD) [MIM:300438] |
(TRMT10C,HSD17B10) |
Hartnup disorder |
Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570] |
(GRIN1,GRIN2A) |
Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616] |
(AFG2A,AFG2B) |
Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities (NEDHSB) [MIM:616577] |
(AFG2A,AFG2B) |
Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities (NEDHISB) [MIM:619854] |
(GNB1,GNAI1) |
Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917] |
(GRIA2,GRIA3) |
Neurodevelopmental disorder with or without variable movement or behavioral abnormalities (NEDMAB) [MIM:619725] |
(CALM1,KCNN2) |
Hartsfield syndrome |
Hartsfield syndrome (HRTFDS) [MIM:615465] |
(FGFR1,FGF9), (FGFR1,FGFR2) |
Heimler syndrome |
Heimler syndrome 1 (HMLR1) [MIM:234580] |
(PEX1,PEX6) |
Heimler syndrome 2 (HMLR2) [MIM:616617] |
(PEX1,PEX6) |
Hemifacial myohyperplasia |
Hemifacial myohyperplasia (HFMH) [MIM:606773] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA) |
Hemochromatosis |
Hemochromatosis 2A (HFE2A) [MIM:602390] |
(GDF5,HJV) |
Hemochromatosis 2B (HFE2B) [MIM:613313] |
(HAMP,SLC40A1) |
Hemochromatosis 4 (HFE4) [MIM:606069] |
(HAMP,SLC40A1) |
Hemophilia A (HEMA) [MIM:306700] |
Hemophilia A (HEMA) [MIM:306700] |
(F8,F9), (F8,VWF) |
Hemophilia B (HEMB) [MIM:306900] |
Hemophilia B (HEMB) [MIM:306900] |
(F8,F9), (F9,SERPINC1) |
Hemorrhagic destruction of the brain with subependymal calcification and cataracts |
Hemorrhagic destruction of the brain with subependymal calcification and cataracts (HDBSCC) [MIM:613730] |
(JAM2,JAM3) |
Hepatocellular carcinoma |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA), (MET,BTK) |
Hirschsprung disease |
Hirschsprung disease 1 (HSCR1) [MIM:142623] |
(RET,ALK), (RET,MAPK1), (RET,GDNF), (RET,STAT3) |
Hirschsprung disease 3 (HSCR3) [MIM:613711] |
(RET,GDNF) |
Holoprosencephaly 3 (HPE3) [MIM:142945] |
Holoprosencephaly 3 (HPE3) [MIM:142945] |
(IHH,SHH) |
Houge-Janssens syndrome |
Houge-Janssens syndrome 1 (HJS1) [MIM:616355] |
(PPP2CA,PPP2R5D) |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA,PPP2R5D), (PPP2CA,PTPA) |
Hutchinson-Gilford progeria syndrome |
Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
(LMNA,LMNB2), (LMNA,LMNB1), (BANF1,LMNA) |
Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections (HIES1) [MIM:147060] |
Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections (HIES1) [MIM:147060] |
(PIK3R1,STAT3) |
Hypercholesterolemia |
Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890] |
(LDLR,PCSK9) |
Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776] |
(LDLR,PCSK9) |
Hyperekplexia |
Hyperekplexia 1 (HKPX1) [MIM:149400] |
(GLRA1,GLRB) |
Hyperekplexia 2 (HKPX2) [MIM:614619] |
(GLRA1,GLRB), (GLRA2,GLRB) |
Hyperinsulinemic hypoglycemia |
Hyperinsulinemic hypoglycemia, familial, 1 (HHF1) [MIM:256450] |
(ABCC8,KCNJ11) |
Hyperinsulinemic hypoglycemia, familial, 2 (HHF2) [MIM:601820] |
(ABCC8,KCNJ11) |
Leucine-induced hypoglycemia (LIH) [MIM:240800] |
(ABCC8,KCNJ11) |
Hyperlipoproteinemia |
Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947] |
(LPL,GPIHBP1) |
Hyperprolactinemia |
Hyperprolactinemia (HPRL) [MIM:615555] |
(GH1,PRLR) |
Hyperthyroidism |
Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152] |
(TSHR,GNAS) |
Hypocalcemia |
Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677] |
(KCNJ18,KCNJ5) |
Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361] |
(GNA11,GNB1) |
Hypocalciuric hypercalcemia |
Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980] |
(CASR,GNAS) |
Hypochondroplasia |
Hypochondroplasia (HCH) [MIM:146000] |
(FGFR2,FGFR3) |
Hypogonadotropic hypogonadism |
Hypogonadotropic hypogonadism 13 with or without anosmia (HH13) [MIM:614842] |
(KISS1,KISS1R) |
Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] |
(FGFR1,FGF9), (FGFR1,FGFR2) |
Hypogonadotropic hypogonadism 8 with or without anosmia (HH8) [MIM:614837] |
(KISS1,KISS1R) |
Hypothyroidism |
Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200] |
(TSHR,GNAS) |
Hypothyroidism, congenital, non-goitrous, 7 (CHNG7) [MIM:618573] |
(TRHR,GNAS) |
Hystrix-like ichthyosis with deafness |
Ichthyosis hystrix-like with deafness syndrome (HID syndrome) [MIM:602540] |
(GJB2,GJA8), (GJB1,GJB2) |
Ichthyosis |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT14,KRT2), (KRT2,KRT12), (DES,KRT2), (KRT2,KRT17), (KRT2,KRT25), (KRT16,KRT2) |
Ichthyosis, annular epidermolytic, 1 (AEI1) [MIM:607602] |
(KRT1,KRT10) |
Ichthyosis, annular epidermolytic, 2 (AEI2) [MIM:620148] |
(KRT1,DES), (KRT1,KRT10) |
Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277] |
(ABCA1,ABCA12) |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
(SUZ12,EZH2) |
Immunodeficiency |
Immunodeficiency 26 with or without neurologic abnormalities (IMD26) [MIM:615966] |
(PRKDC,DCLRE1C) |
Immunodeficiency 31A (IMD31A) [MIM:614892] |
(STAT3,STAT1) |
Infections recurrent associated with encephalopathy hepatic dysfunction and cardiovascular malformations |
Infections, recurrent, associated with encephalopathy, hepatic dysfunction and cardiovascular malformations (IEHDCM) [MIM:613759] |
(FAS,FADD) |
Insulin-like growth factor 1 resistance |
Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450] |
(INSR,IGF1R), (INS,IGF1R) |
Intellectual developmental disorder, X-linked, syndromic, Wu type (MRXSW) [MIM:300699] |
Intellectual developmental disorder, X-linked, syndromic, Wu type (MRXSW) [MIM:300699] |
(GRIA2,GRIA3) |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
(TRIO,RAC1) |
Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970] |
Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970] |
(GRIN1,GRIN2B) |
Jackson-Weiss syndrome |
Jackson-Weiss syndrome (JWS) [MIM:123150] |
(FGF10,FGFR2), (FGFR1,FGF9) |
Jervell and Lange-Nielsen syndrome |
Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400] |
(KCNE1,KCNQ1) |
Jervell and Lange-Nielsen syndrome 2 (JLNS2) [MIM:612347] |
(KCNE1,KCNQ1) |
Juvenile polyposis |
Juvenile polyposis syndrome (JPS) [MIM:174900] |
(SMAD4,SMAD2), (SMAD3,SMAD4) |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050] |
(SMAD4,SMAD2), (SMAD3,SMAD4) |
Keratinocytic non-epidermolytic nevus |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
(FGFR3,FGF9), (NRAS,BRAF) |
Keratitis-ichthyosis-deafness syndrome |
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210] |
(GJB2,GJA8), (GJB1,GJB2) |
Keratosis |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3R1,PIK3CA), (FGFR2,FGFR3), (FGFR3,FGF9), (PIK3R2,PIK3CA) |
Kniest dysplasia |
Cardioacrofacial dysplasia 1 (CAFD1) [MIM:619142] |
(PRKACA,AKT1), (PRKAR1A,PRKACA) |
Cardioacrofacial dysplasia 2 (CAFD2) [MIM:619143] |
(PRKAR1A,PRKACB) |
Lacrimo-auriculo-dento-digital syndrome II |
Lacrimo-auriculo-dento-digital syndrome 3 (LADD3) [MIM:620193] |
(FGF10,FGFR2) |
Laron syndrome |
Laron syndrome (LARS) [MIM:262500] |
(GH1,GHR) |
Leber congenital amaurosis |
Leber congenital amaurosis 9 (LCA9) [MIM:608553] |
(PCYT1A,NMNAT1) |
Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879] |
(TUBB,TUBB4B) |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
(MT-CO1,MT-CO3), (MT-ND4L,MT-ND6) |
Leber optic neuropathy |
Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
(MT-ND3,MT-ND6) |
Left ventricular non-compaction |
Congenital heart defects, multiple types, 8, with or without heterotaxy (CHTD8) [MIM:619657] |
(SKI,SMAD2) |
Left ventricular non-compaction 9 (LVNC9) [MIM:611878] |
(TPM1,TNNT2), (TPM1,TNNT1) |
Left ventricular non-compaction 5 (LVNC5) [MIM:613426] |
Left ventricular non-compaction 5 (LVNC5) [MIM:613426] |
(MYH7,XRCC4) |
Leigh syndrome |
Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
(PDHA1,PDHB) |
Leigh syndrome (LS) [MIM:256000] |
Leigh syndrome (LS) [MIM:256000] |
(POLG,POLG2), (MT-ND3,MT-ND6), (MT-ND4L,MT-ND6) |
Leopard syndrome |
LEOPARD syndrome 2 (LPRD2) [MIM:611554] |
(RAF1,YWHAG) |
Leprechaunism |
Leprechaunism (LEPRCH) [MIM:246200] |
(INSR,IGF1R), (INS,INSR) |
Leukemia |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS,NF1), (KRAS,SOS1) |
Leukodystrophy hypomyelinating |
Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494] |
(POLR1C,POLR3B), (POLR3A,POLR1C), (POLR1C,POLR1D) |
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
(POLR3A,POLR1D), (POLR3A,POLR3B), (POLR3A,POLR1C), (POLR3A,POLR3K) |
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD8) [MIM:614381] |
(POLR1C,POLR3B) |
Leukodystrophy with vanishing white matter |
Leukoencephalopathy with vanishing white matter 2 (VWM2) [MIM:620312] |
(EIF2B2,EIF2B4) |
Leukoencephalopathy with vanishing white matter 3 (VWM3) [MIM:620313] |
(EIF2B3,EIF2B4) |
Leukoencephalopathy with vanishing white matter 4 (VWM4) [MIM:620314] |
(EIF2B2,EIF2B4), (EIF2B3,EIF2B4), (EIF2B5,EIF2B4) |
Leukoencephalopathy with vanishing white matter 5 (VWM5) [MIM:620315] |
(EIF2B5,EIF2B4) |
Li-Fraumeni syndrome |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53,TP63) |
Limb-girdle muscular dystrophy |
Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
(LMNA,LMNB2), (LMNA,LMNB1), (KRT6A,LMNA) |
Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B14 (MDDGB14) [MIM:615351] |
(GMPPA,GMPPB) |
Lipodystrophy |
Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660] |
(LMNA,LMNB2), (LMNA,LMNB1), (BANF1,LMNA) |
Lipodystrophy, familial partial, 3 (FPLD3) [MIM:604367] |
(PPARG,NR2E3) |
Partial acquired lipodystrophy (APLD) [MIM:608709] |
(LMNB1,LMNB2), (LMNA,LMNB2) |
Lipoprotein lipase deficiency |
Hyperlipoproteinemia 1 (HLPP1) [MIM:238600] |
(LPL,GPIHBP1) |
Lissencephaly |
Lissencephaly 3 (LIS3) [MIM:611603] |
(TUBB,TUBA1A), (MAPT,TUBA1A), (TUBB3,TUBA1A) |
Loeys-Dietz syndrome |
Loeys-Dietz syndrome 3 (LDS3) [MIM:613795] |
(SMAD3,SMAD4) |
Loeys-Dietz syndrome 6 (LDS6) [MIM:619656] |
Loeys-Dietz syndrome 6 (LDS6) [MIM:619656] |
(SMAD4,SMAD2) |
Long QT syndrome |
Long QT syndrome 1 (LQT1) [MIM:192500] |
(CALM1,KCNQ1), (CALM2,KCNQ1), (KCNE1,KCNQ1) |
Long QT syndrome 14 (LQT14) [MIM:616247] |
(CALM1,SCN5A), (KCNN4,CALM1), (CALM1,KCNQ1), (CALM1,FAS), (CALM1,KCNN2), (CALM1,IQSEC2), (CALM1,MYLK), (KCNQ2,CALM1) |
Long QT syndrome 15 (LQT15) [MIM:616249] |
(CALM2,KCNQ1), (CALM2,TNNI3) |
Long QT syndrome 16 (LQT16) [MIM:618782] |
(KCNQ2,CALM3) |
Long QT syndrome 7 (LQT7) [MIM:170390] |
(KCNJ18,KCNJ2) |
Long QT syndrome 3 (LQT3) [MIM:603830] |
Long QT syndrome 3 (LQT3) [MIM:603830] |
(CALM1,SCN5A), (FGF12,SCN5A) |
Macrodactyly |
Macrodactyly (MADAC) [MIM:155500] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA) |
Mandibuloacral dysplasia |
Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370] |
(BANF1,LMNA) |
Mandibulofacial dysostosis with alopecia |
Mandibulofacial dysostosis with alopecia (MFDA) [MIM:616367] |
(EDNRA,GNAS), (EDN1,EDNRA) |
Maple syrup urine disease |
Maple syrup urine disease 1A (MSUD1A) [MIM:248600] |
(BCKDHA,BCKDHB) |
Maple syrup urine disease 1B (MSUD1B) [MIM:620698] |
(BCKDHA,BCKDHB) |
Marbach-Schaaf neurodevelopmental syndrome (MASNS) [MIM:619680] |
Marbach-Schaaf neurodevelopmental syndrome (MASNS) [MIM:619680] |
(PRKAR1A,PRKAR1B) |
Maturity-onset diabetes of the young |
Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370] |
(INS,INSR), (INS,IGF1R) |
Maturity-onset diabetes of the young 3 (MODY3) [MIM:600496] |
(HNF1A,HNF1B) |
McCune-Albright syndrome |
McCune-Albright syndrome (MAS) [MIM:174800] |
(GNB1,GNAS), (AVPR2,GNAS) |
Medullary thyroid carcinoma |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
(RET,ALK), (RET,MAPK1), (RET,GDNF) |
Meesmann corneal dystrophy |
Corneal dystrophy, Meesmann 2 (MECD2) [MIM:618767] |
(KRT14,KRT3), (KRT3,DES), (KRT16,KRT3) |
Megacystis-microcolon-intestinal hypoperistalsis syndrome |
Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431] |
(ACTA2,ACTG2), (ACTG2,ACTC1), (ACTG2,ACTA1) |
Megalencephaly-capillary malformation-polymicrogyria syndrome |
Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501] |
(PIK3R1,PIK3CA), (PIK3R2,PIK3CA) |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387] |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387] |
(PIK3R2,PIK3CA) |
Meier-Gorlin syndrome |
Meier-Gorlin syndrome 1 (MGORS1) [MIM:224690] |
(ORC4,ORC1) |
Meier-Gorlin syndrome 2 (MGORS2) [MIM:613800] |
(ORC4,ORC1) |
Melanoma |
Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601] |
(CDK4,CDKN2A) |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4,CDKN1C), (CDK4,CDKN2A) |
Mental retardation |
Intellectual developmental disorder, X-linked 1 (XLID1) [MIM:309530] |
(CALM1,IQSEC2) |
Intellectual developmental disorder, X-linked, syndromic, Pilorge type (MRXSP) [MIM:301076] |
(GLRA2,GLRB) |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNA11,GNB1), (GNB1,GNAI1), (AVPR2,GNB1), (GNB1,GNAS), (GNAO1,GNB1), (MC4R,GNB1) |
Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635] |
(RAD21,STAG1) |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
(TRIO,RAC1), (CYBB,RAC1), (NCF2,RAC1) |
Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825] |
(TRIO,RAC1) |
Metachromatic leukodystrophy |
Metachromatic leukodystrophy (MLD) [MIM:250100] |
(ARSA,SUMF1) |
Metaphyseal chondrodysplasia |
Metaphyseal chondrodysplasia, Jansen type (MCDJ) [MIM:156400] |
(GNAS,PTH1R) |
Methylmalonic aciduria |
Methylmalonic aciduria type cblA (MMAA) [MIM:251100] |
(MMUT,MMAA) |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000] |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000] |
(MMUT,MMAA) |
Microcephaly |
Microcephaly 26, primary, autosomal dominant (MCPH26) [MIM:619179] |
(LMNB1,LMNB2), (LMNA,LMNB1) |
Microcephaly 27, primary, autosomal dominant (MCPH27) [MIM:619180] |
(LMNA,LMNB2), (LMNB1,LMNB2) |
Microcephaly-capillary malformation syndrome |
Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261] |
(PRKN,STAMBP) |
Mitochondrial DNA depletion syndrome |
Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700] |
(POLG,POLG2) |
Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662] |
(POLG,POLG2) |
Mitochondrial complex |
Mitochondrial complex I deficiency, nuclear type 37 (MC1DN37) [MIM:619272] |
(NDUFA8,NDUFA13) |
Mitochondrial complex II deficiency, nuclear type 1 (MC2DN1) [MIM:252011] |
(SDHB,SDHA) |
Mitochondrial complex II deficiency, nuclear type 4 (MC2DN4) [MIM:619224] |
(SDHB,SDHA) |
Mitochondrial complex V deficiency, nuclear type 4A (MC5DN4A) [MIM:620358] |
(ATP5F1B,ATP5F1A) |
Mitochondrial complex V deficiency, nuclear type 4B (MC5DN4B) [MIM:615228] |
(ATP5F1B,ATP5F1A) |
Mitochondrial complex deficiency |
Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014] |
(MT-ND3,MT-ND6) |
Mitochondrial complex I deficiency, nuclear type 2 (MC1DN2) [MIM:618222] |
(NDUFS8,NDUFS6), (NDUFS8,NDUFS2), (NDUFS8,MT-ND1) |
Mitochondrial complex I deficiency, nuclear type 28 (MC1DN28) [MIM:618249] |
(NDUFA8,NDUFA13) |
Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6) [MIM:618228] |
(NDUFS8,NDUFS2), (NDUFS2,MT-ND1) |
Mitochondrial complex I deficiency, nuclear type 9 (MC1DN9) [MIM:618232] |
(NDUFS8,NDUFS6) |
Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
(MT-CO1,MT-CO3) |
Mitochondrial complex V deficiency, nuclear type 3 (MC5DN3) [MIM:614053] |
(ATP5F1D,ATP5F1E) |
Mitochondrial complex V deficiency, nuclear type 5 (MC5DN5) [MIM:618120] |
(ATP5F1D,ATP5F1E) |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
(MT-ND3,MT-ND6), (NDUFS2,MT-ND1), (MT-ND4L,MT-ND6), (NDUFS8,MT-ND1) |
Monilethrix |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86,KRT16), (KRT16,KRT83), (KRT16,KRT81), (KRT14,KRT81), (KRT86,KRT14) |
Mucopolysaccharidosis |
Mucopolysaccharidosis 4B (MPS4B) [MIM:253010] |
(CTSA,GLB1) |
Muenke syndrome |
Muenke syndrome (MNKS) [MIM:602849] |
(FGFR3,FGF9) |
Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022] |
Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022] |
(RAD21,STAG2) |
Multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) [MIM:615398] |
Multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) [MIM:615398] |
(PIGT,PIGU) |
Multiple neoplasia |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
(RET,MAPK1), (RET,GDNF) |
Multiple neoplasia 2B (MEN2B) [MIM:162300] |
(RET,ALK) |
Multiple sulfatase deficiency |
Multiple sulfatase deficiency (MSD) [MIM:272200] |
(ARSA,SUMF1) |
Multiple synostoses syndrome |
Multiple synostoses syndrome 2 (SYNS2) [MIM:610017] |
(GDF5,BMPR2), (GDF5,NOG), (GDF5,HJV) |
Multiple synostoses syndrome 3 (SYNS3) [MIM:612961] |
(FGFR3,FGF9), (FGFR1,FGF9) |
Muscular dystrophy-dystroglycanopathy |
Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A14 (MDDGA14) [MIM:615350] |
(GMPPA,GMPPB) |
Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14) [MIM:615352] |
(GMPPA,GMPPB) |
Myasthenic syndrome |
Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304] |
(MUSK,LRP4) |
Myasthenic syndrome, congenital, 18 (CMS18) [MIM:616330] |
(SNAP25,VAMP2) |
Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9) [MIM:616325] |
(MUSK,LRP4) |
Myopathy |
Congenital myopathy 15 (CMYP15) [MIM:620161] |
(TNNC2,TNNI3) |
Congenital myopathy 23 (CMYP23) [MIM:609285] |
(TPM2,TPM1) |
Congenital myopathy 4A, autosomal dominant (CMYP4A) [MIM:255310] |
(TPM3,TNNT1) |
Congenital myopathy 7A, myosin storage, autosomal dominant (CMYP7A) [MIM:608358] |
(MYH7,XRCC4) |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS,NF1), (HRAS,SOS1) |
Myopathy, distal, 1 (MPD1) [MIM:160500] |
(MYH7,XRCC4) |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT14,DES), (DES,KRT12), (DES,KRT2), (DES,KRT17), (KRT1,DES), (GFAP,DES), (KRT6B,DES), (KRT6A,DES), (KRT3,DES), (DES,KRT6C), (KRT16,DES), (KRT5,DES) |
Myopathy, myofibrillar, 2 (MFM2) [MIM:608810] |
(CRYAB,HSPB1), (CRYAA,CRYAB), (CRYAB,HSPB8) |
Nemaline myopathy |
Congenital myopathy 2A, typical, autosomal dominant (CMYP2A) [MIM:161800] |
(ACTB,ACTA1), (ACTC1,ACTA1), (ACTA2,ACTA1), (ACTG2,ACTA1) |
Nemaline myopathy 5B, autosomal recessive, childhood-onset (NEM5B) [MIM:620386] |
(TPM3,TNNT1), (TPM1,TNNT1) |
Nephrogenic syndrome |
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539] |
(AVPR2,GNAS) |
Nephrotic syndrome |
Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1 (CHINE1) [MIM:301108] |
(DKC1,NOP10) |
Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 2 (CHINE2) [MIM:620425] |
(DKC1,NOP10) |
Nestor-Guillermo progeria syndrome |
Nestor-Guillermo progeria syndrome (NGPS) [MIM:614008] |
(BANF1,LMNA) |
Neuroblastoma |
Neuroblastoma 3 (NBLST3) [MIM:613014] |
(RET,ALK) |
Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis |
Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis (NEDBSS) [MIM:618590] |
(GPAA1,PIGU), (PIGT,PIGU) |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements (NEDHAHM) [MIM:618760] |
(SNAP25,VAMP2) |
Neurodevelopmental disorder with involuntary movements |
Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493] |
(GNAO1,GNB1) |
Neurodevelopmental disorder with seizures and speech and walking impairment (NEDSSWI) [MIM:618480] |
(DHPS,EIF5A) |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
(GRIN1,GRIN2B), (GRIN1,GRIN2A), (GRIN2D,GRIN1) |
Neurodevelopmental, jaw, eye, and digital syndrome |
Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914] |
(CTNNB1,FBXW11), (NFKBIA,FBXW11) |
Neurofibromatosis |
Neurofibromatosis 1 (NF1) [MIM:162200] |
(HRAS,NF1), (KRAS,NF1) |
Neurofibromatosis-Noonan syndrome |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
(HRAS,NF1), (KRAS,NF1) |
Neuropathy |
Neuronopathy, distal hereditary motor, autosomal dominant 2 (HMND2) [MIM:158590] |
(CRYAB,HSPB8) |
Neuronopathy, distal hereditary motor, autosomal dominant 3 (HMND3) [MIM:608634] |
(CRYAA,HSPB1), (CRYAB,HSPB1) |
Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400] |
(SPTLC1,SPTLC2) |
Neuropathy, hereditary sensory and autonomic, 1C (HSAN1C) [MIM:613640] |
(SPTLC1,SPTLC2) |
Neutropenia |
Neutropenia, severe congenital, X-linked (XLN) [MIM:300299] |
(WAS,CDC42) |
Niemann-Pick disease |
Niemann-Pick disease C1 (NPC1) [MIM:257220] |
(NPC1,NPC2) |
Niemann-Pick disease C2 (NPC2) [MIM:607625] |
(NPC1,NPC2) |
Noonan syndrome |
Noonan syndrome 11 (NS11) [MIM:618499] |
(MRAS,SHOC2) |
Noonan syndrome 13 (NS13) [MIM:619087] |
(MAPK1,RPS6KA3), (RET,MAPK1) |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS,NF1), (KRAS,SOS1) |
Noonan syndrome 4 (NS4) [MIM:610733] |
(KRAS,SOS1), (HRAS,SOS1) |
Noonan syndrome 5 (NS5) [MIM:611553] |
(RAF1,YWHAG) |
Noonan syndrome 6 (NS6) [MIM:613224] |
(NRAS,BRAF) |
Noonan syndrome 7 (NS7) [MIM:613706] |
(BRAF,YWHAG) |
Noonan syndrome-like disorder with loose anagen hair 1 (NSLH1) [MIM:607721] |
(MRAS,SHOC2) |
Norrie disease |
Norrie disease (ND) [MIM:310600] |
(NDP,FZD4) |
Obesity |
Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) [MIM:619475] |
(SPTBN1,SPTAN1) |
Obesity (OBESITY) [MIM:601665] |
(MC4R,GNAS), (MC4R,GNB1) |
Thrombocytopenia 8, with dysmorphic features and developmental delay (THC8) [MIM:620475] |
(ACTB,ACTA1), (PFN1,ACTB) |
Oculoectodermal syndrome |
Oculoectodermal syndrome (OES) [MIM:600268] |
(KRAS,SOS1), (KRAS,NF1) |
Osseous heteroplasia |
Progressive osseous heteroplasia (POH) [MIM:166350] |
(GNB1,GNAS) |
Osteogenesis imperfecta |
Osteogenesis imperfecta 1 (OI1) [MIM:166200] |
(COL1A1,COL1A2) |
Osteogenesis imperfecta 17 (OI17) [MIM:616507] |
(COL3A1,SPARC) |
Osteogenesis imperfecta 2 (OI2) [MIM:166210] |
(COL1A1,GP6), (COL1A1,COL1A2) |
Osteogenesis imperfecta 3 (OI3) [MIM:259420] |
(COL1A1,GP6), (COL1A1,COL1A2) |
Osteogenesis imperfecta 4 (OI4) [MIM:166220] |
(COL1A1,COL1A2) |
Pachyonychia congenita |
Pachyonychia congenita 1 (PC1) [MIM:167200] |
(KRT86,KRT16), (KRT16,KRT5), (KRT6A,KRT16), (KRT16,KRT83), (KRT16,KRT81), (KRT16,KRT4), (KRT16,KRT3), (KRT16,KRT2), (KRT16,DES) |
Pachyonychia congenita 2 (PC2) [MIM:167210] |
(DES,KRT17), (KRT6A,KRT17), (KRT5,KRT17), (KRT2,KRT17) |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A,KRT16), (KRT6A,KRT17), (KRT6A,DES), (KRT14,KRT6A), (KRT6A,LMNA) |
Pachyonychia congenita 4 (PC4) [MIM:615728] |
(KRT6B,DES) |
Palmoplantar keratoderma |
Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350] |
(GJB1,GJB2) |
Palmoplantar keratoderma, non-epidermolytic, focal or diffuse (PPKNEFD) [MIM:615735] |
(DES,KRT6C) |
Woolly hair autosomal recessive 3 (ARWH3) [MIM:616760] |
(KRT5,KRT25), (KRT2,KRT25) |
Pancreatitis |
Pancreatitis, hereditary (PCTT) [MIM:167800] |
(SPINK1,PRSS1) |
Tropical calcific pancreatitis (TCP) [MIM:608189] |
(SPINK1,PRSS1) |
Paraganglioma |
Pheochromocytoma/paraganglioma syndrome 1 (PPGL1) [MIM:168000] |
(SDHD,SDHB) |
Pheochromocytoma/paraganglioma syndrome 4 (PPGL4) [MIM:115310] |
(SDHB,SDHA), (SDHD,SDHB) |
Parietal foramina |
Parietal foramina 1 (PFM1) [MIM:168500] |
(POU1F1,MSX2), (MSX2,PITX1) |
Parkinson disease |
Parkinson disease (PARK) [MIM:168600] |
(PRKN,STAMBP) |
Parkinson disease 2 (PARK2) [MIM:600116] |
(PRKN,STAMBP) |
Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development (PARK25) [MIM:620482] |
(PPP2CA,PTPA) |
Parkinson disease 8 (PARK8) [MIM:607060] |
(YWHAG,LRRK2) |
Peroxisome biogenesis disorder |
Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100] |
(PEX1,PEX6) |
Peroxisome biogenesis disorder 1B (PBD1B) [MIM:601539] |
(PEX1,PEX6) |
Peroxisome biogenesis disorder 4A (PBD4A) [MIM:614862] |
(PEX1,PEX6) |
Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:614862] |
(PEX1,PEX6) |
Pfeiffer syndrome |
Pfeiffer syndrome (PS) [MIM:101600] |
(FGFR2,FGFR3), (FGF10,FGFR2), (FGFR1,FGF9), (FGFR1,FGFR2) |
Pheochromocytoma (PCC) [MIM:171300] |
Pheochromocytoma (PCC) [MIM:171300] |
(RET,MAPK1), (VHL,EPAS1), (MYCN,MAX), (MAX,TCF12) |
Pick disease of the brain (PIDB) [MIM:172700] |
Pick disease of the brain (PIDB) [MIM:172700] |
(MAPT,TUBA1A), (MAPT,YWHAG) |
Pigmented adrenocortical disease |
Primary pigmented nodular adrenocortical disease 4 (PPNAD4) [MIM:615830] |
(PRKAR1A,PRKACA), (PRKACA,SIK3) |
Pilomatrixoma |
Pilomatrixoma (PTR) [MIM:132600] |
(CTNNB1,FBXW11) |
Pitt-Hopkins syndrome |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4,TWIST1) |
Pituitary hormone deficiency |
Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038] |
(POU1F1,MSX2), (POU1F1,LHX4) |
Pituitary hormone deficiency, combined, 4 (CPHD4) [MIM:262700] |
(POU1F1,LHX4) |
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732] |
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732] |
(CSNK2B,CSNK2A1) |
Polydactyly-macrocephaly syndrome |
Polydactyly-macrocephaly syndrome (PDMCS) [MIM:620712] |
(MYCN,MAX), (MAX,TCF12) |
Pontocerebellar hypoplasia |
Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678] |
(EXOSC5,EXOSC3), (EXOSC9,EXOSC3) |
Pontocerebellar hypoplasia 1D (PCH1D) [MIM:618065] |
(EXOSC9,EXOSC3) |
Pontocerebellar hypoplasia 9 (PCH9) [MIM:615809] |
(AMPD3,AMPD2) |
Premature ovarian failure |
Premature ovarian failure 7 (POF7) [MIM:612964] |
(NR0B1,NR5A1) |
Progressive external ophthalmoplegia |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4) [MIM:610131] |
(POLG,POLG2) |
Pseudohypoaldosteronism |
Pseudohypoaldosteronism 1, autosomal dominant (PHA1A) [MIM:177735] |
(NR3C1,NR3C2) |
Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491] |
(WNK4,KLHL3) |
Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495] |
(WNK4,KLHL3) |
Pseudohypoparathyroidism |
Albright hereditary osteodystrophy (AHO) [MIM:103580] |
(CASR,GNAS), (TRHR,GNAS), (GNB1,GNAS), (TSHR,GNAS), (AVPR2,GNAS), (EDNRA,GNAS), (MC4R,GNAS), (GNAS,PTH1R) |
Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580] |
(GNB1,GNAS) |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(CASR,GNAS), (TRHR,GNAS), (TSHR,GNAS), (AVPR2,GNAS), (EDNRA,GNAS), (MC4R,GNAS), (GNAS,PTH1R) |
Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600] |
Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600] |
(GDF5,BMPR2) |
Pyropoikilocytosis |
Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
(SPTA1,SPTB) |
Pyruvate carboxylase deficiency |
Pyruvate dehydrogenase E1-beta deficiency (PDHBD) [MIM:614111] |
(PDHA1,PDHB) |
Question mark ears |
Question mark ears, isolated (QME) [MIM:612798] |
(EDN1,EDNRA) |
Rabson-Mendenhall syndrome |
Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
(INSR,IGF1R), (INS,INSR) |
Radioulnar synostosis with amegakaryocytic thrombocytopenia |
Thrombocytopenia 6 (THC6) [MIM:616937] |
(LYN,SRC) |
Refsum disease |
Autoinflammatory disease, systemic, with vasculitis (SAIDV) [MIM:620376] |
(LYN,SRC) |
Charcot-Marie-Tooth disease, axonal, 2F (CMT2F) [MIM:606595] |
(CRYAA,HSPB1), (CRYAB,HSPB1) |
Von Willebrand disease, platelet-type (VWDP) [MIM:177820] |
(F2,GP1BA), (VWF,GP1BA) |
Renal cell carcinoma |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET,BTK) |
Retinitis pigmentosa |
Retinitis pigmentosa 13 (RP13) [MIM:600059] |
(SNRNP200,PRPF8) |
Retinitis pigmentosa 33 (RP33) [MIM:610359] |
Retinitis pigmentosa 33 (RP33) [MIM:610359] |
(SNRNP200,PRPF8) |
SHORT syndrome |
SHORT syndrome (SHORTS) [MIM:269880] |
(PIK3R1,PIK3CA), (PIK3R1,STAT3) |
Skin creases, congenital symmetric circumferential, 1 (CSCSC1) [MIM:156610] |
(TUBB,TUBB2B), (TUBB,TUBB4B), (TUBB,TUBB2A) |
Saethre-Chotzen syndrome |
Saethre-Chotzen syndrome (SCS) [MIM:101400] |
(TCF4,TWIST1) |
Scaphocephaly syndrome |
Familial scaphocephaly syndrome (FSPC) [MIM:609579] |
(FGFR2,FGFR3), (FGFR1,FGFR2) |
Schimmelpenning-Feuerstein-Mims syndrome |
Schimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM:163200] |
(KRAS,NF1), (KRAS,SOS1), (HRAS,SOS1) |
Sclerosteosis |
Sclerosteosis 2 (SOST2) [MIM:614305] |
(MUSK,LRP4) |
Seizures |
Febrile seizures, familial, 8 (FEB8) [MIM:607681] |
(GABRB1,GABRG2), (GABRG2,GABRB2), (GABRG2,GABRA5), (GABRG2,GABRB3) |
Seizures, benign familial infantile, 3 (BFIS3) [MIM:607745] |
(SCN2B,SCN2A) |
Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200] |
(KCNQ2,CALM1), (KCNQ2,CALM3) |
Sensory ataxic neuropathy dysarthria and ophthalmoparesis |
Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
(POLG,POLG2) |
Severe combined immunodeficiency |
Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation (RSSCID) [MIM:602450] |
(PRKDC,DCLRE1C) |
Short QT syndrome |
Short QT syndrome 3 (SQT3) [MIM:609622] |
(KCNJ18,KCNJ2) |
Short stature |
Hemolytic uremic syndrome, atypical, 1 (AHUS1) [MIM:235400] |
(C3,CFH) |
Hemolytic uremic syndrome, atypical, 2 (AHUS2) [MIM:612922] |
(C3,CD46) |
Hemolytic uremic syndrome, atypical, 3 (AHUS3) [MIM:612923] |
(CFI,CFH) |
Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925] |
(C3,CD46), (C3,CFH) |
Short stature, microcephaly, and endocrine dysfunction (SSMED) [MIM:616541] |
(MYH7,XRCC4) |
Shprintzen-Goldberg craniosynostosis syndrome |
Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212] |
(SKI,SMAD2) |
Sick sinus syndrome |
Sick sinus syndrome 1 (SSS1) [MIM:608567] |
(CALM1,SCN5A) |
Sitosterolemia |
Sitosterolemia 1 (STSL1) [MIM:210250] |
(ABCG8,ABCG5) |
Sitosterolemia 2 (STSL2) [MIM:618666] |
Sitosterolemia 2 (STSL2) [MIM:618666] |
(ABCG8,ABCG5) |
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (SPG91) [MIM:620538] |
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (SPG91) [MIM:620538] |
(SPTBN2,SPTAN1), (SPTB,SPTAN1) |
Spinocerebellar ataxia |
Spinocerebellar ataxia 5 (SCA5) [MIM:600224] |
(SPTBN2,SPTAN1) |
Spinocerebellar ataxia with epilepsy (SCAE) [MIM:607459] |
(POLG,POLG2) |
Spondyloepimetaphyseal dysplasia |
Spondyloepimetaphyseal dysplasia, Krakow type (SEMDK) [MIM:618162] |
(PRKACA,SIK3) |
Stargardt disease 1 (STGD1) [MIM:248200] |
Stargardt disease 1 (STGD1) [MIM:248200] |
(CNGA3,CNGB3) |
Stolerman neurodevelopmental syndrome |
Stolerman neurodevelopmental syndrome (NEDSST) [MIM:618505] |
(KDM6B,H3C12) |
Supranuclear palsy |
Progressive supranuclear palsy 1 (PSNP1) [MIM:601104] |
(MAPT,TUBB3) |
Symphalangism |
Symphalangism, proximal 1A (SYM1A) [MIM:185800] |
(GDF5,NOG) |
Symphalangism, proximal 1B (SYM1B) [MIM:615298] |
(GDF5,NOG), (GDF5,HJV) |
Systemic lupus erythematosus |
Systemic lupus erythematosus 17 (SLEB17) [MIM:301080] |
(TLR8,TLR7) |
Tangier disease |
Tangier disease (TGD) [MIM:205400] |
(ABCA1,ABCA12) |
Tarsal-carpal coalition syndrome |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
(GDF5,NOG) |
Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879] |
Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879] |
(H3-3B,DNMT3A) |
Temple-Baraitser syndrome |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1,KCNB1) |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 1 (TEBIVANED1) [MIM:619758] |
(H4C16,H3-3B) |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950] |
(H4C16,H3-3B) |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 4 (TEBIVANED4) [MIM:619951] |
(H4C16,H3-3B) |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 2 (TEBIVANED2) [MIM:619759] |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 2 (TEBIVANED2) [MIM:619759] |
(H4C16,H3-3B) |
Thanatophoric dysplasia |
Thanatophoric dysplasia 1 (TD1) [MIM:187600] |
(FGFR2,FGFR3), (FGFR3,FGF9) |
Thanatophoric dysplasia 2 (TD2) [MIM:187601] |
(FGFR2,FGFR3) |
Thrombocytopenia |
Amegakaryocytic thrombocytopenia, congenital, 1 (CAMT1) [MIM:604498] |
(THPO,MPL) |
Amegakaryocytic thrombocytopenia, congenital, 2 (CAMT2) [MIM:620481] |
(THPO,MPL) |
Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies (THC11) [MIM:620654] |
(RAP1B,RASGRP2) |
Thrombocytopenia 9 (THC9) [MIM:620478] |
(THPO,MPL) |
Thrombophilia |
Thrombophilia due to activated protein C resistance (THPH2) [MIM:188055] |
(F2,F5) |
Thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:612356] |
(F2,SERPIND1) |
Thrombophilia due to protein C deficiency, autosomal dominant (THPH3) [MIM:176860] |
(F2,PROC) |
Thyrotoxic hypokalemic periodic paralysis |
Thyrotoxic periodic paralysis 2 (TTPP2) [MIM:613239] |
(KCNJ18,KCNJ2), (KCNJ18,KCNJ5) |
Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500] |
Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500] |
(EDA,EDAR) |
Treacher Collins syndrome |
Treacher Collins syndrome 2 (TCS2) [MIM:613717] |
(POLR3A,POLR1D), (POLR1C,POLR1D) |
Trichothiodystrophy |
Trichothiodystrophy 3, photosensitive (TTD3) [MIM:616395] |
(XPA,GTF2H5) |
Tuberous sclerosis |
Tuberous sclerosis 2 (TSC2) [MIM:613254] |
(TSC2,TSC1) |
Tuberous sclerosis 1 (TSC1) [MIM:191100] |
Tuberous sclerosis 1 (TSC1) [MIM:191100] |
(TSC2,TSC1) |
Ventricular tachycardia |
Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916] |
(CALM1,SCN5A), (KCNQ2,CALM1), (CALM1,KCNQ1), (CALM1,KCNN2) |
Vohwinkel syndrome |
Vohwinkel syndrome (VOWNKL) [MIM:124500] |
(GJB1,GJB2) |
Von Hippel-Lindau disease |
Von Hippel-Lindau disease (VHLD) [MIM:193300] |
(VHL,EPAS1) |
Von Willebrand disease |
Von Willebrand disease 2 (VWD2) [MIM:613554] |
(F8,VWF), (VWF,GP1BA) |
Weaver syndrome |
Weaver syndrome (WVS) [MIM:277590] |
(SUZ12,EZH2), (H3C12,EZH2), (EED,EZH2) |
White sponge nevus |
White sponge nevus 1 (WSN1) [MIM:193900] |
(KRT16,KRT4), (KRT14,KRT4) |
White-Kernohan syndrome |
White-Kernohan syndrome (WHIKERS) [MIM:619426] |
(DDB1,DDB2) |
Xeroderma pigmentosum |
Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700] |
(XPA,GTF2H5) |
Xeroderma pigmentosum complementation group E (XP-E) [MIM:278740] |
(DDB1,DDB2) |
Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
(ERCC1,ERCC4) |
Zimmermann-Laband syndrome |
Zimmermann-Laband syndrome 1 (ZLS1) [MIM:135500] |
(KCNH1,KCNB1) |
[Show all]
|
Diseases having interaction interfaces enriched with mutations |
Disease
| Disease phenotype (**)
| Interaction
| Log_2 Enrich.
| P-val
| Corr. P-val
|
3-methylglutaconic aciduria |
3-methylglutaconic aciduria 7A (MGCA7A) [MIM:619835] |
(CLPB, CLPB) |
1.318 |
0.0259 |
0.0259 |
Abetalipoproteinemia |
Abetalipoproteinemia (ABL) [MIM:200100] |
(P4HB, MTTP) |
2.317 |
0.0179 |
0.0179 |
Acromesomelic dysplasia |
Acromesomelic dysplasia 2B (AMD2B) [MIM:228900] |
(GDF5, TWSG1) |
1.853 |
0.00587 |
0.0411 |
All phenotypes |
(GDF5, TWSG1) |
1.531 |
0.0228 |
0.183 |
Acyl-CoA dehydrogenase deficiency |
Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475] |
(ACADVL, ACADVL) |
0.769 |
0.0286 |
0.0286 |
All phenotypes |
(ACADVL, ACADVL) |
0.769 |
0.0286 |
0.114 |
Adenomatous polyposis |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
(APC, DLG3) |
4.862 |
0.0339 |
0.0451 |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
(APC, DLG1) |
4.640 |
0.0395 |
0.0451 |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
(APC, SCRIB) |
4.640 |
0.0395 |
0.0451 |
Familial adenomatous polyposis 1 (FAP1) [MIM:175100] |
(APC, PTPN13) |
4.447 |
0.0451 |
0.0451 |
Adrenal hyperplasia |
ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) [MIM:219080] |
(AVPR2, GNAS) |
2.978 |
0.0161 |
0.0644 |
All phenotypes |
(AVPR2, GNAS) |
2.978 |
0.0161 |
0.129 |
Adrenocorticotropic hormone deficiency |
ACTH deficiency, isolated (IAD) [MIM:201400] |
(TBX19, PITX1) |
4.939 |
0.0326 |
0.0489 |
ACTH deficiency, isolated (IAD) [MIM:201400] |
(TBX19, VENTX) |
4.939 |
0.0326 |
0.0489 |
Adrenoleukodystrophy |
Adrenoleukodystrophy (ALD) [MIM:300100] |
(ABCD1, ABCD1) |
0.466 |
0.00055 |
0.00165 |
Adrenoleukodystrophy (ALD) [MIM:300100] |
(ABCD3, ABCD1) |
0.353 |
0.0494 |
0.0741 |
Agammaglobulinemia |
All phenotypes |
(MET, BTK) |
0.618 |
0.0297 |
0.238 |
X-linked agammaglobulinemia (XLA) [MIM:300755] |
(MET, BTK) |
0.618 |
0.0297 |
0.178 |
Aicardi-Goutieres syndrome |
Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846] |
(DDX3X, IFIH1) |
2.441 |
0.0493 |
0.0493 |
All phenotypes |
(DDX3X, IFIH1) |
2.441 |
0.0493 |
0.345 |
Alazami-Yuan syndrome |
Alazami-Yuan syndrome (ALYUS) [MIM:617126] |
(TAF6, TAF9) |
2.484 |
0.0319 |
0.0639 |
Alzheimer disease |
All phenotypes |
(APP, ) |
3.389 |
0.0151 |
0.0579 |
All phenotypes |
(APP, PITRM1) |
3.389 |
0.0151 |
0.0579 |
All phenotypes |
(APP, LCN2) |
2.859 |
0.03 |
0.0987 |
All phenotypes |
(IGKC, APP) |
2.752 |
0.0344 |
0.099 |
All phenotypes |
(APP, PSEN2) |
2.672 |
7.57e-10 |
8.7e-9 |
All phenotypes |
(APP, PSEN1) |
2.120 |
2.02e-20 |
4.66e-19 |
All phenotypes |
(APP, APP) |
1.323 |
6.64e-6 |
5.09e-5 |
All phenotypes |
(NOTCH1, PSEN1) |
0.777 |
0.00112 |
0.00646 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, PSEN1) |
4.112 |
2.74e-13 |
3.84e-12 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, PSEN2) |
3.974 |
7.76e-13 |
5.43e-12 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, ) |
3.389 |
0.0151 |
0.0423 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, PITRM1) |
3.389 |
0.0151 |
0.0423 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, LCN2) |
2.859 |
0.03 |
0.0688 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(IGKC, APP) |
2.752 |
0.0344 |
0.0688 |
Alzheimer disease 1 (AD1) [MIM:104300] |
(APP, APP) |
1.323 |
6.64e-6 |
3.1e-5 |
Alzheimer disease 3 (AD3) [MIM:607822] |
(APP, PSEN1) |
0.914 |
2.5e-5 |
0.00015 |
Alzheimer disease 3 (AD3) [MIM:607822] |
(NOTCH1, PSEN1) |
0.777 |
0.00112 |
0.00337 |
Amelogenesis imperfecta |
Amelogenesis imperfecta 1H (AI1H) [MIM:616221] |
(TGFB3, ITGB6) |
4.531 |
0.00245 |
0.0056 |
Amelogenesis imperfecta 1H (AI1H) [MIM:616221] |
(TGFB1, ITGB6) |
4.222 |
0.00374 |
0.0056 |
Amyloidosis |
All phenotypes |
(GSN, GSN) |
2.963 |
0.0164 |
0.115 |
Amyloidosis, hereditary systemic 4, Finnish type (AMYLD4) [MIM:105120] |
(GSN, GSN) |
2.963 |
0.0164 |
0.0164 |
Amyotrophic lateral sclerosis |
All phenotypes |
(SHC1, ERBB4) |
5.865 |
0.0172 |
0.0549 |
All phenotypes |
(FUS, TNPO1) |
4.024 |
2.92e-15 |
4.67e-14 |
All phenotypes |
(HNRNPA1, TNPO1) |
2.699 |
0.0295 |
0.0785 |
All phenotypes |
(HNRNPA1, HNRNPA1L2) |
2.547 |
0.00501 |
0.0267 |
All phenotypes |
(ANXA11, TARDBP) |
2.124 |
0.0125 |
0.0501 |
All phenotypes |
(TARDBP, TARDBP) |
0.961 |
8.88e-7 |
7.11e-6 |
Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069] |
(ANXA11, TARDBP) |
2.124 |
0.0125 |
0.0125 |
Amyotrophic lateral sclerosis 10 (ALS10) [MIM:612069] |
(TARDBP, TARDBP) |
0.961 |
8.88e-7 |
1.78e-6 |
Amyotrophic lateral sclerosis 19 (ALS19) [MIM:615515] |
(SHC1, ERBB4) |
5.865 |
0.0172 |
0.0172 |
Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426] |
(HNRNPA1, TNPO1) |
2.699 |
0.0295 |
0.0442 |
Amyotrophic lateral sclerosis 20 (ALS20) [MIM:615426] |
(HNRNPA1, HNRNPA1L2) |
2.547 |
0.00501 |
0.015 |
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030] |
(FUS, TNPO1) |
4.024 |
2.92e-15 |
2.92e-15 |
Anhidrosis |
Anhidrosis, isolated, with normal sweat glands (ANHD) [MIM:106190] |
(ITPR2, TRPC4) |
5.401 |
0.0237 |
0.0237 |
Antithrombin III deficiency |
Antithrombin III deficiency (AT3D) [MIM:613118] |
(F9, SERPINC1) |
0.982 |
0.0382 |
0.141 |
Aortic aneurysm |
All phenotypes |
(CALM1, MYLK) |
4.680 |
0.00199 |
0.016 |
All phenotypes |
(MYL12A, MYLK) |
3.542 |
0.00945 |
0.0378 |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
(CALM1, MYLK) |
4.680 |
0.00199 |
0.00399 |
Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780] |
(MYL12A, MYLK) |
3.542 |
0.00945 |
0.00945 |
Apert syndrome |
Apert syndrome (APRS) [MIM:101200] |
(FGF4, FGFR2) |
4.138 |
0.000183 |
0.000877 |
Apert syndrome (APRS) [MIM:101200] |
(FGF10, FGFR2) |
3.945 |
0.000274 |
0.000877 |
Apert syndrome (APRS) [MIM:101200] |
(FGF5, FGFR2) |
3.909 |
0.000295 |
0.000877 |
Apert syndrome (APRS) [MIM:101200] |
(FGF2, FGFR2) |
3.775 |
0.00039 |
0.000877 |
Apert syndrome (APRS) [MIM:101200] |
(FGF7, FGFR2) |
3.623 |
0.000535 |
0.000963 |
Apert syndrome (APRS) [MIM:101200] |
(FGFR2, FGF8) |
3.512 |
0.000674 |
0.00101 |
Apert syndrome (APRS) [MIM:101200] |
(FGF1, FGFR2) |
3.057 |
0.00173 |
0.00223 |
Arthrogryposis |
All phenotypes |
(MET, SH2B1) |
6.555 |
0.0106 |
0.0348 |
All phenotypes |
(SH2B2, MET) |
6.555 |
0.0106 |
0.0348 |
All phenotypes |
(MET, SH2B3) |
6.429 |
0.0116 |
0.0348 |
Arthrogryposis, distal, 11 (DA11) [MIM:620019] |
(MET, SH2B1) |
6.555 |
0.0106 |
0.0271 |
Arthrogryposis, distal, 11 (DA11) [MIM:620019] |
(SH2B2, MET) |
6.555 |
0.0106 |
0.0271 |
Arthrogryposis, distal, 11 (DA11) [MIM:620019] |
(MET, SH2B3) |
6.429 |
0.0116 |
0.0271 |
Ataxia telangiectasia |
All phenotypes |
(NBN, MRE11) |
2.539 |
0.0395 |
0.158 |
Ataxia-telangiectasia-like disorder 1 (ATLD1) [MIM:604391] |
(NBN, MRE11) |
2.539 |
0.0395 |
0.079 |
Atrial septal defect |
All phenotypes |
(SCN2B, SCN2A) |
3.667 |
0.0062 |
0.0786 |
All phenotypes |
(SCN2B, SCN3A) |
3.288 |
0.0105 |
0.0786 |
All phenotypes |
(NKX2-5, MEF2A) |
2.000 |
0.0351 |
0.132 |
All phenotypes |
(NKX2-5, MEF2B) |
2.000 |
0.0351 |
0.132 |
Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378] |
(SCN2B, SCN2A) |
3.667 |
0.0062 |
0.0105 |
Atrial fibrillation, familial, 14 (ATFB14) [MIM:615378] |
(SCN2B, SCN3A) |
3.288 |
0.0105 |
0.0105 |
Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900] |
(NKX2-5, MEF2A) |
2.000 |
0.0351 |
0.0701 |
Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) [MIM:108900] |
(NKX2-5, MEF2B) |
2.000 |
0.0351 |
0.0701 |
Auriculocondylar syndrome |
Auriculocondylar syndrome 1 (ARCND1) [MIM:602483] |
(GNAI3, PCP2) |
2.652 |
0.00619 |
0.00756 |
Auriculocondylar syndrome 1 (ARCND1) [MIM:602483] |
(GNAI3, GPSM3) |
2.618 |
0.00662 |
0.00756 |
Auriculocondylar syndrome 1 (ARCND1) [MIM:602483] |
(GNAI3, GPSM2) |
2.553 |
0.00756 |
0.00756 |
Autoimmune disease, multisystem, infantile-onset, |
All phenotypes |
(SMARCB1, H2AC6) |
5.551 |
9.71e-6 |
0.000165 |
All phenotypes |
(H2BC12, SMARCB1) |
4.743 |
5.2e-5 |
0.000442 |
All phenotypes |
(H2BC10, SMARCB1) |
4.644 |
0.0021 |
0.00891 |
All phenotypes |
(ERBB2, STAT3) |
4.310 |
0.0495 |
0.124 |
All phenotypes |
(SMARCB1, H2AC19) |
4.303 |
0.00013 |
0.000737 |
All phenotypes |
(STAT3, STAT2) |
2.865 |
0.0257 |
0.0875 |
Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952] |
(ERBB2, STAT3) |
4.310 |
0.0495 |
0.0918 |
Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952] |
(STAT3, STAT2) |
2.865 |
0.0257 |
0.0918 |
Coffin-Siris syndrome 3 (CSS3) [MIM:614608] |
(SMARCB1, H2AC6) |
5.551 |
9.71e-6 |
3.88e-5 |
Coffin-Siris syndrome 3 (CSS3) [MIM:614608] |
(H2BC12, SMARCB1) |
4.743 |
5.2e-5 |
0.000104 |
Coffin-Siris syndrome 3 (CSS3) [MIM:614608] |
(H2BC10, SMARCB1) |
4.644 |
0.0021 |
0.0021 |
Coffin-Siris syndrome 3 (CSS3) [MIM:614608] |
(SMARCB1, H2AC19) |
4.303 |
0.00013 |
0.000173 |
Autoimmune polyendocrine syndrome |
Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300] |
(AIRE, AIRE) |
2.106 |
0.0184 |
0.0368 |
Autoinflammation, antibody deficiency, and immune dysregulation |
Autoinflammation, antibody deficiency, and immune dysregulation (APLAID) [MIM:614878] |
(ERBB2, PLCG2) |
6.253 |
0.0131 |
0.0131 |
Baraitser-Winter syndrome |
All phenotypes |
(ACTB, ACTR3) |
2.032 |
0.025 |
0.2 |
Baraitser-Winter syndrome 1 (BRWS1) [MIM:243310] |
(ACTB, ACTR3) |
2.032 |
0.025 |
0.125 |
Bardet-Biedl syndrome |
All phenotypes |
(BBS1, BBS2) |
1.811 |
0.0234 |
0.206 |
All phenotypes |
(BBS1, BBS4) |
1.245 |
0.0316 |
0.206 |
Bardet-Biedl syndrome 2 (BBS2) [MIM:615981] |
(BBS1, BBS2) |
1.811 |
0.0234 |
0.0937 |
Basal cell nevus syndrome |
All phenotypes |
(ACTB, CCT7) |
5.229 |
0.0267 |
0.147 |
All phenotypes |
(ACTB, MZT1) |
5.091 |
0.0293 |
0.147 |
All phenotypes |
(ACTB, PDCL3) |
4.463 |
0.0453 |
0.189 |
All phenotypes |
(NRAS, HLA-A) |
3.519 |
0.00975 |
0.135 |
All phenotypes |
(NRAS, GRB10) |
2.934 |
0.0215 |
0.147 |
All phenotypes |
(NRAS, RASA1) |
2.178 |
0.0108 |
0.135 |
Becker nevus syndrome (BNS) [MIM:604919] |
(ACTB, CCT7) |
5.229 |
0.0267 |
0.194 |
Becker nevus syndrome (BNS) [MIM:604919] |
(ACTB, MZT1) |
5.091 |
0.0293 |
0.194 |
Becker nevus syndrome (BNS) [MIM:604919] |
(ACTB, PDCL3) |
4.463 |
0.0453 |
0.194 |
Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550] |
(NRAS, HLA-A) |
3.519 |
0.00975 |
0.0324 |
Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550] |
(NRAS, GRB10) |
2.934 |
0.0215 |
0.043 |
Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550] |
(NRAS, RASA1) |
2.178 |
0.0108 |
0.0324 |
Basal ganglia calcification |
Basal ganglia calcification, idiopathic, 5 (IBGC5) [MIM:615483] |
(PDGFB, PDGFC) |
4.331 |
0.0497 |
0.248 |
Bethlem myopathy |
All phenotypes |
(ACTG2, ACTG2) |
1.824 |
2.12e-5 |
0.000276 |
Visceral myopathy 1 (VSCM1) [MIM:155310] |
(ACTG2, ACTG2) |
1.824 |
2.12e-5 |
0.000191 |
Bladder cancer |
Bladder cancer (BLC) [MIM:109800] |
(FGF1, FGFR3) |
2.688 |
0.0339 |
0.0951 |
Bladder cancer (BLC) [MIM:109800] |
(FGFR3, FGFR3) |
1.985 |
0.007 |
0.049 |
Bleeding disorder |
All phenotypes |
(ITGA2B, FLNA) |
6.326 |
0.000155 |
0.00124 |
All phenotypes |
(TBXA2R, WDR36) |
6.013 |
0.0155 |
0.0577 |
All phenotypes |
(RAP1B, RASGRP2) |
2.362 |
0.0497 |
0.0794 |
All phenotypes |
(ITGB3, ITGA2B) |
1.767 |
0.0254 |
0.0577 |
Bleeding disorder, platelet-type, 13 (BDPLT13) [MIM:614009] |
(TBXA2R, WDR36) |
6.013 |
0.0155 |
0.031 |
Bleeding disorder, platelet-type, 16 (BDPLT16) [MIM:187800] |
(ITGA2B, FLNA) |
6.326 |
0.000155 |
0.000311 |
Bleeding disorder, platelet-type, 18 (BDPLT18) [MIM:615888] |
(RAP1B, RASGRP2) |
2.362 |
0.0497 |
0.0497 |
Bleeding disorder, platelet-type, 24 (BDPLT24) [MIM:619271] |
(ITGB3, TLN1) |
5.114 |
0.0289 |
0.0577 |
Blepharocheilodontic syndrome |
Blepharocheilodontic syndrome 1 (BCDS1) [MIM:119580] |
(CDH1, CDH1) |
3.787 |
0.00525 |
0.00525 |
Blepharophimosis-impaired intellectual development syndrome |
Blepharophimosis-impaired intellectual development syndrome (BIS) [MIM:619293] |
(SMARCA2, SMARCA2) |
2.893 |
0.00136 |
0.00136 |
Brachycephaly, trichomegaly, and developmental delay |
All phenotypes |
(KEAP1, NFE2L2) |
2.916 |
0.00363 |
0.0109 |
Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) [MIM:617744] |
(KEAP1, NFE2L2) |
2.916 |
0.00363 |
0.00726 |
Brachydactyly |
All phenotypes |
(IHH, CDON) |
2.935 |
0.0235 |
0.0875 |
All phenotypes |
(IHH, BOC) |
2.865 |
0.0257 |
0.0875 |
All phenotypes |
(BMP2, NOG) |
2.565 |
0.000293 |
0.00249 |
All phenotypes |
(BMP7, NOG) |
1.892 |
0.0115 |
0.0649 |
All phenotypes |
(GDF5, NOG) |
1.762 |
0.000269 |
0.00249 |
Brachydactyly A1 (BDA1) [MIM:112500] |
(IHH, CDON) |
2.935 |
0.0235 |
0.0386 |
Brachydactyly A1 (BDA1) [MIM:112500] |
(IHH, BOC) |
2.865 |
0.0257 |
0.0386 |
Brachydactyly B2 (BDB2) [MIM:611377] |
(BMP2, NOG) |
2.565 |
0.000293 |
0.00117 |
Brachydactyly B2 (BDB2) [MIM:611377] |
(GDF5, NOG) |
2.214 |
0.000954 |
0.00191 |
Brachydactyly B2 (BDB2) [MIM:611377] |
(BMP7, NOG) |
1.892 |
0.0115 |
0.0153 |
Breast cancer |
All phenotypes |
(PLCG1, PIK3CA) |
6.253 |
0.000255 |
0.00255 |
All phenotypes |
(HLA-A, PIK3CA) |
5.891 |
0.000421 |
0.00281 |
All phenotypes |
(PIK3CA, GRB2) |
5.476 |
0.000746 |
0.00373 |
All phenotypes |
(BRCA2, PALB2) |
4.839 |
9.17e-6 |
0.000183 |
All phenotypes |
(BRCA1, ATRIP) |
3.452 |
0.00207 |
0.00689 |
All phenotypes |
(BRCA1, BRAT1) |
3.452 |
0.00207 |
0.00689 |
All phenotypes |
(BRCA1, RBBP8) |
2.789 |
0.00756 |
0.0216 |
All phenotypes |
(BRCA1, ACACA) |
2.578 |
0.0113 |
0.0283 |
All phenotypes |
(BRCA1, ABRAXAS1) |
2.179 |
0.0239 |
0.0523 |
All phenotypes |
(BRCA1, BRIP1) |
2.130 |
0.0262 |
0.0523 |
All phenotypes |
(RAD51C, XRCC3) |
1.763 |
0.0417 |
0.0757 |
Breast cancer (BC) [MIM:114480] |
(PLCG1, PIK3CA) |
6.253 |
0.000255 |
0.0023 |
Breast cancer (BC) [MIM:114480] |
(HLA-A, PIK3CA) |
5.891 |
0.000421 |
0.00253 |
Breast cancer (BC) [MIM:114480] |
(PIK3CA, GRB2) |
5.476 |
0.000746 |
0.00336 |
Breast cancer (BC) [MIM:114480] |
(BRCA2, PALB2) |
4.839 |
9.17e-6 |
0.000165 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, ATRIP) |
3.452 |
0.00207 |
0.0062 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, BRAT1) |
3.452 |
0.00207 |
0.0062 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, RBBP8) |
2.789 |
0.00756 |
0.0194 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, ACACA) |
2.578 |
0.0113 |
0.0255 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, ABRAXAS1) |
2.179 |
0.0239 |
0.0471 |
Breast cancer (BC) [MIM:114480] |
(BRCA1, BRIP1) |
2.130 |
0.0262 |
0.0471 |
Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370] |
(BRCA1, BARD1) |
3.230 |
0.0114 |
0.0114 |
Breast-ovarian cancer, familial, 3 (BROVCA3) [MIM:613399] |
(RAD51C, XRCC3) |
1.763 |
0.0417 |
0.0833 |
Bryant-Li-Bhoj neurodevelopmental syndrome |
All phenotypes |
(H3-3B, MORC3) |
1.948 |
0.0397 |
0.485 |
All phenotypes |
(RPS27A, H3-3B) |
1.469 |
0.0494 |
0.485 |
All phenotypes |
(UBB, H3-3B) |
1.469 |
0.0494 |
0.485 |
Buratti-Harel syndrome |
Buratti-Harel syndrome (BURHAS) [MIM:619314] |
(SIAH1, AXIN2) |
2.579 |
0.0391 |
0.156 |
CIMDAG syndrome |
CIMDAG syndrome (CIMDAG) [MIM:619273] |
(VPS4A, VPS4A) |
1.836 |
0.00616 |
0.00616 |
CLAPO syndrome |
CLAPO syndrome (CLAPO) [MIM:613089] |
(PLCG1, PIK3CA) |
6.253 |
0.0131 |
0.0447 |
CLAPO syndrome (CLAPO) [MIM:613089] |
(HLA-A, PIK3CA) |
5.891 |
0.0168 |
0.0447 |
CLAPO syndrome (CLAPO) [MIM:613089] |
(PIK3CA, GRB2) |
5.476 |
0.0223 |
0.0447 |
CLOVE syndrome |
Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) [MIM:612918] |
(PLCG1, PIK3CA) |
6.253 |
0.0131 |
0.0447 |
Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) [MIM:612918] |
(HLA-A, PIK3CA) |
5.891 |
0.0168 |
0.0447 |
Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) [MIM:612918] |
(PIK3CA, GRB2) |
5.476 |
0.0223 |
0.0447 |
Camurati-Engelmann disease |
Camurati-Engelmann disease (CAEND) [MIM:131300] |
(TGFB1, TGFB1) |
0.666 |
0.0395 |
0.0395 |
Cardiofaciocutaneous syndrome |
All phenotypes |
(BUB1, MAP2K1) |
2.879 |
0.0232 |
0.349 |
All phenotypes |
(KRAS, SOS1) |
1.518 |
0.00519 |
0.197 |
Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278] |
(KRAS, SOS1) |
1.518 |
0.00519 |
0.0883 |
Cardiofaciocutaneous syndrome 3 (CFC3) [MIM:615279] |
(BUB1, MAP2K1) |
2.879 |
0.0232 |
0.116 |
Cardiomyopathy |
All phenotypes |
(BAG3, HSPA1A) |
2.261 |
0.0135 |
0.103 |
All phenotypes |
(ACTB, ACTC1) |
2.100 |
0.01 |
0.0875 |
All phenotypes |
(BAG3, HSPA8) |
2.084 |
0.0192 |
0.13 |
All phenotypes |
(ACTC1, ACTBL2) |
1.814 |
0.0472 |
0.288 |
All phenotypes |
(CFL1, ACTC1) |
1.796 |
0.00828 |
0.0842 |
All phenotypes |
(MYL3, MYH7) |
1.418 |
8.6e-10 |
5.25e-8 |
All phenotypes |
(TPM1, TNNI3) |
1.414 |
0.00292 |
0.0445 |
All phenotypes |
(LMNA, LMNB2) |
1.042 |
0.00243 |
0.0445 |
All phenotypes |
(LMNA, LMNB1) |
1.032 |
0.00262 |
0.0445 |
All phenotypes |
(LMNA, LMNA) |
0.493 |
0.00684 |
0.0835 |
Cardiomyopathy, dilated, 1A (CMD1A) [MIM:115200] |
(LMNA, LMNB2) |
1.051 |
0.00323 |
0.0121 |
Cardiomyopathy, dilated, 1A (CMD1A) [MIM:115200] |
(LMNA, LMNB1) |
1.040 |
0.00346 |
0.0121 |
Cardiomyopathy, dilated, 1A (CMD1A) [MIM:115200] |
(LMNA, LMNA) |
0.471 |
0.0138 |
0.0323 |
Cardiomyopathy, dilated, 1D (CMD1D) [MIM:601494] |
(TPM1, TNNT2) |
2.420 |
0.0427 |
0.0427 |
Cardiomyopathy, dilated, 1HH (CMD1HH) [MIM:613881] |
(BAG3, HSPA1A) |
2.261 |
0.0135 |
0.0192 |
Cardiomyopathy, dilated, 1HH (CMD1HH) [MIM:613881] |
(BAG3, HSPA8) |
2.084 |
0.0192 |
0.0192 |
Cardiomyopathy, dilated, 1S (CMD1S) [MIM:613426] |
(MYH7, ACTC1) |
3.430 |
0.00041 |
0.00164 |
Cardiomyopathy, familial hypertrophic, 11 (CMH11) [MIM:612098] |
(ACTB, ACTC1) |
2.421 |
0.0039 |
0.0273 |
Cardiomyopathy, familial hypertrophic, 11 (CMH11) [MIM:612098] |
(ACTC1, ACTBL2) |
2.136 |
0.0251 |
0.117 |
Cardiomyopathy, familial hypertrophic, 11 (CMH11) [MIM:612098] |
(CFL1, ACTC1) |
2.118 |
0.00237 |
0.0273 |
Cardiomyopathy, familial hypertrophic, 1 (CMH1) [MIM:192600] |
(MYL3, MYH7) |
2.156 |
2.7e-15 |
1.62e-14 |
Cardiomyopathy, familial hypertrophic, 7 (CMH7) [MIM:613690] |
(TPM1, TNNI3) |
1.617 |
0.00643 |
0.0257 |
Cardiomyopathy, familial hypertrophic, 8 (CMH8) [MIM:608751] |
(MYL3, MYH7) |
0.991 |
0.0323 |
0.0323 |
Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210] |
(TPM1, TNNI3) |
1.907 |
0.011 |
0.0441 |
Cataract |
All phenotypes |
(EPHA2, PTPRR) |
5.098 |
0.0289 |
0.546 |
Cataract 6, multiple types (CTRCT6) [MIM:116600] |
(EPHA2, PTPRR) |
5.098 |
0.0289 |
0.0578 |
Cerebellar atrophy, visual impairment, and psychomotor retardation |
All phenotypes |
(SPTAN1, SPTBN4) |
6.174 |
0.0139 |
0.129 |
All phenotypes |
(SPTAN1, SPTAN1) |
5.382 |
0.024 |
0.129 |
All phenotypes |
(SPTB, SPTAN1) |
5.067 |
0.0298 |
0.129 |
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (SPG91) [MIM:620538] |
(SPTAN1, SPTBN4) |
6.174 |
0.0139 |
0.0398 |
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (SPG91) [MIM:620538] |
(SPTAN1, SPTAN1) |
5.382 |
0.024 |
0.0398 |
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (SPG91) [MIM:620538] |
(SPTB, SPTAN1) |
5.067 |
0.0298 |
0.0398 |
Cerebral amyloid angiopathy |
All phenotypes |
(APP, PITRM1) |
5.675 |
1.25e-5 |
9.43e-5 |
All phenotypes |
(APP, ) |
5.523 |
1.72e-5 |
9.43e-5 |
All phenotypes |
(APP, LCN2) |
5.144 |
3.75e-5 |
0.000103 |
All phenotypes |
(IGHG1, APP) |
5.144 |
3.75e-5 |
0.000103 |
All phenotypes |
(APP, ) |
5.090 |
0.00127 |
0.00174 |
All phenotypes |
(APP, IDE) |
4.597 |
0.000116 |
0.000256 |
All phenotypes |
(IGKC, APP) |
4.452 |
0.00303 |
0.00371 |
All phenotypes |
(APP, PSEN1) |
3.938 |
0.000452 |
0.000828 |
All phenotypes |
(APP, PSEN2) |
3.800 |
0.000599 |
0.000941 |
All phenotypes |
(APP, APP) |
1.323 |
0.0255 |
0.0281 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, PITRM1) |
5.675 |
1.25e-5 |
8.58e-5 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, ) |
5.523 |
1.72e-5 |
8.58e-5 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, LCN2) |
5.144 |
3.75e-5 |
9.39e-5 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(IGHG1, APP) |
5.144 |
3.75e-5 |
9.39e-5 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, ) |
5.090 |
0.00127 |
0.00159 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, IDE) |
4.597 |
0.000116 |
0.000233 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(IGKC, APP) |
4.452 |
0.00303 |
0.00337 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, PSEN1) |
3.938 |
0.000452 |
0.000753 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, PSEN2) |
3.800 |
0.000599 |
0.000856 |
Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714] |
(APP, APP) |
1.323 |
0.0255 |
0.0255 |
Cerebral cavernous malformations |
All phenotypes |
(HLA-A, PIK3CA) |
6.306 |
0.000212 |
0.00169 |
All phenotypes |
(PLCG1, PIK3CA) |
5.668 |
0.0195 |
0.0781 |
All phenotypes |
(PIK3CA, GRB2) |
4.891 |
0.0333 |
0.0889 |
Cerebral cavernous malformations 4 (CCM4) [MIM:619538] |
(HLA-A, PIK3CA) |
6.306 |
0.000212 |
0.00127 |
Cerebral cavernous malformations 4 (CCM4) [MIM:619538] |
(PLCG1, PIK3CA) |
5.668 |
0.0195 |
0.0586 |
Cerebral cavernous malformations 4 (CCM4) [MIM:619538] |
(PIK3CA, GRB2) |
4.891 |
0.0333 |
0.0667 |
Cerebrocostomandibular syndrome |
Cerebrocostomandibular syndrome (CCMS) [MIM:117650] |
(SNRPB, SF3A3) |
2.694 |
0.00057 |
0.00057 |
Charcot-Marie-Tooth disease |
All phenotypes |
(GJB1, GJB1) |
0.217 |
0.0237 |
0.285 |
Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800] |
(GJB1, GJB1) |
0.217 |
0.0237 |
0.0474 |
Cherubism |
Cherubism (CRBM) [MIM:118400] |
(SH3BP2, TNKS2) |
3.492 |
4.38e-8 |
4.38e-8 |
Chronic infantile neurologic cutaneous and articular syndrome |
Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
(EIF2AK2, NLRP3) |
4.349 |
0.00431 |
0.0129 |
Cirrhosis |
Cirrhosis (CIRRH) [MIM:215600] |
(KRT8, KRT8) |
4.164 |
0.000174 |
0.000174 |
Coagulation factor deficiency |
All phenotypes |
(F2, NID2) |
3.048 |
0.0231 |
0.148 |
All phenotypes |
(F12, APP) |
2.803 |
0.000388 |
0.0124 |
All phenotypes |
(F2, F5) |
2.429 |
0.00443 |
0.0698 |
All phenotypes |
(F2, F2R) |
1.874 |
0.00655 |
0.0698 |
All phenotypes |
(F2, SERPINC1) |
1.855 |
0.0181 |
0.145 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, NID2) |
3.048 |
0.0231 |
0.0983 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, F5) |
2.429 |
0.00443 |
0.0557 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, F2R) |
1.874 |
0.00655 |
0.0557 |
Factor II deficiency (FA2D) [MIM:613679] |
(F2, SERPINC1) |
1.855 |
0.0181 |
0.0983 |
Factor XII deficiency (FA12D) [MIM:234000] |
(F12, APP) |
2.803 |
0.000388 |
0.000388 |
Coffin-Siris syndrome |
Coffin-Siris syndrome 8 (CSS8) [MIM:618362] |
(SMARCC2, BRD7) |
2.663 |
0.0309 |
0.0557 |
Cohen-Gibson syndrome |
Cohen-Gibson syndrome (COGIS) [MIM:617561] |
(EED, EZH1) |
1.361 |
0.0157 |
0.063 |
Colorectal cancer |
All phenotypes |
(PLCG1, PIK3CA) |
5.446 |
0.000883 |
0.0178 |
All phenotypes |
(HLA-A, CTNNB1) |
5.072 |
0.0297 |
0.113 |
All phenotypes |
(PIK3CA, GRB2) |
4.668 |
0.00255 |
0.0178 |
All phenotypes |
(HRAS, PPP1R16A) |
4.418 |
0.0468 |
0.128 |
All phenotypes |
(BRAF, YWHAQ) |
3.224 |
0.0024 |
0.0178 |
All phenotypes |
(BRAF, YWHAB) |
3.183 |
0.0026 |
0.0178 |
All phenotypes |
(BRAF, YWHAE) |
3.183 |
0.0026 |
0.0178 |
All phenotypes |
(BRAF, YWHAG) |
3.183 |
0.0026 |
0.0178 |
All phenotypes |
(BRAF, MAP2K1) |
2.546 |
0.00925 |
0.0474 |
All phenotypes |
(BRAF, MAP2K2) |
2.446 |
0.0112 |
0.0512 |
All phenotypes |
(PIK3R2, PIK3CA) |
1.943 |
0.0343 |
0.113 |
All phenotypes |
(PIK3CA, PIK3R3) |
1.919 |
0.0358 |
0.113 |
All phenotypes |
(BRAF, YWHAZ) |
1.894 |
0.0326 |
0.113 |
All phenotypes |
(MLH1, PMS2) |
1.263 |
0.00588 |
0.0344 |
All phenotypes |
(BRAF, BRAF) |
0.900 |
0.0442 |
0.128 |
Colorectal cancer (CRC) [MIM:114500] |
(PLCG1, PIK3CA) |
5.446 |
0.000883 |
0.00955 |
Colorectal cancer (CRC) [MIM:114500] |
(HLA-A, CTNNB1) |
5.072 |
0.0297 |
0.0656 |
Colorectal cancer (CRC) [MIM:114500] |
(PIK3CA, GRB2) |
4.668 |
0.00255 |
0.00955 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAQ) |
3.224 |
0.0024 |
0.00955 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAB) |
3.183 |
0.0026 |
0.00955 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAE) |
3.183 |
0.0026 |
0.00955 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAG) |
3.183 |
0.0026 |
0.00955 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, MAP2K1) |
2.546 |
0.00925 |
0.0291 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, MAP2K2) |
2.446 |
0.0112 |
0.0309 |
Colorectal cancer (CRC) [MIM:114500] |
(PIK3R2, PIK3CA) |
1.943 |
0.0343 |
0.0656 |
Colorectal cancer (CRC) [MIM:114500] |
(PIK3CA, PIK3R3) |
1.919 |
0.0358 |
0.0656 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, YWHAZ) |
1.894 |
0.0326 |
0.0656 |
Colorectal cancer (CRC) [MIM:114500] |
(BRAF, BRAF) |
0.900 |
0.0442 |
0.0747 |
Lynch syndrome 2 (LYNCH2) [MIM:609310] |
(MLH1, PMS2) |
1.276 |
0.00793 |
0.0238 |
Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470] |
(HRAS, PPP1R16A) |
4.418 |
0.0468 |
0.29 |
Combined immunodeficiency |
All phenotypes |
(TLR8, TLR8) |
2.652 |
0.000641 |
0.00834 |
All phenotypes |
(TLR8, TLR7) |
2.570 |
0.00729 |
0.0474 |
Immunodeficiency 98 with autoinflammation, X-linked (IMD98) [MIM:301078] |
(TLR8, TLR8) |
2.652 |
0.000641 |
0.00128 |
Immunodeficiency 98 with autoinflammation, X-linked (IMD98) [MIM:301078] |
(TLR8, TLR7) |
2.570 |
0.00729 |
0.00729 |
Complement component deficiency |
All phenotypes |
(GLA, PSAP) |
2.907 |
0.0244 |
0.317 |
Metachromatic leukodystrophy due to saposin B deficiency (MLDSAPB) [MIM:249900] |
(GLA, PSAP) |
2.907 |
0.0244 |
0.0487 |
Complement factors deficiency |
All phenotypes |
(CFH, CFHR3) |
2.411 |
0.0485 |
0.167 |
Complement factor H deficiency (CFHD) [MIM:609814] |
(CFH, CFHR3) |
2.411 |
0.0485 |
0.133 |
Congenital heart defects |
All phenotypes |
(CDC42, LRRK2) |
4.992 |
0.0314 |
0.281 |
All phenotypes |
(HERC2, CDC42) |
4.770 |
0.0366 |
0.281 |
Takenouchi-Kosaki syndrome (TKS) [MIM:616737] |
(CDC42, LRRK2) |
4.992 |
0.0314 |
0.281 |
Takenouchi-Kosaki syndrome (TKS) [MIM:616737] |
(HERC2, CDC42) |
4.770 |
0.0366 |
0.281 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, MZT1) |
5.091 |
6.37e-10 |
1.21e-8 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, PDCL3) |
4.463 |
8.68e-9 |
8.25e-8 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(SMARCA4, ACTB) |
3.850 |
1.11e-7 |
7.04e-7 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, TUBGCP6) |
3.693 |
2.14e-7 |
9.96e-7 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, NAA80) |
3.644 |
2.62e-7 |
9.96e-7 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, CCT7) |
3.644 |
0.00993 |
0.00993 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, EP400) |
3.506 |
4.64e-7 |
1.47e-6 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(PLS3, ACTB) |
3.341 |
9.23e-7 |
2.5e-6 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, ACTN3) |
3.158 |
1.97e-6 |
4.69e-6 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(MGMT, ACTB) |
3.059 |
2.99e-6 |
6.3e-6 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, DSTN) |
2.907 |
5.62e-6 |
1.07e-5 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTN2, ACTB) |
2.850 |
7.11e-6 |
1.23e-5 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, ACTR3) |
2.769 |
9.95e-6 |
1.58e-5 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, CFL2) |
2.743 |
1.11e-5 |
1.62e-5 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(SPTBN2, ACTB) |
2.528 |
2.71e-5 |
3.53e-5 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(CFL1, ACTB) |
2.506 |
2.97e-5 |
3.53e-5 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(GSN, ACTB) |
2.506 |
2.97e-5 |
3.53e-5 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, TWF1) |
2.442 |
3.88e-5 |
4.34e-5 |
Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) [MIM:620470] |
(ACTB, ACTB) |
1.401 |
0.00295 |
0.00311 |
Congenital stationary night blindness |
All phenotypes |
(FYN, GUCY2D) |
5.865 |
0.0172 |
0.0343 |
Night blindness, congenital stationary, 1I (CSNB1I) [MIM:618555] |
(FYN, GUCY2D) |
5.865 |
0.0172 |
0.0172 |
Congenital sucrase-isomaltase deficiency |
Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
(SI, SI) |
1.281 |
0.0206 |
0.0411 |
Corneal dystrophy |
All phenotypes |
(TGFBI, TGFBI) |
2.170 |
0.011 |
0.0329 |
Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200] |
(TGFBI, TGFBI) |
2.578 |
0.0123 |
0.0123 |
Cornelia de Lange syndrome |
All phenotypes |
(SMC1A, SMC3) |
1.500 |
0.0413 |
0.23 |
Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590] |
(SMC1A, SMC3) |
1.500 |
0.0413 |
0.0827 |
Cortical dysplasia complex with other brain malformations |
All phenotypes |
(TUBB3, TUBA1A) |
1.664 |
0.0436 |
0.496 |
Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039] |
(TUBB3, TUBA1A) |
1.664 |
0.0436 |
0.14 |
Corticosterone methyloxidase deficiency |
All phenotypes |
(FDX1, CYP11B2) |
2.274 |
0.0174 |
0.0319 |
All phenotypes |
(CYP11B2, CYP11B2) |
1.952 |
0.0319 |
0.0319 |
Corticosterone methyloxidase 2 deficiency (CMO-2 deficiency) [MIM:610600] |
(FDX1, CYP11B2) |
2.537 |
0.00941 |
0.0176 |
Corticosterone methyloxidase 2 deficiency (CMO-2 deficiency) [MIM:610600] |
(CYP11B2, CYP11B2) |
2.215 |
0.0176 |
0.0176 |
Cowden disease |
All phenotypes |
(PLCG1, PIK3CA) |
4.668 |
0.0387 |
0.262 |
Cowden syndrome 5 (CWS5) [MIM:615108] |
(PLCG1, PIK3CA) |
4.668 |
0.0387 |
0.164 |
Creutzfeldt-Jakob disease |
Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
(PRNP, PRNP) |
0.652 |
0.0423 |
0.0423 |
Crigler-Najjar syndrome |
All phenotypes |
(UGT1A1, UGT1A8) |
1.775 |
0.000968 |
0.00492 |
All phenotypes |
(UGT1A9, UGT1A1) |
1.762 |
0.00205 |
0.00546 |
All phenotypes |
(UGT1A1, UGT1A10) |
1.726 |
0.00123 |
0.00492 |
All phenotypes |
(UGT1A1, UGT1A1) |
1.605 |
0.00402 |
0.00643 |
All phenotypes |
(UGT1A1, UGT1A3) |
1.570 |
0.00826 |
0.00944 |
All phenotypes |
(UGT1A1, UGT1A4) |
1.570 |
0.00826 |
0.00944 |
All phenotypes |
(UGT1A6, UGT1A1) |
1.545 |
0.00292 |
0.00583 |
All phenotypes |
(UGT1A1, UGT1A7) |
1.463 |
0.0121 |
0.0121 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A10) |
2.293 |
0.000334 |
0.00267 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A1) |
2.119 |
0.00185 |
0.00371 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A8) |
2.119 |
0.00185 |
0.00371 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A6, UGT1A1) |
2.112 |
0.000714 |
0.00286 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A3) |
2.014 |
0.00654 |
0.00747 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A4) |
2.014 |
0.00654 |
0.00747 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A9, UGT1A1) |
2.014 |
0.00654 |
0.00747 |
Crigler-Najjar syndrome 1 (CN1) [MIM:218800] |
(UGT1A1, UGT1A7) |
1.907 |
0.0089 |
0.0089 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A9, UGT1A1) |
1.883 |
0.0098 |
0.061 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A8) |
1.725 |
0.0152 |
0.061 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A3) |
1.561 |
0.0435 |
0.0768 |
Crigler-Najjar syndrome 2 (CN2) [MIM:606785] |
(UGT1A1, UGT1A4) |
1.561 |
0.0435 |
0.0768 |
Cutis laxa |
All phenotypes |
(ATP6V1B2, ATP6V1E1) |
2.199 |
0.0474 |
0.166 |
All phenotypes |
(PYCR1, PYCR1) |
0.815 |
0.0449 |
0.166 |
Cutis laxa, autosomal recessive, 2C (ARCL2C) [MIM:617402] |
(ATP6V1B2, ATP6V1E1) |
2.199 |
0.0474 |
0.0949 |
D-2-hydroxyglutaric aciduria |
D-2-hydroxyglutaric aciduria 2 (D2HGA2) [MIM:613657] |
(HLA-B, IDH2) |
5.365 |
0.000589 |
0.000589 |
Deafness |
All phenotypes |
(CDC7, MCM2) |
6.854 |
0.00864 |
0.124 |
All phenotypes |
(AIFM1, AIFM1) |
3.509 |
0.0109 |
0.124 |
All phenotypes |
(AIFM1, CHCHD4) |
3.509 |
0.0109 |
0.124 |
All phenotypes |
(CCT3, ACTG1) |
2.225 |
0.0225 |
0.192 |
Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717] |
(CCT3, ACTG1) |
2.225 |
0.0225 |
0.203 |
Deafness, autosomal dominant, 70 (DFNA70) [MIM:616968] |
(CDC7, MCM2) |
6.854 |
0.00864 |
0.00864 |
Deafness, X-linked, 5, with peripheral neuropathy (DFNX5) [MIM:300614] |
(AIFM1, AIFM1) |
3.509 |
0.0109 |
0.0109 |
Deafness, X-linked, 5, with peripheral neuropathy (DFNX5) [MIM:300614] |
(AIFM1, CHCHD4) |
3.509 |
0.0109 |
0.0109 |
Dehydrated hereditary stomatocytosis 2 |
All phenotypes |
(KCNN4, KCNN4) |
1.523 |
0.0421 |
0.168 |
Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689] |
(KCNN4, KCNN4) |
1.523 |
0.0421 |
0.126 |
Dejerine-Sottas syndrome |
All phenotypes |
(ERBB2, ABL2) |
5.215 |
0.0269 |
0.0661 |
All phenotypes |
(NDUFS2, MT-ND5) |
4.941 |
0.0323 |
0.0661 |
All phenotypes |
(HSP90AB1, ERBB3) |
4.641 |
0.0397 |
0.0661 |
Leber-like hereditary optic neuropathy, autosomal recessive 2 (LHONAR2) [MIM:620569] |
(NDUFS2, MT-ND5) |
4.941 |
0.0323 |
0.0646 |
Visceral neuropathy, familial, 1, autosomal recessive (VSCN1) [MIM:243180] |
(HSP90AB1, ERBB3) |
4.641 |
0.0397 |
0.0397 |
Visceral neuropathy, familial, 2, autosomal recessive (VSCN2) [MIM:619465] |
(ERBB2, ABL2) |
5.215 |
0.0269 |
0.0538 |
Dementia |
All phenotypes |
(MAPT, MAPT) |
0.529 |
0.0122 |
0.184 |
Frontotemporal dementia (FTD) [MIM:600274] |
(MAPT, MAPT) |
0.529 |
0.0122 |
0.0857 |
Diabetes mellitus |
All phenotypes |
(ABCC8, KCNJ11) |
2.277 |
1.96e-7 |
5.88e-6 |
All phenotypes |
(INS, INSR) |
1.414 |
0.000194 |
0.00194 |
All phenotypes |
(INS, IGF1R) |
0.888 |
0.0103 |
0.0442 |
All phenotypes |
(INS, INS) |
0.866 |
0.000386 |
0.00289 |
All phenotypes |
(INS-IGF2, INS) |
0.821 |
0.00186 |
0.0112 |
All phenotypes |
(KCNJ11, KCNJ11) |
0.806 |
3.84e-5 |
0.000576 |
All phenotypes |
(INS, IDE) |
0.794 |
0.00235 |
0.0117 |
Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856] |
(ABCC8, KCNJ11) |
1.066 |
0.0405 |
0.0607 |
Diabetes mellitus, permanent neonatal, 2 (PNDM2) [MIM:618856] |
(KCNJ11, KCNJ11) |
0.757 |
0.000613 |
0.00184 |
Diabetes mellitus, permanent neonatal, 3 (PNDM3) [MIM:618857] |
(ABCC8, KCNJ11) |
3.231 |
1.98e-5 |
1.98e-5 |
Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858] |
(INS, IGF1R) |
0.981 |
0.00485 |
0.0116 |
Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858] |
(INS-IGF2, INS) |
0.914 |
0.000431 |
0.00212 |
Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858] |
(INS, IDE) |
0.887 |
0.000553 |
0.00212 |
Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858] |
(INS, INSR) |
0.887 |
0.000553 |
0.00212 |
Diabetes mellitus, permanent neonatal, 4 (PNDM4) [MIM:618858] |
(INS, INS) |
0.860 |
0.000706 |
0.00212 |
Transient neonatal diabetes mellitus 3 (TNDM3) [MIM:610582] |
(ABCC9, KCNJ11) |
1.715 |
0.0395 |
0.0886 |
Type 2 diabetes mellitus (T2D) [MIM:125853] |
(INSR, SH2B1) |
5.279 |
0.0255 |
0.0557 |
Type 2 diabetes mellitus (T2D) [MIM:125853] |
(SH2B2, INSR) |
5.153 |
0.0278 |
0.0557 |
Diarrhea |
Diarrhea 1, secretory chloride, congenital (DIAR1) [MIM:214700] |
(SLC26A3, SLC26A3) |
0.981 |
0.028 |
0.028 |
Dihydrolipoamide dehydrogenase deficiency |
Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900] |
(DLD, DBT) |
3.006 |
0.0244 |
0.0366 |
Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900] |
(PDHX, DLD) |
2.421 |
0.0157 |
0.0366 |
Dysfibrinogenemia |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
(F2, FGB) |
6.143 |
0.0142 |
0.075 |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
(FGA, KLK6) |
5.544 |
0.0214 |
0.075 |
Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004] |
(F2, FGA) |
4.392 |
0.0476 |
0.111 |
Dyskeratosis congenita |
All phenotypes |
(DKC1, DKC1) |
1.968 |
3.12e-7 |
1.87e-6 |
Dyskeratosis congenita, X-linked (DKCX) [MIM:305000] |
(DKC1, DKC1) |
1.968 |
3.12e-7 |
6.24e-7 |
Dystonia |
All phenotypes |
(SPR, SPR) |
2.273 |
0.0428 |
0.257 |
All phenotypes |
(GCH1, GCH1) |
0.399 |
0.0269 |
0.257 |
Dystonia, dopa-responsive (DRD) [MIM:128230] |
(GCH1, GCH1) |
0.399 |
0.0269 |
0.0539 |
Dystonia, DOPA-responsive, due to sepiapterin reductase deficiency (DRDSPRD) [MIM:612716] |
(SPR, SPR) |
2.273 |
0.0428 |
0.0428 |
Ectodermal dysplasia |
All phenotypes |
(NFKBIA, FBXW11) |
5.931 |
0.0164 |
0.459 |
Ectodermal dysplasia and immunodeficiency 2 (EDAID2) [MIM:612132] |
(NFKBIA, FBXW11) |
5.931 |
0.0164 |
0.0164 |
Ectrodactyly-ectodermal dysplasia |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292] |
(PPP1R13L, TP63) |
3.872 |
6.94e-14 |
2.08e-13 |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292] |
(TP53BP2, TP63) |
3.688 |
3.54e-13 |
5.31e-13 |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) [MIM:604292] |
(PPP1R13B, TP63) |
3.429 |
3.97e-9 |
3.97e-9 |
Ehlers-Danlos syndrome |
All phenotypes |
(COL3A1, COL3A1) |
1.121 |
1.19e-11 |
4.74e-11 |
Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050] |
(COL3A1, COL3A1) |
1.161 |
1.3e-12 |
2.61e-12 |
Elliptocytosis |
All phenotypes |
(SPTA1, SPTB) |
4.680 |
1.32e-19 |
3.97e-19 |
All phenotypes |
(SPTA1, SPTBN1) |
4.242 |
6.22e-15 |
9.33e-15 |
Elliptocytosis 2 (EL2) [MIM:130600] |
(SPTA1, SPTB) |
5.117 |
2.74e-16 |
5.49e-16 |
Elliptocytosis 2 (EL2) [MIM:130600] |
(SPTA1, SPTBN1) |
4.242 |
6.22e-15 |
6.22e-15 |
Elliptocytosis 3 (EL3) [MIM:617948] |
(SPTA1, SPTB) |
4.203 |
2.43e-5 |
4.85e-5 |
Elliptocytosis 3 (EL3) [MIM:617948] |
(SPTB, SPTAN1) |
3.343 |
0.000251 |
0.000251 |
Emery-Dreifuss muscular dystrophy |
All phenotypes |
(LMNA, MAPRE2) |
1.450 |
0.00848 |
0.0594 |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350] |
(LMNA, MAPRE2) |
1.307 |
0.0223 |
0.156 |
Epidermolysis bullosa |
All phenotypes |
(KRT14, KRT76) |
1.508 |
0.000257 |
0.000964 |
All phenotypes |
(KRT14, KRT2) |
1.481 |
0.000304 |
0.000964 |
All phenotypes |
(KRT14, KRT4) |
1.481 |
0.000304 |
0.000964 |
All phenotypes |
(KRT14, KRT6C) |
1.481 |
0.000304 |
0.000964 |
All phenotypes |
(KRT14, KRT84) |
1.481 |
0.000304 |
0.000964 |
All phenotypes |
(KRT86, KRT14) |
1.481 |
0.000304 |
0.000964 |
All phenotypes |
(KRT14, KRT6A) |
1.455 |
0.000359 |
0.000964 |
All phenotypes |
(KRT14, KRT6B) |
1.455 |
0.000359 |
0.000964 |
All phenotypes |
(KRT14, KRT77) |
1.455 |
0.000359 |
0.000964 |
All phenotypes |
(KRT14, KRT80) |
1.455 |
0.000359 |
0.000964 |
All phenotypes |
(KRT14, KRT81) |
1.455 |
0.000359 |
0.000964 |
All phenotypes |
(KRT14, KRT85) |
1.455 |
0.000359 |
0.000964 |
All phenotypes |
(KRT14, PRPH) |
1.455 |
0.000359 |
0.000964 |
All phenotypes |
(KRT75, KRT14) |
1.455 |
0.000359 |
0.000964 |
All phenotypes |
(KRT14, KRT3) |
1.429 |
0.000422 |
0.000964 |
All phenotypes |
(KRT14, KRT7) |
1.429 |
0.000422 |
0.000964 |
All phenotypes |
(KRT14, KRT72) |
1.429 |
0.000422 |
0.000964 |
All phenotypes |
(KRT14, KRT78) |
1.429 |
0.000422 |
0.000964 |
All phenotypes |
(KRT14, KRT79) |
1.429 |
0.000422 |
0.000964 |
All phenotypes |
(KRT14, KRT8) |
1.429 |
0.000422 |
0.000964 |
All phenotypes |
(KRT14, DES) |
1.378 |
0.000577 |
0.00126 |
All phenotypes |
(KRT14, KRT5) |
1.323 |
4.78e-5 |
0.000964 |
All phenotypes |
(KRT5, KRT12) |
1.200 |
0.0137 |
0.0275 |
All phenotypes |
(KRT5, KRT24) |
1.200 |
0.0137 |
0.0275 |
All phenotypes |
(KRT18, KRT5) |
1.105 |
0.0366 |
0.0671 |
All phenotypes |
(KRT5, KRT17) |
1.105 |
0.0366 |
0.0671 |
All phenotypes |
(KRT13, KRT5) |
1.079 |
0.0399 |
0.0671 |
All phenotypes |
(KRT5, KRT20) |
1.079 |
0.0399 |
0.0671 |
All phenotypes |
(KRT16, KRT5) |
1.053 |
0.0434 |
0.0671 |
All phenotypes |
(KRT5, KRT32) |
1.053 |
0.0434 |
0.0671 |
All phenotypes |
(KRT5, KRT35) |
1.053 |
0.0434 |
0.0671 |
All phenotypes |
(KRT5, DES) |
1.027 |
0.047 |
0.0684 |
All phenotypes |
(KRT5, KRT15) |
1.027 |
0.047 |
0.0684 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT76) |
1.624 |
0.00672 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT2) |
1.597 |
0.00734 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT4) |
1.597 |
0.00734 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT5) |
1.597 |
0.00734 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT6C) |
1.597 |
0.00734 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT84) |
1.597 |
0.00734 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT86, KRT14) |
1.597 |
0.00734 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT6A) |
1.570 |
0.008 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT6B) |
1.570 |
0.008 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT77) |
1.570 |
0.008 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT80) |
1.570 |
0.008 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT81) |
1.570 |
0.008 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT85) |
1.570 |
0.008 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, PRPH) |
1.570 |
0.008 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT75, KRT14) |
1.570 |
0.008 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT3) |
1.544 |
0.0087 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT7) |
1.544 |
0.0087 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT72) |
1.544 |
0.0087 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT78) |
1.544 |
0.0087 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT79) |
1.544 |
0.0087 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, KRT8) |
1.544 |
0.0087 |
0.00953 |
Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800] |
(KRT14, DES) |
1.494 |
0.0103 |
0.0107 |
Epidermolytic hyperkeratosis |
All phenotypes |
(KRT1, DES) |
1.909 |
0.00134 |
0.00376 |
All phenotypes |
(KRT1, KRT40) |
1.859 |
0.00159 |
0.00376 |
All phenotypes |
(KRT1, KRT33B) |
1.811 |
0.00188 |
0.00376 |
All phenotypes |
(KRT37, KRT1) |
1.811 |
0.00188 |
0.00376 |
All phenotypes |
(KRT1, KRT10) |
0.766 |
0.0143 |
0.0229 |
Epidermolytic hyperkeratosis 1 (EHK1) [MIM:113800] |
(KRT1, DES) |
1.909 |
0.00134 |
0.00329 |
Epidermolytic hyperkeratosis 1 (EHK1) [MIM:113800] |
(KRT1, KRT40) |
1.859 |
0.00159 |
0.00329 |
Epidermolytic hyperkeratosis 1 (EHK1) [MIM:113800] |
(KRT1, KRT33B) |
1.811 |
0.00188 |
0.00329 |
Epidermolytic hyperkeratosis 1 (EHK1) [MIM:113800] |
(KRT37, KRT1) |
1.811 |
0.00188 |
0.00329 |
Epilepsy |
All phenotypes |
(GRIN2D, GRIN2B) |
5.115 |
0.0285 |
0.16 |
All phenotypes |
(GRIN2B, GRIN2B) |
4.893 |
0.00166 |
0.0263 |
All phenotypes |
(ATP6V0A1, ATP6V0B) |
4.802 |
0.00129 |
0.0238 |
All phenotypes |
(SPTBN1, SPTAN1) |
4.607 |
0.041 |
0.198 |
All phenotypes |
(FBXO5, FZR1) |
4.138 |
0.000183 |
0.0095 |
All phenotypes |
(ATP6V0C, ATP6V0A1) |
3.775 |
0.00533 |
0.0592 |
All phenotypes |
(CYFIP2, WASF2) |
3.596 |
0.000565 |
0.0157 |
All phenotypes |
(SNAP23, STX1B) |
2.859 |
0.019 |
0.141 |
All phenotypes |
(USP8, YWHAG) |
2.790 |
0.0209 |
0.144 |
All phenotypes |
(YWHAG, STK11) |
2.749 |
0.0221 |
0.144 |
All phenotypes |
(MAST3, MELK) |
2.557 |
0.000833 |
0.0185 |
All phenotypes |
(YWHAG, BAIAP2) |
2.459 |
0.0331 |
0.175 |
All phenotypes |
(CLCN2, CLCN2) |
2.353 |
0.0383 |
0.193 |
All phenotypes |
(GABRB1, GABRA2) |
2.013 |
0.00266 |
0.0368 |
All phenotypes |
(GABRA2, GABRB2) |
1.446 |
0.00666 |
0.0672 |
All phenotypes |
(GABRG2, GABRB2) |
1.290 |
0.0127 |
0.101 |
All phenotypes |
(KCNT1, KCNT1) |
1.282 |
0.0113 |
0.0963 |
All phenotypes |
(GABRB3, GABRA2) |
1.214 |
0.000257 |
0.0095 |
All phenotypes |
(GABRG2, GABRA5) |
1.110 |
0.00388 |
0.0478 |
All phenotypes |
(CHRNB2, CHRNA4) |
1.091 |
0.0485 |
0.215 |
All phenotypes |
(GABRG2, GABRB3) |
1.034 |
0.000159 |
0.0095 |
All phenotypes |
(HCN1, HCN1) |
0.989 |
0.00902 |
0.0834 |
All phenotypes |
(GABRD, GABRB3) |
0.954 |
0.0256 |
0.158 |
All phenotypes |
(GABRB3, GABRA4) |
0.925 |
0.0288 |
0.16 |
All phenotypes |
(GABRB3, GABRB3) |
0.791 |
0.0494 |
0.215 |
Developmental and epileptic encephalopathy 104 (DEE104) [MIM:619970] |
(ATP6V0A1, ATP6V0B) |
4.802 |
0.00129 |
0.00257 |
Developmental and epileptic encephalopathy 104 (DEE104) [MIM:619970] |
(ATP6V0C, ATP6V0A1) |
3.775 |
0.00533 |
0.00533 |
Developmental and epileptic encephalopathy 108 (DEE108) [MIM:620115] |
(MAST3, MELK) |
2.557 |
0.000833 |
0.000833 |
Developmental and epileptic encephalopathy 109 (DEE109) [MIM:620145] |
(FBXO5, FZR1) |
4.138 |
0.000183 |
0.000183 |
Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959] |
(KCNT1, KCNT1) |
1.382 |
0.0229 |
0.0229 |
Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871] |
(HCN1, HCN1) |
1.060 |
0.0205 |
0.0616 |
Developmental and epileptic encephalopathy 27 (DEE27) [MIM:616139] |
(GRIN2D, GRIN2B) |
5.115 |
0.0285 |
0.0428 |
Developmental and epileptic encephalopathy 27 (DEE27) [MIM:616139] |
(GRIN2B, GRIN2B) |
4.893 |
0.00166 |
0.00498 |
Developmental and epileptic encephalopathy 43 (DEE43) [MIM:617113] |
(GABRB3, GABRA2) |
0.960 |
0.0415 |
0.088 |
Developmental and epileptic encephalopathy 56 (DEE56) [MIM:617665] |
(USP8, YWHAG) |
2.790 |
0.0209 |
0.198 |
Developmental and epileptic encephalopathy 56 (DEE56) [MIM:617665] |
(YWHAG, STK11) |
2.749 |
0.0221 |
0.198 |
Developmental and epileptic encephalopathy 56 (DEE56) [MIM:617665] |
(YWHAG, BAIAP2) |
2.459 |
0.0331 |
0.198 |
Developmental and epileptic encephalopathy 5 (DEE5) [MIM:613477] |
(SPTBN1, SPTAN1) |
4.607 |
0.041 |
0.0575 |
Developmental and epileptic encephalopathy 65 (DEE65) [MIM:618008] |
(CYFIP2, WASF2) |
3.596 |
0.000565 |
0.000565 |
Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396] |
(GABRG2, GABRB3) |
1.205 |
0.00666 |
0.0333 |
Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396] |
(GABRG2, GABRA5) |
1.037 |
0.0438 |
0.11 |
Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557] |
(GABRB1, GABRA2) |
2.134 |
0.00471 |
0.00666 |
Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557] |
(GABRB3, GABRA2) |
1.495 |
0.00561 |
0.00666 |
Developmental and epileptic encephalopathy 78 (DEE78) [MIM:618557] |
(GABRA2, GABRB2) |
1.446 |
0.00666 |
0.00666 |
Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172] |
(SNAP23, STX1B) |
2.859 |
0.019 |
0.095 |
Erythrocytosis |
All phenotypes |
(EGLN2, EPAS1) |
4.406 |
1.1e-8 |
4.96e-8 |
All phenotypes |
(EPAS1, EGLN3) |
4.406 |
1.1e-8 |
4.96e-8 |
All phenotypes |
(VHL, EPAS1) |
4.236 |
2.22e-5 |
4.99e-5 |
All phenotypes |
(EPAS1, EGLN1) |
3.224 |
4.64e-7 |
1.39e-6 |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(EPAS1, EGLN1) |
4.480 |
8.1e-9 |
1.47e-8 |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(EGLN2, EPAS1) |
4.406 |
1.1e-8 |
1.47e-8 |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(EPAS1, EGLN3) |
4.406 |
1.1e-8 |
1.47e-8 |
Erythrocytosis, familial, 4 (ECYT4) [MIM:611783] |
(VHL, EPAS1) |
4.236 |
2.22e-5 |
2.22e-5 |
Exudative vitreoretinopathy |
All phenotypes |
(NDP, FZD4) |
1.229 |
0.00412 |
0.0165 |
FG syndrome |
FG syndrome 4 (FGS4) [MIM:300422] |
(CASK, CASKIN1) |
5.725 |
0.0189 |
0.0378 |
FG syndrome 4 (FGS4) [MIM:300422] |
(CASK, SRPK2) |
4.515 |
0.0437 |
0.0437 |
Fabry disease |
Fabry disease (FD) [MIM:301500] |
(GLA, GLA) |
0.700 |
0.00953 |
0.0191 |
Faciocutaneoskeletal syndrome |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RASA1) |
1.793 |
0.00012 |
0.000522 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RASGRF1) |
1.755 |
0.000149 |
0.000522 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RIN1) |
1.511 |
0.00448 |
0.00535 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, NF1) |
1.464 |
0.012 |
0.012 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, RASGRP4) |
1.373 |
0.00339 |
0.00535 |
Costello syndrome (CSTLO) [MIM:218040] |
(RGL2, HRAS) |
1.309 |
0.00458 |
0.00535 |
Costello syndrome (CSTLO) [MIM:218040] |
(HRAS, SOS1) |
0.975 |
0.000301 |
0.000702 |
Familial advanced sleep-phase syndrome |
Advanced sleep phase syndrome, familial, 2 (FASPS2) [MIM:615224] |
(GRK2, CSNK1D) |
3.654 |
0.00631 |
0.0379 |
Advanced sleep phase syndrome, familial, 2 (FASPS2) [MIM:615224] |
(CSNK1D, MARK4) |
2.704 |
0.0235 |
0.0559 |
Advanced sleep phase syndrome, familial, 2 (FASPS2) [MIM:615224] |
(CSNK1D, MAPK14) |
2.581 |
0.0279 |
0.0559 |
Fanconi anemia |
All phenotypes |
(BRCA1, ATRIP) |
5.037 |
0.0305 |
0.162 |
All phenotypes |
(BRCA1, BRAT1) |
5.037 |
0.0305 |
0.162 |
All phenotypes |
(BRCA1, RBBP8) |
4.374 |
0.0482 |
0.174 |
All phenotypes |
(BRCA2, SEM1) |
2.784 |
0.0263 |
0.162 |
Fanconi anemia complementation group D1 (FANCD1) [MIM:605724] |
(BRCA2, SEM1) |
2.784 |
0.0263 |
0.0526 |
Fanconi anemia, complementation group S (FANCS) [MIM:617883] |
(BRCA1, ATRIP) |
5.037 |
0.0305 |
0.0761 |
Fanconi anemia, complementation group S (FANCS) [MIM:617883] |
(BRCA1, BRAT1) |
5.037 |
0.0305 |
0.0761 |
Fanconi anemia, complementation group S (FANCS) [MIM:617883] |
(BRCA1, RBBP8) |
4.374 |
0.0482 |
0.0761 |
Fibrodysplasia ossificans progressiva |
Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
(FKBP1B, ACVR1) |
2.935 |
0.00548 |
0.0164 |
Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
(FKBP1A, ACVR1) |
2.350 |
0.0168 |
0.0252 |
Fibrosis of extraocular muscles |
All phenotypes |
(KIF21A, KIF21A) |
3.651 |
2.57e-8 |
7.72e-8 |
All phenotypes |
(MAPT, TUBB3) |
3.550 |
2.11e-5 |
3.17e-5 |
Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700] |
(KIF21A, KIF21A) |
3.651 |
2.57e-8 |
2.57e-8 |
Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638] |
(MAPT, TUBB3) |
3.550 |
2.11e-5 |
4.23e-5 |
Focal segmental glomerulosclerosis |
All phenotypes |
(ACTN4, IQGAP1) |
5.340 |
4.29e-5 |
0.000343 |
All phenotypes |
(LMX1B, HOXA1) |
4.030 |
0.00375 |
0.015 |
Focal segmental glomerulosclerosis 10 (FSGS10) [MIM:256020] |
(LMX1B, HOXA1) |
4.030 |
0.00375 |
0.00375 |
Focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278] |
(ACTN4, IQGAP1) |
5.340 |
4.29e-5 |
0.000258 |
Frontometaphyseal dysplasia |
Frontometaphyseal dysplasia 2 (FMD2) [MIM:617137] |
(MAP3K7, HSP90AA1) |
3.149 |
0.0161 |
0.0644 |
Frontotemporal |
All phenotypes |
(SPTLC1, SPTLC1) |
4.957 |
0.0318 |
0.165 |
All phenotypes |
(SPTLC1, ORMDL3) |
3.083 |
0.00164 |
0.0197 |
Amyotrophic lateral sclerosis 27, juvenile (ALS27) [MIM:620285] |
(SPTLC1, SPTLC1) |
4.957 |
0.0318 |
0.0318 |
Amyotrophic lateral sclerosis 27, juvenile (ALS27) [MIM:620285] |
(SPTLC1, ORMDL3) |
3.083 |
0.00164 |
0.00329 |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 (FTDALS7) [MIM:600795] |
(CHMP4B, CHMP2B) |
1.693 |
0.0412 |
0.165 |
Galactosemia 1 |
All phenotypes |
(GALT, GALT) |
0.330 |
0.0306 |
0.0613 |
Galactosemia 1 (GALAC1) [MIM:230400] |
(GALT, GALT) |
0.330 |
0.0306 |
0.0306 |
Galloway-Mowat syndrome |
All phenotypes |
(TP53RK, OSGEP) |
1.513 |
0.00324 |
0.00972 |
Galloway-Mowat syndrome 3 (GAMOS3) [MIM:617729] |
(TP53RK, OSGEP) |
1.711 |
0.00245 |
0.00245 |
Gastric cancer |
All phenotypes |
(KRAS, TRBC1) |
4.170 |
2.66e-5 |
0.00027 |
All phenotypes |
(HLA-A, KRAS) |
3.977 |
2.38e-6 |
4.99e-5 |
All phenotypes |
(, KRAS) |
3.655 |
0.000108 |
0.00027 |
All phenotypes |
(HLA-A, KRAS) |
3.655 |
0.000108 |
0.00027 |
All phenotypes |
(HLA-Cw, KRAS) |
3.655 |
0.000108 |
0.00027 |
All phenotypes |
(KRAS, HLA-A) |
3.655 |
0.000108 |
0.00027 |
All phenotypes |
(KRAS, HLA-C) |
3.655 |
0.000108 |
0.00027 |
All phenotypes |
(KRAS, PLAAT3) |
2.840 |
0.000116 |
0.00027 |
All phenotypes |
(KRAS, SOS2) |
2.070 |
0.000182 |
0.000383 |
All phenotypes |
(KRAS, NF1) |
1.807 |
0.0142 |
0.0249 |
All phenotypes |
(KRAS, PPIA) |
1.755 |
0.0458 |
0.074 |
All phenotypes |
(KRAS, SOS1) |
1.518 |
0.00181 |
0.00346 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, TRBC1) |
4.170 |
2.66e-5 |
0.000244 |
Gastric cancer (GASC) [MIM:613659] |
(HLA-A, KRAS) |
3.977 |
2.38e-6 |
4.52e-5 |
Gastric cancer (GASC) [MIM:613659] |
(, KRAS) |
3.655 |
0.000108 |
0.000244 |
Gastric cancer (GASC) [MIM:613659] |
(HLA-A, KRAS) |
3.655 |
0.000108 |
0.000244 |
Gastric cancer (GASC) [MIM:613659] |
(HLA-Cw, KRAS) |
3.655 |
0.000108 |
0.000244 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, HLA-A) |
3.655 |
0.000108 |
0.000244 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, HLA-C) |
3.655 |
0.000108 |
0.000244 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, PLAAT3) |
2.840 |
0.000116 |
0.000244 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, SOS2) |
2.070 |
0.000182 |
0.000346 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, NF1) |
1.807 |
0.0142 |
0.0225 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, PPIA) |
1.755 |
0.0458 |
0.067 |
Gastric cancer (GASC) [MIM:613659] |
(KRAS, SOS1) |
1.518 |
0.00181 |
0.00313 |
Gerstmann-Straussler disease |
Gerstmann-Straussler disease (GSD) [MIM:137440] |
(PRNP, PRNP) |
0.652 |
0.0269 |
0.0269 |
Gitelman syndrome |
Gitelman syndrome (GTLMNS) [MIM:263800] |
(SLC12A3, SLC12A3) |
0.512 |
0.0161 |
0.0161 |
Glanzmann thrombasthenia |
All phenotypes |
(FGG, ITGB3) |
3.546 |
0.000365 |
0.00292 |
All phenotypes |
(FN1, ITGB3) |
2.192 |
0.0108 |
0.0431 |
Glanzmann thrombasthenia 2 (GT2) [MIM:619267] |
(FGG, ITGB3) |
3.546 |
0.000365 |
0.00255 |
Glanzmann thrombasthenia 2 (GT2) [MIM:619267] |
(FN1, ITGB3) |
2.192 |
0.0108 |
0.0378 |
Glioma |
Glioma (GLM) [MIM:137800] |
(H3-3B, ZMYND8) |
3.322 |
0.0127 |
0.205 |
Glioma (GLM) [MIM:137800] |
(H3-3B, SETD2) |
2.791 |
0.026 |
0.205 |
Glutaric aciduria |
All phenotypes |
(ETFA, ETFB) |
1.299 |
0.0413 |
0.165 |
Growth hormone insensitivity |
Growth hormone insensitivity syndrome with immune dysregulation 1, autosomal recessive (GHISID1) [MIM:245590] |
(JAK1, STAT5B) |
4.765 |
0.0364 |
0.0729 |
Growth retardation |
All phenotypes |
(BCL11A, BCL11A) |
2.688 |
0.0299 |
0.0661 |
All phenotypes |
(CSNK2B, CSNK2A1) |
2.535 |
0.0397 |
0.0661 |
All phenotypes |
(CSNK2A1, CDK11A) |
2.448 |
0.00932 |
0.0466 |
Intellectual developmental disorder with persistence of fetal hemoglobin (IDPFH) [MIM:617101] |
(BCL11A, BCL11A) |
2.688 |
0.0299 |
0.0299 |
Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062] |
(CSNK2B, CSNK2A1) |
2.535 |
0.0397 |
0.0793 |
Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062] |
(CSNK2A1, CDK11A) |
2.448 |
0.00932 |
0.0373 |
Hartnup disorder |
All phenotypes |
(SETD1A, WDR5) |
4.744 |
0.0373 |
0.221 |
All phenotypes |
(DKC1, SHQ1) |
4.654 |
0.0397 |
0.221 |
All phenotypes |
(CATSPER2, CACNA1I) |
2.534 |
0.0397 |
0.221 |
All phenotypes |
(AFG2B, AIRIM) |
1.975 |
0.0384 |
0.221 |
All phenotypes |
(EIF4A2, PDCD4) |
1.574 |
0.0315 |
0.221 |
All phenotypes |
(GRIA2, GRIA3) |
1.565 |
0.000734 |
0.0286 |
All phenotypes |
(GRIN1, GRIN2A) |
0.542 |
0.024 |
0.221 |
Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570] |
(GRIN1, GRIN2A) |
0.542 |
0.024 |
0.048 |
Neurodevelopmental disorder with dystonia and seizures (NEDDS) [MIM:619922] |
(DKC1, SHQ1) |
4.654 |
0.0397 |
0.0397 |
Neurodevelopmental disorder with hearing loss and spasticity (NEDHLS) [MIM:619616] |
(AFG2B, AIRIM) |
1.975 |
0.0384 |
0.0768 |
Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures (NEDHSS) [MIM:620455] |
(EIF4A2, PDCD4) |
1.574 |
0.0315 |
0.0944 |
Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917] |
(GRIA2, GRIA3) |
1.565 |
0.000734 |
0.00147 |
Neurodevelopmental disorder with speech impairment and dysmorphic facies (NEDSID) [MIM:619056] |
(SETD1A, WDR5) |
4.744 |
0.0373 |
0.0373 |
Neurodevelopmental disorder with speech impairment and with or without seizures (NEDSIS) [MIM:620114] |
(CATSPER2, CACNA1I) |
2.534 |
0.0397 |
0.0795 |
Hematopoiesis |
Cyclic haematopoiesis (CH) [MIM:162800] |
(ELANE, GZMB) |
0.873 |
0.0209 |
0.0627 |
Hemifacial myohyperplasia |
Hemifacial myohyperplasia (HFMH) [MIM:606773] |
(PLCG1, PIK3CA) |
6.668 |
0.000128 |
0.00077 |
Hemifacial myohyperplasia (HFMH) [MIM:606773] |
(PIK3CA, GRB2) |
5.891 |
0.000376 |
0.00113 |
Hemifacial myohyperplasia (HFMH) [MIM:606773] |
(HLA-A, PIK3CA) |
5.306 |
0.0251 |
0.0427 |
Hemifacial myohyperplasia (HFMH) [MIM:606773] |
(PIK3R2, PIK3CA) |
2.581 |
0.0345 |
0.0427 |
Hemifacial myohyperplasia (HFMH) [MIM:606773] |
(PIK3CA, PIK3R3) |
2.557 |
0.0356 |
0.0427 |
Hemochromatosis |
All phenotypes |
(HAMP, SLC40A1) |
1.536 |
0.0113 |
0.0789 |
Hemochromatosis 4 (HFE4) [MIM:606069] |
(HAMP, SLC40A1) |
2.022 |
0.00484 |
0.00484 |
Hemolytic anemia |
All phenotypes |
(ABCB6, ABCB6) |
1.693 |
0.0296 |
0.127 |
All phenotypes |
(PKLR, PKLR) |
0.389 |
0.0422 |
0.127 |
Pseudohyperkalemia, familial, 2, due to red cell leak (PSHK2) [MIM:609153] |
(ABCB6, ABCB6) |
1.693 |
0.0296 |
0.0296 |
Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
(PKLR, PKLR) |
0.389 |
0.0422 |
0.0845 |
Hemophilia |
All phenotypes |
(F9, SERPINC1) |
0.641 |
0.0302 |
0.106 |
All phenotypes |
(F8, F8) |
0.452 |
0.00286 |
0.02 |
Hemophilia A (HEMA) [MIM:306700] |
(F8, F8) |
0.452 |
0.00286 |
0.0143 |
Hemophilia B (HEMB) [MIM:306900] |
(F9, SERPINC1) |
0.641 |
0.0302 |
0.0907 |
Hepatocellular carcinoma |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(PLCG1, PIK3CA) |
7.253 |
0.00655 |
0.0562 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(PIK3CA, GRB2) |
6.476 |
0.0112 |
0.0562 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET, PASK) |
6.429 |
0.0116 |
0.0562 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET, GRB7) |
4.571 |
0.00232 |
0.037 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET, GRB14) |
4.475 |
0.00264 |
0.037 |
Hepatocellular carcinoma (HCC) [MIM:114550] |
(MET, KDR) |
3.363 |
0.0121 |
0.0562 |
Hirschsprung disease |
All phenotypes |
(RET, GRB10) |
1.667 |
0.0113 |
0.111 |
All phenotypes |
(RET, PTK2) |
1.622 |
0.0131 |
0.111 |
Hirschsprung disease 1 (HSCR1) [MIM:142623] |
(RET, GRB10) |
1.667 |
0.0113 |
0.104 |
Hirschsprung disease 1 (HSCR1) [MIM:142623] |
(RET, PTK2) |
1.622 |
0.0131 |
0.104 |
Houge-Janssens syndrome |
All phenotypes |
(PPP2CA, INTS8) |
3.687 |
0.00014 |
0.00186 |
All phenotypes |
(PPP2R1A, PPP2R5C) |
3.587 |
0.000159 |
0.00186 |
All phenotypes |
(PPP2R1A, PPP2R5A) |
3.279 |
0.00263 |
0.00614 |
All phenotypes |
(PPP2R1A, CDC6) |
2.871 |
0.00107 |
0.0046 |
All phenotypes |
(PPP2R1A, PPP2R3B) |
2.871 |
0.00107 |
0.0046 |
All phenotypes |
(PPP2CA, PABIR1) |
2.812 |
0.00142 |
0.0046 |
All phenotypes |
(PPP2R1A, PPP2R2D) |
2.751 |
0.00147 |
0.0046 |
All phenotypes |
(PPP2R1A, PPP2R2B) |
2.722 |
0.00159 |
0.0046 |
All phenotypes |
(PPP2R1A, PPP2R5D) |
2.722 |
0.00159 |
0.0046 |
All phenotypes |
(PPP2R1A, PPP2R2A) |
2.694 |
0.00171 |
0.0046 |
All phenotypes |
(PPP2R1A, PPP2R5B) |
2.694 |
0.00171 |
0.0046 |
All phenotypes |
(PPP2R1A, PPP2R5E) |
2.562 |
0.00241 |
0.00603 |
All phenotypes |
(ARPP19, PPP2CA) |
2.534 |
0.0119 |
0.0231 |
All phenotypes |
(PPP2CA, PPP2R5D) |
2.469 |
7.06e-5 |
0.00186 |
All phenotypes |
(PPP2CA, PPME1) |
2.317 |
0.00508 |
0.0111 |
All phenotypes |
(PPP2CA, PTPA) |
2.271 |
0.00145 |
0.0046 |
All phenotypes |
(PPP2CB, PPP2CA) |
2.271 |
0.0195 |
0.0359 |
All phenotypes |
(PPP2CA, PPP2R5C) |
2.227 |
0.00638 |
0.0131 |
All phenotypes |
(PPP2CA, PPP2R5E) |
2.213 |
0.0217 |
0.0381 |
All phenotypes |
(PPP2CA, INTS6) |
2.049 |
0.000708 |
0.0046 |
Houge-Janssens syndrome 1 (HJS1) [MIM:616355] |
(PPP2CA, PPP2R5D) |
2.439 |
0.045 |
0.045 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R5C) |
3.587 |
0.000159 |
0.00239 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R5A) |
3.279 |
0.00263 |
0.00395 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, CDC6) |
2.871 |
0.00107 |
0.0032 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R3B) |
2.871 |
0.00107 |
0.0032 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R2D) |
2.751 |
0.00147 |
0.0032 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R2B) |
2.722 |
0.00159 |
0.0032 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R5D) |
2.722 |
0.00159 |
0.0032 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R2A) |
2.694 |
0.00171 |
0.0032 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R5B) |
2.694 |
0.00171 |
0.0032 |
Houge-Janssens syndrome 2 (HJS2) [MIM:616362] |
(PPP2R1A, PPP2R5E) |
2.562 |
0.00241 |
0.00395 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA, INTS8) |
3.687 |
0.00014 |
0.00281 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA, PABIR1) |
2.812 |
0.00142 |
0.00579 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(ARPP19, PPP2CA) |
2.534 |
0.0119 |
0.0297 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA, PPME1) |
2.317 |
0.00508 |
0.0169 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA, PPP2R5D) |
2.308 |
0.00129 |
0.00579 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA, PTPA) |
2.271 |
0.00145 |
0.00579 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CB, PPP2CA) |
2.271 |
0.0195 |
0.0433 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA, PPP2R5C) |
2.227 |
0.00638 |
0.0182 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA, PPP2R5E) |
2.213 |
0.0217 |
0.0435 |
Houge-Janssens syndrome 3 (HJS3) [MIM:618354] |
(PPP2CA, INTS6) |
2.049 |
0.000708 |
0.00579 |
Hoyeraal-Hreidarsson syndrome |
Hoyeraal-Hreidarsson syndrome (HHS) [MIM:305000] |
(DKC1, DKC1) |
1.994 |
0.0229 |
0.0229 |
Hutchinson-Gilford progeria syndrome |
Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
(BANF1, LMNA) |
2.641 |
0.0383 |
0.153 |
Hypercholesterolemia |
All phenotypes |
(, PCSK9) |
2.637 |
0.0101 |
0.0607 |
All phenotypes |
(LDLR, APOH) |
1.436 |
0.0246 |
0.0738 |
All phenotypes |
(LDLR, PCSK9) |
1.033 |
0.0435 |
0.087 |
Hypercholesterolemia, familial, 1 (FHCL1) [MIM:143890] |
(LDLR, APOH) |
1.436 |
0.0246 |
0.123 |
Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776] |
(LDLR, PCSK9) |
2.927 |
0.0268 |
0.0268 |
Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776] |
(, PCSK9) |
2.637 |
0.0101 |
0.0202 |
Hyperekplexia |
All phenotypes |
(GLRA1, GLRA1) |
0.896 |
0.000938 |
0.00281 |
All phenotypes |
(GLRA1, GLRB) |
0.842 |
0.0023 |
0.00344 |
Hyperekplexia 1 (HKPX1) [MIM:149400] |
(GLRA1, GLRB) |
1.191 |
6.32e-5 |
0.000126 |
Hyperekplexia 1 (HKPX1) [MIM:149400] |
(GLRA1, GLRA1) |
0.896 |
0.000938 |
0.000938 |
Hyperinsulinemic hypoglycemia |
All phenotypes |
(INSR, GRB7) |
5.369 |
0.0242 |
0.073 |
All phenotypes |
(INSR, IRS1) |
5.279 |
0.0258 |
0.073 |
All phenotypes |
(INSR, GRB10) |
5.236 |
0.0265 |
0.073 |
All phenotypes |
(INSR, GRB14) |
5.236 |
0.0265 |
0.073 |
Hyperinsulinemic hypoglycemia, familial, 5 (HHF5) [MIM:609968] |
(INSR, GRB7) |
5.369 |
0.0242 |
0.0265 |
Hyperinsulinemic hypoglycemia, familial, 5 (HHF5) [MIM:609968] |
(INSR, IRS1) |
5.279 |
0.0258 |
0.0265 |
Hyperinsulinemic hypoglycemia, familial, 5 (HHF5) [MIM:609968] |
(INSR, GRB10) |
5.236 |
0.0265 |
0.0265 |
Hyperinsulinemic hypoglycemia, familial, 5 (HHF5) [MIM:609968] |
(INSR, GRB14) |
5.236 |
0.0265 |
0.0265 |
Leucine-induced hypoglycemia (LIH) [MIM:240800] |
(ABCC8, KCNJ11) |
4.453 |
0.0456 |
0.0456 |
Hyperlipoproteinemia |
All phenotypes |
(APOE, BCL2) |
2.576 |
1.82e-5 |
7.26e-5 |
Hyperlipoproteinemia 3 (HLPP3) [MIM:617347] |
(APOE, BCL2) |
2.576 |
1.82e-5 |
5.45e-5 |
Hypocalcemia |
All phenotypes |
(KCNJ5, KCNJ15) |
1.115 |
0.0209 |
0.0493 |
All phenotypes |
(KCNJ18, KCNJ5) |
1.068 |
0.0247 |
0.0493 |
All phenotypes |
(CASR, CASR) |
0.990 |
0.000377 |
0.00226 |
Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677] |
(KCNJ5, KCNJ15) |
1.115 |
0.0209 |
0.0247 |
Hyperaldosteronism, familial, 3 (HALD3) [MIM:613677] |
(KCNJ18, KCNJ5) |
1.068 |
0.0247 |
0.0247 |
Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198] |
(CASR, CASR) |
0.990 |
0.000377 |
0.000377 |
Hypocalciuric hypercalcemia |
Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980] |
(CASR, CASR) |
0.517 |
0.0252 |
0.151 |
Hypogonadotropic hypogonadism |
All phenotypes |
(FGF19, FGFR1) |
1.217 |
0.0435 |
0.775 |
Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] |
(FGF19, FGFR1) |
1.217 |
0.0435 |
0.626 |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281] |
(DARS1, DARS1) |
1.469 |
0.0148 |
0.0148 |
Hypophosphataemic rickets |
Hypophosphatemic rickets, autosomal dominant (ADHR) [MIM:193100] |
(FGF23, KL) |
1.888 |
0.0197 |
0.0197 |
Hypophosphatemic nephrolithiasis/osteoporosis |
Osteoporosis (OSTEOP) [MIM:166710] |
(WNT1, WLS) |
2.163 |
0.0498 |
0.0498 |
Ichthyosis |
All phenotypes |
(KRT15, KRT2) |
1.665 |
0.000258 |
0.0063 |
All phenotypes |
(KRT19, KRT2) |
1.617 |
0.000332 |
0.0063 |
All phenotypes |
(DES, KRT2) |
1.324 |
0.0139 |
0.0465 |
All phenotypes |
(KRT2, KRT32) |
1.299 |
0.0152 |
0.0465 |
All phenotypes |
(KRT18, KRT2) |
1.274 |
0.0165 |
0.0465 |
All phenotypes |
(KRT2, KRT31) |
1.274 |
0.0165 |
0.0465 |
All phenotypes |
(KRT2, KRT33B) |
1.274 |
0.0165 |
0.0465 |
All phenotypes |
(KRT2, KRT40) |
1.274 |
0.0165 |
0.0465 |
All phenotypes |
(KRT20, KRT2) |
1.274 |
0.0165 |
0.0465 |
All phenotypes |
(KRT2, KRT12) |
1.250 |
0.018 |
0.0465 |
All phenotypes |
(KRT2, KRT35) |
1.250 |
0.018 |
0.0465 |
All phenotypes |
(KRT36, KRT2) |
1.250 |
0.018 |
0.0465 |
All phenotypes |
(KRT13, KRT2) |
1.226 |
0.0196 |
0.0465 |
All phenotypes |
(KRT2, KRT27) |
1.226 |
0.0196 |
0.0465 |
All phenotypes |
(KRT37, KRT2) |
1.226 |
0.0196 |
0.0465 |
All phenotypes |
(KRT38, KRT2) |
1.226 |
0.0196 |
0.0465 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT15, KRT2) |
1.665 |
0.000258 |
0.00398 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT19, KRT2) |
1.617 |
0.000332 |
0.00398 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(DES, KRT2) |
1.324 |
0.0139 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT32) |
1.299 |
0.0152 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT18, KRT2) |
1.274 |
0.0165 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT31) |
1.274 |
0.0165 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT33B) |
1.274 |
0.0165 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT40) |
1.274 |
0.0165 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT20, KRT2) |
1.274 |
0.0165 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT12) |
1.250 |
0.018 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT35) |
1.250 |
0.018 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT36, KRT2) |
1.250 |
0.018 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT13, KRT2) |
1.226 |
0.0196 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT2, KRT27) |
1.226 |
0.0196 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT37, KRT2) |
1.226 |
0.0196 |
0.0294 |
Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
(KRT38, KRT2) |
1.226 |
0.0196 |
0.0294 |
Imagawa-Matsumoto syndrome |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
(SUZ12, EZH2) |
2.468 |
0.0059 |
0.00739 |
Imagawa-Matsumoto syndrome (IMMAS) [MIM:618786] |
(SUZ12, EZH1) |
2.360 |
0.00739 |
0.00739 |
Immunodeficiency |
All phenotypes |
(NFKBIE, IKBKG) |
3.252 |
0.014 |
0.417 |
Immunodeficiency 31A (IMD31A) [MIM:614892] |
(STAT1, STAT1) |
1.702 |
0.0467 |
0.14 |
Immunodeficiency 33 (IMD33) [MIM:300636] |
(NFKBIE, IKBKG) |
3.252 |
0.014 |
0.0701 |
Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome |
Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [MIM:304790] |
(FOXP3, FOXP3) |
0.830 |
0.0423 |
0.0847 |
Incontinentia pigmenti |
Incontinentia pigmenti (IP) [MIM:308300] |
(NFKBIE, IKBKG) |
2.614 |
0.00969 |
0.0678 |
Intellectual developmental disorder |
Intellectual developmental disorder, autosomal dominant 44, with microcephaly (MRD44) [MIM:617061] |
(TRIO, RAC1) |
4.630 |
2.66e-6 |
2.66e-6 |
Intellectual developmental disorder with hypotonia and behavioral abnormalities |
Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748] |
(BUB1, CDK8) |
2.696 |
0.0352 |
0.0704 |
Intellectual developmental disorder with hypotonia and behavioral abnormalities (IDDHBA) [MIM:618748] |
(BMPR1A, CDK8) |
1.790 |
0.0171 |
0.0685 |
Jackson-Weiss syndrome |
Jackson-Weiss syndrome (JWS) [MIM:123150] |
(FGF19, FGFR1) |
4.440 |
0.0461 |
0.175 |
Jervell and Lange-Nielsen syndrome |
All phenotypes |
(KCNE1, KCNQ1) |
2.247 |
0.0221 |
0.0662 |
Juvenile polyposis |
All phenotypes |
(BMPR1A, BMPR1A) |
2.944 |
0.0259 |
0.17 |
Juvenile polyposis syndrome (JPS) [MIM:174900] |
(BMPR1A, BMPR1A) |
2.944 |
0.0259 |
0.096 |
Keratinocytic non-epidermolytic nevus |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
(NRAS, GRB10) |
2.934 |
0.0215 |
0.129 |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
(NRAS, RIN1) |
2.297 |
0.00843 |
0.0971 |
Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
(NRAS, RASA1) |
2.178 |
0.0108 |
0.0971 |
Keratitis-ichthyosis-deafness syndrome |
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD) [MIM:148210] |
(GJB2, GJA8) |
2.007 |
0.00384 |
0.0153 |
Keratosis |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PLCG1, PIK3CA) |
6.838 |
1.12e-6 |
1.46e-5 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3CA, GRB2) |
6.061 |
5.63e-6 |
3.66e-5 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(HLA-A, PIK3CA) |
4.891 |
0.0333 |
0.0618 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3R2, PIK3CA) |
2.751 |
0.00507 |
0.0138 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3CA, PIK3R3) |
2.727 |
0.00532 |
0.0138 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(PIK3R1, PIK3CA) |
2.186 |
0.0157 |
0.034 |
Keratosis, seborrheic (KERSEB) [MIM:182000] |
(FGFR3, FGFR3) |
2.084 |
0.000395 |
0.00171 |
Kniest dysplasia |
All phenotypes |
(PRKACB, PKIA) |
2.679 |
0.00587 |
0.0645 |
All phenotypes |
(PRKAR1A, PRKACB) |
1.886 |
0.0283 |
0.156 |
Cardioacrofacial dysplasia 2 (CAFD2) [MIM:619143] |
(PRKACB, PKIA) |
2.679 |
0.00587 |
0.0117 |
Cardioacrofacial dysplasia 2 (CAFD2) [MIM:619143] |
(PRKAR1A, PRKACB) |
1.886 |
0.0283 |
0.0283 |
Kury-Isidor syndrome |
Kury-Isidor syndrome (KURIS) [MIM:619762] |
(H2AC7, BAP1) |
3.346 |
0.000249 |
0.000249 |
Kury-Isidor syndrome (KURIS) [MIM:619762] |
(UBB, BAP1) |
2.742 |
0.000161 |
0.000249 |
Kury-Isidor syndrome (KURIS) [MIM:619762] |
(UBC, BAP1) |
2.704 |
0.000183 |
0.000249 |
Leber congenital amaurosis |
All phenotypes |
(DAPK1, TUBB4B) |
4.944 |
0.00106 |
0.00739 |
All phenotypes |
(TUBB, TUBB4B) |
2.774 |
0.0214 |
0.0748 |
Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879] |
(DAPK1, TUBB4B) |
4.944 |
0.00106 |
0.00211 |
Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879] |
(TUBB, TUBB4B) |
2.774 |
0.0214 |
0.0214 |
Leber optic neuropathy |
All phenotypes |
(MT-ND1, MT-ND6) |
2.203 |
0.00143 |
0.01 |
Leber hereditary optic neuropathy (LHON) [MIM:535000] |
(MT-ND1, MT-ND6) |
1.951 |
0.0292 |
0.175 |
Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
(MT-ND1, MT-ND6) |
2.688 |
0.0241 |
0.0482 |
Left ventricular non-compaction |
All phenotypes |
(UBE2D2, MIB1) |
4.962 |
0.0321 |
0.289 |
Left ventricular non-compaction 7 (LVNC7) [MIM:615092] |
(UBE2D2, MIB1) |
4.962 |
0.0321 |
0.0641 |
Leopard syndrome |
All phenotypes |
(CD28, PTPN11) |
5.162 |
4.39e-9 |
5.71e-8 |
All phenotypes |
(IRS1, PTPN11) |
4.631 |
3.89e-8 |
2.53e-7 |
All phenotypes |
(ERBB2, PTPN11) |
2.889 |
0.00137 |
0.00595 |
All phenotypes |
(PTPN6, PTPN11) |
1.545 |
0.0174 |
0.0564 |
All phenotypes |
(PTPN11, PTPN11) |
1.314 |
0.0335 |
0.0872 |
LEOPARD syndrome 1 (LPRD1) [MIM:151100] |
(CD28, PTPN11) |
5.162 |
4.39e-9 |
2.2e-8 |
LEOPARD syndrome 1 (LPRD1) [MIM:151100] |
(IRS1, PTPN11) |
4.631 |
3.89e-8 |
9.72e-8 |
LEOPARD syndrome 1 (LPRD1) [MIM:151100] |
(ERBB2, PTPN11) |
2.889 |
0.00137 |
0.00229 |
LEOPARD syndrome 1 (LPRD1) [MIM:151100] |
(PTPN6, PTPN11) |
1.545 |
0.0174 |
0.0217 |
LEOPARD syndrome 1 (LPRD1) [MIM:151100] |
(PTPN11, PTPN11) |
1.314 |
0.0335 |
0.0335 |
Leukemia |
All phenotypes |
(KRAS, TRBC1) |
4.755 |
5.08e-5 |
0.000264 |
All phenotypes |
(MET, PTPN11) |
4.387 |
1.3e-7 |
1.68e-6 |
All phenotypes |
(, KRAS) |
4.240 |
0.000148 |
0.000321 |
All phenotypes |
(HLA-A, KRAS) |
4.240 |
0.000148 |
0.000321 |
All phenotypes |
(HLA-Cw, KRAS) |
4.240 |
0.000148 |
0.000321 |
All phenotypes |
(KRAS, HLA-A) |
4.240 |
0.000148 |
0.000321 |
All phenotypes |
(KRAS, HLA-C) |
4.240 |
0.000148 |
0.000321 |
All phenotypes |
(HLA-Cw, NRAS) |
4.104 |
0.00338 |
0.00628 |
All phenotypes |
(HLA-A, NRAS) |
3.967 |
0.00409 |
0.00709 |
All phenotypes |
(KRAS, PLAAT3) |
3.103 |
0.00158 |
0.00315 |
All phenotypes |
(GRB2, PTPN11) |
3.024 |
4.78e-8 |
1.24e-6 |
All phenotypes |
(DNMT3A, DNMT3A) |
2.812 |
0.0203 |
0.0278 |
All phenotypes |
(KRAS, NF1) |
2.392 |
0.00691 |
0.0112 |
All phenotypes |
(ERBB2, PTPN11) |
2.336 |
0.0187 |
0.0271 |
All phenotypes |
(PTPN6, PTPN11) |
2.256 |
5.0e-6 |
4.34e-5 |
All phenotypes |
(NRAS, RASA1) |
2.178 |
0.0488 |
0.0604 |
All phenotypes |
(KRAS, SOS2) |
2.070 |
0.0135 |
0.0206 |
All phenotypes |
(PTPN11, PTPN11) |
2.024 |
1.99e-5 |
0.000129 |
All phenotypes |
(KRAS, SOS1) |
1.518 |
0.0426 |
0.0554 |
Leukemia, acute myelogenous (AML) [MIM:601626] |
(DNMT3A, DNMT3A) |
2.812 |
0.0203 |
0.0406 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, TRBC1) |
4.755 |
5.08e-5 |
0.000244 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(MET, PTPN11) |
4.387 |
1.3e-7 |
1.56e-6 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(, KRAS) |
4.240 |
0.000148 |
0.000296 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(HLA-A, KRAS) |
4.240 |
0.000148 |
0.000296 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(HLA-Cw, KRAS) |
4.240 |
0.000148 |
0.000296 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, HLA-A) |
4.240 |
0.000148 |
0.000296 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, HLA-C) |
4.240 |
0.000148 |
0.000296 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(HLA-Cw, NRAS) |
4.104 |
0.00338 |
0.00579 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(HLA-A, NRAS) |
3.967 |
0.00409 |
0.00654 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, PLAAT3) |
3.103 |
0.00158 |
0.00291 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(GRB2, PTPN11) |
3.024 |
4.78e-8 |
1.15e-6 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, NF1) |
2.392 |
0.00691 |
0.0104 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(ERBB2, PTPN11) |
2.336 |
0.0187 |
0.025 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(PTPN6, PTPN11) |
2.256 |
5.0e-6 |
4.0e-5 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(NRAS, RASA1) |
2.178 |
0.0488 |
0.0586 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, SOS2) |
2.070 |
0.0135 |
0.0191 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(PTPN11, PTPN11) |
2.024 |
1.99e-5 |
0.000119 |
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785] |
(KRAS, SOS1) |
1.518 |
0.0426 |
0.0538 |
Leukodystrophy hypomyelinating |
All phenotypes |
(POLR3A, POLR1C) |
2.515 |
0.0151 |
0.423 |
Leukodystrophy with vanishing white matter |
All phenotypes |
(EIF2B5, EIF2B4) |
2.456 |
0.000697 |
0.00209 |
All phenotypes |
(EIF2B5, EIF2B1) |
2.144 |
0.0298 |
0.0596 |
All phenotypes |
(EIF2B2, EIF2B5) |
2.071 |
2.4e-5 |
0.000144 |
All phenotypes |
(EIF2B3, EIF2B4) |
1.905 |
0.0415 |
0.0622 |
Leukoencephalopathy with vanishing white matter 3 (VWM3) [MIM:620313] |
(EIF2B3, EIF2B4) |
2.445 |
0.0465 |
0.0465 |
Leukoencephalopathy with vanishing white matter 4 (VWM4) [MIM:620314] |
(EIF2B5, EIF2B4) |
3.257 |
0.00275 |
0.00825 |
Leukoencephalopathy with vanishing white matter 5 (VWM5) [MIM:620315] |
(EIF2B5, EIF2B4) |
2.251 |
0.0246 |
0.0298 |
Leukoencephalopathy with vanishing white matter 5 (VWM5) [MIM:620315] |
(EIF2B5, EIF2B1) |
2.144 |
0.0298 |
0.0298 |
Leukoencephalopathy with vanishing white matter 5 (VWM5) [MIM:620315] |
(EIF2B2, EIF2B5) |
2.071 |
2.4e-5 |
7.2e-5 |
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation |
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
(DARS2, DARS2) |
1.687 |
0.000571 |
0.00114 |
Li-Fraumeni syndrome |
All phenotypes |
(TERT, POT1) |
2.720 |
0.0353 |
0.123 |
All phenotypes |
(HLA-A, TP53) |
1.581 |
0.0154 |
0.108 |
All phenotypes |
(TP53, TP53BP2) |
1.581 |
0.000635 |
0.0133 |
All phenotypes |
(TP53, BCL2L1) |
0.944 |
0.0211 |
0.111 |
All phenotypes |
(TP53, TP53BP1) |
0.803 |
0.0275 |
0.115 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(HLA-A, TP53) |
1.581 |
0.0154 |
0.0875 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53, TP53BP2) |
1.581 |
0.000635 |
0.0108 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53, BCL2L1) |
0.944 |
0.0211 |
0.0898 |
Li-Fraumeni syndrome (LFS) [MIM:151623] |
(TP53, TP53BP1) |
0.803 |
0.0275 |
0.0934 |
Tumor predisposition syndrome 3 (TPDS3) [MIM:615848] |
(TERT, POT1) |
2.720 |
0.0353 |
0.106 |
Limb-girdle muscular dystrophy |
All phenotypes |
(SMCHD1, SMCHD1) |
1.626 |
0.0147 |
0.206 |
Facioscapulohumeral muscular dystrophy 2, digenic (FSHD2) [MIM:158901] |
(SMCHD1, SMCHD1) |
1.626 |
0.0147 |
0.0147 |
Lipodystrophy |
All phenotypes |
(LMNA, MAPRE2) |
2.218 |
0.024 |
0.288 |
Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660] |
(LMNA, MAPRE2) |
2.218 |
0.024 |
0.144 |
Lissencephaly |
All phenotypes |
(MAPT, TUBA1A) |
3.544 |
1.77e-6 |
2.3e-5 |
All phenotypes |
(NFKB2, TUBA1A) |
3.314 |
0.0026 |
0.0169 |
All phenotypes |
(NFKBIA, TUBA1A) |
2.758 |
0.00772 |
0.0335 |
All phenotypes |
(TUBAL3, TUBA1A) |
1.976 |
0.0336 |
0.0929 |
All phenotypes |
(TUBB4B, TUBA1A) |
1.943 |
0.0357 |
0.0929 |
Lissencephaly 3 (LIS3) [MIM:611603] |
(MAPT, TUBA1A) |
3.544 |
1.77e-6 |
1.24e-5 |
Lissencephaly 3 (LIS3) [MIM:611603] |
(NFKB2, TUBA1A) |
3.314 |
0.0026 |
0.0091 |
Lissencephaly 3 (LIS3) [MIM:611603] |
(NFKBIA, TUBA1A) |
2.758 |
0.00772 |
0.018 |
Lissencephaly 3 (LIS3) [MIM:611603] |
(TUBAL3, TUBA1A) |
1.976 |
0.0336 |
0.05 |
Lissencephaly 3 (LIS3) [MIM:611603] |
(TUBB4B, TUBA1A) |
1.943 |
0.0357 |
0.05 |
Lissencephaly with microcephaly |
Lissencephaly 6, with microcephaly (LIS6) [MIM:616212] |
(KATNA1, KATNB1) |
2.436 |
0.0342 |
0.0359 |
Lissencephaly 6, with microcephaly (LIS6) [MIM:616212] |
(KATNB1, KATNAL1) |
2.399 |
0.0359 |
0.0359 |
Loeys-Dietz syndrome |
All phenotypes |
(SMAD3, SMAD4) |
1.961 |
0.0286 |
0.284 |
Loeys-Dietz syndrome 3 (LDS3) [MIM:613795] |
(SMAD3, SMAD4) |
1.961 |
0.0286 |
0.0859 |
Long QT syndrome |
All phenotypes |
(HCN4, KCNE2) |
2.621 |
0.00659 |
0.136 |
All phenotypes |
(KCNJ2, KCNJ15) |
1.102 |
0.000482 |
0.0198 |
All phenotypes |
(KCNJ18, KCNJ2) |
1.075 |
0.000582 |
0.0198 |
All phenotypes |
(KCNJ2, KCNJ2) |
0.696 |
0.00802 |
0.136 |
All phenotypes |
(CALM2, MYO6) |
0.634 |
0.0297 |
0.404 |
All phenotypes |
(KCNQ1, KCNQ1) |
0.208 |
0.048 |
0.544 |
Long QT syndrome 15 (LQT15) [MIM:616249] |
(CALM2, MYO6) |
0.634 |
0.0297 |
0.356 |
Long QT syndrome 1 (LQT1) [MIM:192500] |
(KCNQ1, KCNQ1) |
0.208 |
0.048 |
0.288 |
Long QT syndrome 6 (LQT6) [MIM:613693] |
(HCN4, KCNE2) |
2.621 |
0.00659 |
0.00659 |
Long QT syndrome 7 (LQT7) [MIM:170390] |
(KCNJ2, KCNJ15) |
1.102 |
0.000482 |
0.000873 |
Long QT syndrome 7 (LQT7) [MIM:170390] |
(KCNJ18, KCNJ2) |
1.075 |
0.000582 |
0.000873 |
Long QT syndrome 7 (LQT7) [MIM:170390] |
(KCNJ2, KCNJ2) |
0.696 |
0.00802 |
0.00802 |
Lung cancer |
Lung cancer (LNCR) [MIM:211980] |
(BRAF, MAPKAPK3) |
3.113 |
0.0134 |
0.0541 |
Lung cancer (LNCR) [MIM:211980] |
(BRAF, MAPK3) |
2.768 |
0.0215 |
0.0541 |
Lung cancer (LNCR) [MIM:211980] |
(BRAF, AKT1) |
2.715 |
0.0232 |
0.0541 |
Lymphedema |
Facial palsy, congenital, with ptosis and velopharyngeal dysfunction (FPVEPD) [MIM:617732] |
(NFKB2, TUBB6) |
4.845 |
0.0348 |
0.0348 |
Macrodactyly |
Macrodactyly (MADAC) [MIM:155500] |
(HLA-A, PIK3CA) |
6.306 |
0.000212 |
0.00127 |
Macrodactyly (MADAC) [MIM:155500] |
(PLCG1, PIK3CA) |
5.668 |
0.0195 |
0.0586 |
Macrodactyly (MADAC) [MIM:155500] |
(PIK3CA, GRB2) |
4.891 |
0.0333 |
0.0667 |
Maple syrup urine disease |
All phenotypes |
(BCKDHB, BCKDHB) |
1.861 |
0.0346 |
0.104 |
Maple syrup urine disease 1B (MSUD1B) [MIM:620698] |
(BCKDHB, BCKDHB) |
1.861 |
0.0346 |
0.0693 |
Mastocytosis, cutaneous |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(NCK2, KIT) |
6.598 |
3.33e-8 |
9.98e-8 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(BCAR3, KIT) |
6.376 |
6.15e-8 |
1.11e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(GRAP2, KIT) |
6.376 |
6.15e-8 |
1.11e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, SLA2) |
6.183 |
1.18e-9 |
1.06e-8 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, GRB2) |
6.183 |
1.05e-7 |
1.57e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, RASA1) |
6.013 |
1.67e-7 |
1.88e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, STAP1) |
6.013 |
1.67e-7 |
1.88e-7 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, VAV3) |
5.920 |
2.93e-9 |
1.32e-8 |
Mastocytosis, cutaneous (MASTC) [MIM:154800] |
(KIT, SH2B3) |
5.724 |
3.72e-7 |
3.72e-7 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(NCK2, KIT) |
7.183 |
4.73e-5 |
0.00016 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(BCAR3, KIT) |
6.961 |
6.44e-5 |
0.00016 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(GRAP2, KIT) |
6.961 |
6.44e-5 |
0.00016 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, GRB2) |
6.768 |
8.42e-5 |
0.00016 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, RASA1) |
6.598 |
0.000107 |
0.00016 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, STAP1) |
6.598 |
0.000107 |
0.00016 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, SLA2) |
6.446 |
0.000132 |
0.000169 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, SH2B3) |
6.309 |
0.000159 |
0.000179 |
Mastocytosis, systemic (MASTSYS) [MIM:154800] |
(KIT, VAV3) |
6.183 |
0.000189 |
0.000189 |
Maturity-onset diabetes of the young |
All phenotypes |
(HLA-A, INS) |
2.959 |
0.0208 |
0.478 |
Maturity-onset diabetes of the young 10 (MODY10) [MIM:613370] |
(HLA-A, INS) |
2.959 |
0.0208 |
0.208 |
McCune-Albright syndrome |
McCune-Albright syndrome (MAS) [MIM:174800] |
(AVPR2, GNAS) |
2.978 |
0.00204 |
0.00817 |
McCune-Albright syndrome (MAS) [MIM:174800] |
(GNAS, GNAS) |
1.789 |
0.0242 |
0.0323 |
McCune-Albright syndrome (MAS) [MIM:174800] |
(GNB1, GNAS) |
1.789 |
0.0242 |
0.0323 |
McCune-Albright syndrome (MAS) [MIM:174800] |
(CHRM3, GNAS) |
1.472 |
0.0468 |
0.0468 |
Medullary thyroid carcinoma |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
(RET, GDNF) |
3.384 |
0.000523 |
0.00325 |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
(RET, ARTN) |
3.215 |
0.000812 |
0.00325 |
Medullary thyroid carcinoma (MTC) [MIM:155240] |
(RET, NRTN) |
2.741 |
0.0027 |
0.00721 |
Medulloblastoma |
Medulloblastoma (MDB) [MIM:155255] |
(HLA-A, CTNNB1) |
5.072 |
0.000884 |
0.00354 |
Medulloblastoma (MDB) [MIM:155255] |
(CTNNB1, BTRC) |
4.860 |
0.0341 |
0.0683 |
Meesmann corneal dystrophy |
All phenotypes |
(KRT2, KRT12) |
1.947 |
0.00118 |
0.00429 |
All phenotypes |
(KRT75, KRT12) |
1.895 |
0.00141 |
0.00429 |
All phenotypes |
(KRT76, KRT12) |
1.895 |
0.00141 |
0.00429 |
All phenotypes |
(KRT8, KRT12) |
1.895 |
0.00141 |
0.00429 |
All phenotypes |
(KRT5, KRT12) |
1.870 |
0.00153 |
0.00429 |
All phenotypes |
(DES, KRT12) |
1.845 |
0.00167 |
0.00429 |
All phenotypes |
(KRT7, KRT12) |
1.845 |
0.00167 |
0.00429 |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
(KRT2, KRT12) |
1.947 |
0.00118 |
0.00167 |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
(KRT75, KRT12) |
1.895 |
0.00141 |
0.00167 |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
(KRT76, KRT12) |
1.895 |
0.00141 |
0.00167 |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
(KRT8, KRT12) |
1.895 |
0.00141 |
0.00167 |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
(KRT5, KRT12) |
1.870 |
0.00153 |
0.00167 |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
(DES, KRT12) |
1.845 |
0.00167 |
0.00167 |
Corneal dystrophy, Meesmann 1 (MECD1) [MIM:122100] |
(KRT7, KRT12) |
1.845 |
0.00167 |
0.00167 |
Megacystis-microcolon-intestinal hypoperistalsis syndrome |
Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431] |
(POTEF, ACTG2) |
2.104 |
0.0274 |
0.06 |
Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431] |
(POTEJ, ACTG2) |
2.055 |
0.03 |
0.06 |
Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (MMIHS5) [MIM:619431] |
(ACTG2, ACTG2) |
1.503 |
0.00728 |
0.0437 |
Megalencephalic leukoencephalopathy |
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) [MIM:616779] |
(HTRA4, HTRA1) |
1.896 |
0.0156 |
0.0312 |
Megalencephaly-capillary malformation-polymicrogyria syndrome |
Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) [MIM:602501] |
(HLA-A, PIK3CA) |
3.984 |
0.00693 |
0.0416 |
Meier-Gorlin syndrome |
All phenotypes |
(MCM6, CDT1) |
2.013 |
0.0152 |
0.0912 |
Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804] |
(MCM6, CDT1) |
2.013 |
0.0152 |
0.0152 |
Melanoma |
All phenotypes |
(PSMD10, CDK4) |
4.189 |
0.00391 |
0.0293 |
All phenotypes |
(CDK4, CDKN1A) |
3.189 |
0.0152 |
0.0542 |
All phenotypes |
(CDK4, CDKN1B) |
3.064 |
0.0181 |
0.0542 |
All phenotypes |
(CDK4, CDKN2C) |
3.064 |
0.0181 |
0.0542 |
All phenotypes |
(CDC7, CDK4) |
2.694 |
0.0296 |
0.0664 |
All phenotypes |
(CDK4, CDKN2D) |
2.604 |
0.0334 |
0.0664 |
All phenotypes |
(CDK4, CDKN1C) |
2.561 |
0.0354 |
0.0664 |
All phenotypes |
(CDK4, CDKN2B) |
2.401 |
0.0438 |
0.073 |
All phenotypes |
(CDK4, CDKN2A) |
1.112 |
0.00116 |
0.0174 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(PSMD10, CDK4) |
4.189 |
0.00391 |
0.0508 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN1A) |
3.189 |
0.0152 |
0.0587 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN1B) |
3.064 |
0.0181 |
0.0587 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN2C) |
3.064 |
0.0181 |
0.0587 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDC7, CDK4) |
2.694 |
0.0296 |
0.0657 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN2D) |
2.604 |
0.0334 |
0.0657 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN1C) |
2.561 |
0.0354 |
0.0657 |
Melanoma, cutaneous malignant 3 (CMM3) [MIM:609048] |
(CDK4, CDKN2B) |
2.401 |
0.0438 |
0.0712 |
Melanosis, neurocutaneous |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
(NRAS, HLA-A) |
4.104 |
0.00338 |
0.0135 |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
(NRAS, GRB10) |
3.519 |
0.00761 |
0.0152 |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
(NRAS, RIN1) |
2.297 |
0.0414 |
0.0488 |
Melanosis, neurocutaneous (NCMS) [MIM:249400] |
(NRAS, RASA1) |
2.178 |
0.0488 |
0.0488 |
Mental retardation |
All phenotypes |
(HNRNPH2, TNPO1) |
4.897 |
3.78e-5 |
0.000636 |
All phenotypes |
(CALM2, CAMK2G) |
4.593 |
0.0414 |
0.225 |
All phenotypes |
(CTCF, STAG1) |
4.335 |
0.00409 |
0.0329 |
All phenotypes |
(UBE2A, UBE2A) |
3.663 |
0.00886 |
0.062 |
All phenotypes |
(TRIO, RAC1) |
3.339 |
0.00031 |
0.00338 |
All phenotypes |
(UBE2A, RNF20) |
2.788 |
0.0285 |
0.176 |
All phenotypes |
(CYBB, RAC1) |
2.678 |
0.00796 |
0.0614 |
All phenotypes |
(GNB1, GPR61) |
2.483 |
1.28e-6 |
7.65e-5 |
All phenotypes |
(GNAI1, GNB1) |
2.409 |
2.07e-6 |
7.65e-5 |
All phenotypes |
(GNB1, GNA12) |
2.322 |
6.13e-5 |
0.000873 |
All phenotypes |
(GNAT3, GNB1) |
2.257 |
2.26e-5 |
0.000424 |
All phenotypes |
(GNAZ, GNB1) |
2.257 |
2.26e-5 |
0.000424 |
All phenotypes |
(TRIM27, UBE2A) |
2.248 |
0.0139 |
0.0917 |
All phenotypes |
(GNA11, GNB1) |
2.208 |
7.51e-6 |
0.000198 |
All phenotypes |
(GNAL, GNB1) |
2.196 |
1.81e-6 |
7.65e-5 |
All phenotypes |
(GNAS, GNB1) |
2.172 |
0.00042 |
0.00415 |
All phenotypes |
(GNAI3, GNB1) |
2.136 |
5.58e-7 |
7.65e-5 |
All phenotypes |
(ADCY5, GNB1) |
2.087 |
0.000196 |
0.00227 |
All phenotypes |
(RAC1, NGEF) |
2.061 |
0.026 |
0.166 |
All phenotypes |
(GNAQ, GNB1) |
2.040 |
1.18e-6 |
7.65e-5 |
All phenotypes |
(GNB1, RXFP1) |
2.031 |
2.29e-5 |
0.000424 |
All phenotypes |
(GNB1, PLCB3) |
2.025 |
8.36e-5 |
0.0011 |
All phenotypes |
(GNB1, GNAS) |
2.011 |
6.66e-6 |
0.000198 |
All phenotypes |
(GNB1, GNA13) |
1.994 |
9.89e-5 |
0.00122 |
All phenotypes |
(RAC1, PKN1) |
1.941 |
0.0325 |
0.194 |
All phenotypes |
(GNAS, GNB1) |
1.918 |
0.000448 |
0.00415 |
All phenotypes |
(GRK2, GNB1) |
1.918 |
0.000448 |
0.00415 |
All phenotypes |
(SMS, SMS) |
1.902 |
0.0087 |
0.062 |
All phenotypes |
(KALRN, RAC1) |
1.885 |
0.0361 |
0.209 |
All phenotypes |
(RAC1, MYO5B) |
1.830 |
0.0399 |
0.224 |
All phenotypes |
(GNAO1, GNB1) |
1.740 |
4.34e-5 |
0.000669 |
All phenotypes |
(VAV1, RAC1) |
1.727 |
0.0482 |
0.252 |
All phenotypes |
(GNAI2, GNB1) |
1.064 |
0.00167 |
0.0147 |
All phenotypes |
(GNB1, GNAI1) |
0.834 |
0.00398 |
0.0329 |
All phenotypes |
(GNB1, GNAS) |
0.814 |
0.00905 |
0.062 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GPR61) |
2.483 |
1.28e-6 |
3.72e-5 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAI1, GNB1) |
2.409 |
2.07e-6 |
3.72e-5 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GNA12) |
2.322 |
6.13e-5 |
0.00046 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAT3, GNB1) |
2.257 |
2.26e-5 |
0.000206 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAZ, GNB1) |
2.257 |
2.26e-5 |
0.000206 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNA11, GNB1) |
2.208 |
7.51e-6 |
9.65e-5 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAL, GNB1) |
2.196 |
1.81e-6 |
3.72e-5 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAS, GNB1) |
2.172 |
0.00042 |
0.00224 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAI3, GNB1) |
2.136 |
5.58e-7 |
3.72e-5 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(ADCY5, GNB1) |
2.087 |
0.000196 |
0.00118 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAQ, GNB1) |
2.040 |
1.18e-6 |
3.72e-5 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, RXFP1) |
2.031 |
2.29e-5 |
0.000206 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, PLCB3) |
2.025 |
8.36e-5 |
0.000579 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GNAS) |
2.011 |
6.66e-6 |
9.65e-5 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GNA13) |
1.994 |
9.89e-5 |
0.000636 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAS, GNB1) |
1.918 |
0.000448 |
0.00224 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GRK2, GNB1) |
1.918 |
0.000448 |
0.00224 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAO1, GNB1) |
1.740 |
4.34e-5 |
0.000355 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNAI2, GNB1) |
1.064 |
0.00167 |
0.00793 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GNAI1) |
0.834 |
0.00398 |
0.0179 |
Intellectual developmental disorder, autosomal dominant 42 (MRD42) [MIM:616973] |
(GNB1, GNAS) |
0.814 |
0.00905 |
0.0388 |
Intellectual developmental disorder, autosomal dominant 47 (MRD47) [MIM:617635] |
(CTCF, STAG1) |
4.335 |
0.00409 |
0.00817 |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
(CYBB, RAC1) |
2.678 |
0.00796 |
0.188 |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
(RAC1, NGEF) |
2.061 |
0.026 |
0.188 |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
(RAC1, PKN1) |
1.941 |
0.0325 |
0.188 |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
(KALRN, RAC1) |
1.885 |
0.0361 |
0.188 |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
(RAC1, MYO5B) |
1.830 |
0.0399 |
0.188 |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
(TRIO, RAC1) |
1.778 |
0.044 |
0.188 |
Intellectual developmental disorder, autosomal dominant 48 (MRD48) [MIM:617751] |
(VAV1, RAC1) |
1.727 |
0.0482 |
0.188 |
Intellectual developmental disorder, autosomal dominant 59 (MRD59) [MIM:618522] |
(CALM2, CAMK2G) |
4.593 |
0.0414 |
0.0414 |
Intellectual developmental disorder, autosomal dominant 63, with macrocephaly (MRD63) [MIM:618825] |
(TRIO, RAC1) |
4.630 |
0.0404 |
0.0404 |
Intellectual developmental disorder, X-linked, syndromic, Bain type (MRXSB) [MIM:300986] |
(HNRNPH2, TNPO1) |
4.897 |
3.78e-5 |
3.78e-5 |
Intellectual developmental disorder, X-linked, syndromic, Nascimento-type (MRXSN) [MIM:300860] |
(UBE2A, UBE2A) |
3.663 |
0.00886 |
0.0416 |
Intellectual developmental disorder, X-linked, syndromic, Nascimento-type (MRXSN) [MIM:300860] |
(UBE2A, RNF20) |
2.788 |
0.0285 |
0.0569 |
Intellectual developmental disorder, X-linked, syndromic, Nascimento-type (MRXSN) [MIM:300860] |
(TRIM27, UBE2A) |
2.248 |
0.0139 |
0.0416 |
Intellectual developmental disorder, X-linked, syndromic, Snyder-Robinson type (MRXSSR) [MIM:309583] |
(SMS, SMS) |
1.902 |
0.0087 |
0.0087 |
Metatropic dysplasia |
Metatropic dysplasia (MTD) [MIM:156530] |
(TRPV4, TRPV4) |
1.290 |
0.000335 |
0.000335 |
Methylmalonic aciduria |
Methylmalonic aciduria type cblA (MMAA) [MIM:251100] |
(MMUT, MMAA) |
0.927 |
0.0315 |
0.063 |
Microphthalmia |
All phenotypes |
(RARB, RXRG) |
2.213 |
0.0149 |
0.0744 |
Microphthalmia, syndromic, 12 (MCOPS12) [MIM:615524] |
(RARB, RXRG) |
2.213 |
0.0149 |
0.0446 |
Mirror movements |
Mirror movements 1 (MRMV1) [MIM:157600] |
(DCC, NTN4) |
5.174 |
0.000767 |
0.00153 |
Mitochondrial DNA depletion syndrome |
All phenotypes |
(SUCLG1, SUCLA2) |
2.510 |
0.0379 |
0.114 |
All phenotypes |
(TWNK, TWNK) |
2.073 |
0.0231 |
0.114 |
Mitochondrial DNA depletion syndrome 5 (MTDPS5) [MIM:612073] |
(SUCLG1, SUCLA2) |
2.510 |
0.0379 |
0.0379 |
Mitochondrial DNA depletion syndrome 7 (MTDPS7) [MIM:271245] |
(TWNK, TWNK) |
2.073 |
0.0231 |
0.0231 |
Mitochondrial complex |
All phenotypes |
(UQCRC2, UQCRC2) |
4.463 |
0.0453 |
0.168 |
All phenotypes |
(NDUFA4, COX6B1) |
2.550 |
0.0291 |
0.168 |
Mitochondrial complex III deficiency, nuclear type 5 (MC3DN5) [MIM:615160] |
(UQCRC2, UQCRC2) |
4.463 |
0.0453 |
0.0453 |
Mitochondrial complex IV deficiency, nuclear type 7 (MC4DN7) [MIM:619051] |
(NDUFA4, COX6B1) |
2.550 |
0.0291 |
0.0291 |
Mitochondrial complex V deficiency, nuclear type 4B (MC5DN4B) [MIM:615228] |
(ATP5F1A, ATP5F1C) |
4.816 |
0.0355 |
0.071 |
Mitochondrial complex deficiency |
All phenotypes |
(MT-ND6, NDUFA9) |
5.812 |
0.0177 |
0.436 |
All phenotypes |
(MT-ND3, NDUFA9) |
2.676 |
0.0304 |
0.436 |
Mitochondrial complex I deficiency, mitochondrial type 1 (MC1DM1) [MIM:500014] |
(MT-ND3, NDUFA9) |
2.676 |
0.0304 |
0.152 |
Mitochondrial complex I deficiency, nuclear type 26 (MC1DN26) [MIM:618247] |
(MT-ND6, NDUFA9) |
5.812 |
0.0177 |
0.0177 |
Monilethrix |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT33B) |
1.902 |
0.000367 |
0.00377 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT31) |
1.877 |
0.000408 |
0.00377 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT32) |
1.877 |
0.000408 |
0.00377 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT34) |
1.877 |
0.000408 |
0.00377 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT35) |
1.804 |
0.000552 |
0.00408 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT14) |
1.368 |
0.0421 |
0.153 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT15) |
1.368 |
0.0421 |
0.153 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT16) |
1.368 |
0.0421 |
0.153 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT36) |
1.342 |
0.0448 |
0.153 |
Monilethrix (MNLIX) [MIM:158000] |
(KRT86, KRT39) |
1.342 |
0.0448 |
0.153 |
Mullegama-Klein-Martinez syndrome |
Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022] |
(CENPU, STAG2) |
4.826 |
0.0348 |
0.0672 |
Mullegama-Klein-Martinez syndrome (MKMS) [MIM:301022] |
(CTCF, STAG2) |
4.585 |
0.0411 |
0.0672 |
Multiple neoplasia |
All phenotypes |
(RET, GDNF) |
3.905 |
2.18e-6 |
2.78e-5 |
All phenotypes |
(RET, ARTN) |
3.735 |
4.28e-6 |
2.78e-5 |
All phenotypes |
(RET, NRTN) |
3.261 |
2.74e-5 |
0.000119 |
All phenotypes |
(MEN1, JUND) |
1.282 |
0.00253 |
0.00821 |
All phenotypes |
(MEN1, KMT2A) |
0.621 |
0.0233 |
0.0607 |
Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
(MEN1, JUND) |
1.282 |
0.00253 |
0.0126 |
Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
(MEN1, KMT2A) |
0.621 |
0.0233 |
0.0583 |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
(RET, GDNF) |
4.107 |
8.75e-7 |
5.18e-6 |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
(RET, ARTN) |
3.937 |
1.73e-6 |
5.18e-6 |
Multiple neoplasia 2A (MEN2A) [MIM:171400] |
(RET, NRTN) |
3.463 |
1.13e-5 |
2.26e-5 |
Multiple self-healing squamous epithelioma |
Multiple self-healing squamous epithelioma (MSSE) [MIM:132800] |
(TGFBR1, TGFBR2) |
3.184 |
0.0169 |
0.0337 |
Multiple sulfatase deficiency |
Multiple sulfatase deficiency (MSD) [MIM:272200] |
(SUMF2, SUMF1) |
1.300 |
0.0422 |
0.127 |
Multiple synostoses syndrome |
All phenotypes |
(GDF5, TWSG1) |
1.590 |
0.0075 |
0.105 |
All phenotypes |
(GDF5, HJV) |
1.364 |
0.0425 |
0.155 |
All phenotypes |
(GDF5, RGMA) |
1.316 |
0.0478 |
0.155 |
All phenotypes |
(GDF5, NOG) |
1.296 |
0.0193 |
0.135 |
Multiple synostoses syndrome 2 (SYNS2) [MIM:610017] |
(GDF5, TWSG1) |
1.590 |
0.0075 |
0.075 |
Multiple synostoses syndrome 2 (SYNS2) [MIM:610017] |
(GDF5, HJV) |
1.364 |
0.0425 |
0.11 |
Multiple synostoses syndrome 2 (SYNS2) [MIM:610017] |
(GDF5, RGMA) |
1.316 |
0.0478 |
0.11 |
Multiple synostoses syndrome 2 (SYNS2) [MIM:610017] |
(GDF5, NOG) |
1.296 |
0.0193 |
0.0967 |
Myasthenic syndrome |
All phenotypes |
(MUSK, LRP4) |
3.471 |
0.013 |
0.104 |
Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304] |
(MUSK, LRP4) |
5.097 |
0.029 |
0.029 |
Myopathy |
All phenotypes |
(HRAS, NF1) |
2.049 |
0.0206 |
0.0812 |
All phenotypes |
(CFL1, ACTA1) |
1.956 |
0.0289 |
0.103 |
All phenotypes |
(MYH7, XRCC4) |
1.955 |
0.0317 |
0.107 |
All phenotypes |
(HRAS, RIN1) |
1.874 |
0.029 |
0.103 |
All phenotypes |
(HRAS, RASA1) |
1.793 |
0.0339 |
0.11 |
All phenotypes |
(HRAS, RASGRF1) |
1.755 |
0.0366 |
0.113 |
All phenotypes |
(DES, KRT20) |
1.606 |
0.000136 |
0.00539 |
All phenotypes |
(KRT14, DES) |
1.553 |
0.000192 |
0.00539 |
All phenotypes |
(KRT16, DES) |
1.528 |
0.000228 |
0.00539 |
All phenotypes |
(KRT5, DES) |
1.523 |
0.000601 |
0.0076 |
All phenotypes |
(DES, KRT17) |
1.468 |
0.000824 |
0.0076 |
All phenotypes |
(DES, KRT33B) |
1.442 |
0.000961 |
0.0076 |
All phenotypes |
(DES, KRT12) |
1.416 |
0.00112 |
0.0076 |
All phenotypes |
(DES, KRT6C) |
1.365 |
0.00149 |
0.0076 |
All phenotypes |
(DES, KRT77) |
1.365 |
0.00149 |
0.0076 |
All phenotypes |
(KRT75, DES) |
1.365 |
0.00149 |
0.0076 |
All phenotypes |
(DES, KRT2) |
1.341 |
0.00171 |
0.0076 |
All phenotypes |
(DES, KRT76) |
1.341 |
0.00171 |
0.0076 |
All phenotypes |
(KRT3, DES) |
1.341 |
0.00171 |
0.0076 |
All phenotypes |
(KRT37, DES) |
1.341 |
0.00171 |
0.0076 |
All phenotypes |
(KRT6A, DES) |
1.341 |
0.00171 |
0.0076 |
All phenotypes |
(KRT6B, DES) |
1.341 |
0.00171 |
0.0076 |
All phenotypes |
(KRT1, DES) |
1.238 |
0.00589 |
0.0246 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS, NF1) |
2.049 |
0.0206 |
0.183 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS, RIN1) |
1.874 |
0.029 |
0.183 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS, RASA1) |
1.793 |
0.0339 |
0.183 |
Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
(HRAS, RASGRF1) |
1.755 |
0.0366 |
0.183 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT20) |
1.606 |
0.000136 |
0.00159 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT14, DES) |
1.553 |
0.000192 |
0.00159 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT16, DES) |
1.528 |
0.000228 |
0.00159 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT5, DES) |
1.523 |
0.000601 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT17) |
1.468 |
0.000824 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT33B) |
1.442 |
0.000961 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT12) |
1.416 |
0.00112 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT6C) |
1.365 |
0.00149 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT77) |
1.365 |
0.00149 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT75, DES) |
1.365 |
0.00149 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT2) |
1.341 |
0.00171 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(DES, KRT76) |
1.341 |
0.00171 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT3, DES) |
1.341 |
0.00171 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT37, DES) |
1.341 |
0.00171 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT6A, DES) |
1.341 |
0.00171 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT6B, DES) |
1.341 |
0.00171 |
0.00225 |
Myopathy, myofibrillar, 1 (MFM1) [MIM:601419] |
(KRT1, DES) |
1.238 |
0.00589 |
0.00727 |
Myotonia congenita |
Myotonia congenita, autosomal dominant (MCAD) [MIM:160800] |
(CLCN1, CLCN1) |
1.434 |
0.00903 |
0.00903 |
N-terminal acetyltransferase deficiency |
N-terminal acetyltransferase deficiency (NATD) [MIM:300855] |
(NAA10, NAA15) |
1.515 |
0.0429 |
0.0858 |
Nabais Sa-de Vries syndrome |
All phenotypes |
(SPOP, PDX1) |
3.008 |
0.00416 |
0.0291 |
All phenotypes |
(SPOP, TP53BP1) |
2.795 |
0.0304 |
0.0719 |
All phenotypes |
(SPOP, BRD3) |
2.713 |
0.0338 |
0.0719 |
All phenotypes |
(SPOP, MACROH2A1) |
2.561 |
0.0411 |
0.0719 |
Nabais Sa-de Vries syndrome 2 (NSDVS2) [MIM:618829] |
(SPOP, PDX1) |
3.593 |
0.000915 |
0.00641 |
Nemaline myopathy |
All phenotypes |
(ACTB, ACTA1) |
0.992 |
7.17e-6 |
0.000129 |
All phenotypes |
(ACTA1, ACTA1) |
0.516 |
4.37e-5 |
0.000393 |
Congenital myopathy 2A, typical, autosomal dominant (CMYP2A) [MIM:161800] |
(ACTB, ACTA1) |
0.992 |
7.17e-6 |
0.0001 |
Congenital myopathy 2A, typical, autosomal dominant (CMYP2A) [MIM:161800] |
(ACTA1, ACTA1) |
0.516 |
4.37e-5 |
0.000306 |
Nephrogenic syndrome |
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539] |
(GNAI3, AVPR2) |
3.392 |
0.00907 |
0.0194 |
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539] |
(AVPR2, GNAI1) |
3.345 |
0.00969 |
0.0194 |
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539] |
(AVPR2, ARRB1) |
2.907 |
0.0178 |
0.0237 |
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539] |
(AVPR2, GNAS) |
2.417 |
0.0351 |
0.0351 |
Nephrotic syndrome |
All phenotypes |
(NUP155, NUP93) |
2.758 |
0.0272 |
0.0901 |
All phenotypes |
(DKC1, NOP10) |
2.236 |
0.0451 |
0.0901 |
Nephrotic syndrome 12 (NPHS12) [MIM:616892] |
(NUP155, NUP93) |
2.758 |
0.0272 |
0.0272 |
Neu-Laxova syndrome |
All phenotypes |
(PHGDH, PHGDH) |
2.677 |
0.0244 |
0.0489 |
Neu-Laxova syndrome 1 (NLS1) [MIM:256520] |
(PHGDH, PHGDH) |
2.677 |
0.0244 |
0.0244 |
Neuroblastoma |
Neuroblastoma 3 (NBLST3) [MIM:613014] |
(HLA-A, ALK) |
3.209 |
0.0193 |
0.029 |
Neuroblastoma 3 (NBLST3) [MIM:613014] |
(HLA-B, ALK) |
3.209 |
0.0193 |
0.029 |
Neurodevelopmental, jaw, eye, and digital syndrome |
Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914] |
(CTNNB1, FBXW11) |
3.891 |
5.0e-6 |
1.0e-5 |
Neurodevelopmental, jaw, eye, and digital syndrome (NEDJED) [MIM:618914] |
(NFKBIA, FBXW11) |
3.614 |
0.00135 |
0.00135 |
Neurodevelopmental disorder with brain, liver, and lung abnormalities |
All phenotypes |
(ARHGDIB, RAC3) |
1.914 |
0.0268 |
0.153 |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF) [MIM:618577] |
(ARHGDIB, RAC3) |
1.914 |
0.0268 |
0.159 |
Neurodevelopmental disorder with hypotonia, seizures, and absent language |
All phenotypes |
(GRIN1, GRIN2C) |
1.790 |
1.06e-7 |
3.19e-7 |
All phenotypes |
(GRIN1, GRIN2A) |
1.591 |
1.09e-8 |
6.54e-8 |
All phenotypes |
(GRIN2D, GRIN1) |
1.532 |
4.63e-7 |
9.26e-7 |
All phenotypes |
(GRIN1, GRIN2B) |
1.483 |
2.74e-6 |
4.12e-6 |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
(GRIN1, GRIN2C) |
1.790 |
1.06e-7 |
2.66e-7 |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
(GRIN1, GRIN2A) |
1.591 |
1.09e-8 |
5.45e-8 |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
(GRIN2D, GRIN1) |
1.532 |
4.63e-7 |
7.71e-7 |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (NDHMSD) [MIM:614254] |
(GRIN1, GRIN2B) |
1.483 |
2.74e-6 |
3.43e-6 |
Neurofibromatosis |
All phenotypes |
(HRAS, NF1) |
2.961 |
2.51e-6 |
5.01e-6 |
All phenotypes |
(KRAS, NF1) |
2.891 |
1.03e-6 |
4.13e-6 |
Neurofibromatosis 1 (NF1) [MIM:162200] |
(HRAS, NF1) |
2.980 |
2.25e-6 |
3.38e-6 |
Neurofibromatosis 1 (NF1) [MIM:162200] |
(KRAS, NF1) |
2.909 |
9.15e-7 |
2.75e-6 |
Neurofibromatosis-Noonan syndrome |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
(NF1, SPRED1) |
6.484 |
0.000198 |
0.000198 |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
(HRAS, NF1) |
5.773 |
2.26e-7 |
6.28e-7 |
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
(KRAS, NF1) |
5.551 |
4.18e-7 |
6.28e-7 |
Neuropathy |
All phenotypes |
(ELP1, ELP2) |
5.349 |
0.0244 |
0.111 |
All phenotypes |
(H2AC17, VRK1) |
4.722 |
0.0373 |
0.133 |
All phenotypes |
(H2AX, VRK1) |
4.722 |
0.0373 |
0.133 |
All phenotypes |
(RHOA, TRPV4) |
4.491 |
0.00198 |
0.0211 |
All phenotypes |
(H2BC10, VRK1) |
4.307 |
0.0495 |
0.158 |
All phenotypes |
(HSPB6, HSPB8) |
2.523 |
0.00167 |
0.0211 |
All phenotypes |
(HSPB7, HSPB8) |
2.471 |
0.000191 |
0.00612 |
All phenotypes |
(CRYAB, HSPB8) |
2.069 |
0.00561 |
0.0428 |
All phenotypes |
(HSPB2, HSPB8) |
1.550 |
0.0218 |
0.111 |
All phenotypes |
(CRYAB, HSPB1) |
1.313 |
0.00669 |
0.0428 |
Neuronopathy, distal hereditary motor, autosomal dominant 2 (HMND2) [MIM:158590] |
(HSPB6, HSPB8) |
2.523 |
0.00167 |
0.00417 |
Neuronopathy, distal hereditary motor, autosomal dominant 2 (HMND2) [MIM:158590] |
(HSPB7, HSPB8) |
2.471 |
0.000191 |
0.000956 |
Neuronopathy, distal hereditary motor, autosomal dominant 2 (HMND2) [MIM:158590] |
(CRYAB, HSPB8) |
2.069 |
0.00561 |
0.00934 |
Neuronopathy, distal hereditary motor, autosomal dominant 2 (HMND2) [MIM:158590] |
(HSPB2, HSPB8) |
1.550 |
0.0218 |
0.0272 |
Neuronopathy, distal hereditary motor, autosomal dominant 3 (HMND3) [MIM:608634] |
(CRYAB, HSPB1) |
1.313 |
0.00669 |
0.0602 |
Neuronopathy, distal hereditary motor, autosomal dominant 8 (HMND8) [MIM:600175] |
(RHOA, TRPV4) |
4.491 |
0.00198 |
0.00198 |
Neuronopathy, distal hereditary motor, autosomal recessive 10 (HMNR10) [MIM:620542] |
(H2AC17, VRK1) |
4.722 |
0.0373 |
0.0825 |
Neuronopathy, distal hereditary motor, autosomal recessive 10 (HMNR10) [MIM:620542] |
(H2AX, VRK1) |
4.722 |
0.0373 |
0.0825 |
Neuronopathy, distal hereditary motor, autosomal recessive 10 (HMNR10) [MIM:620542] |
(H2BC10, VRK1) |
4.307 |
0.0495 |
0.0825 |
Neuropathy, hereditary sensory and autonomic, 3 (HSAN3) [MIM:223900] |
(ELP1, ELP2) |
5.349 |
0.0244 |
0.0244 |
Neutropenia |
All phenotypes |
(CLPB, CLPB) |
1.318 |
0.00417 |
0.0458 |
All phenotypes |
(ELANE, GZMB) |
0.443 |
0.0272 |
0.15 |
Neutropenia, severe congenital 1, autosomal dominant (SCN1) [MIM:202700] |
(ELANE, GZMB) |
0.443 |
0.0272 |
0.0816 |
Neutropenia, severe congenital 9, autosomal dominant (SCN9) [MIM:619813] |
(CLPB, CLPB) |
1.318 |
0.00417 |
0.00417 |
Neutrophil immunodeficiency syndrome |
All phenotypes |
(IKZF1, ZNF580) |
2.536 |
0.0413 |
0.165 |
Immunodeficiency, common variable, 13 (CVID13) [MIM:616873] |
(IKZF1, ZNF580) |
2.536 |
0.0413 |
0.0827 |
Noonan-like syndrome |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(CBL, UBE2E2) |
3.710 |
0.00832 |
0.0129 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(CBL, UBE2E3) |
3.710 |
0.00832 |
0.0129 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(CBL, UBE2D2) |
3.550 |
0.0103 |
0.0129 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(UBC, CBL) |
3.550 |
0.0103 |
0.0129 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
(CBL, UBE2L3) |
3.274 |
0.0149 |
0.0149 |
Noonan syndrome |
All phenotypes |
(RAF1, SFN) |
3.898 |
1.13e-7 |
1.06e-5 |
All phenotypes |
(RAF1, YWHAZ) |
3.506 |
7.16e-7 |
3.33e-5 |
All phenotypes |
(KRAS, TRB) |
3.240 |
0.0176 |
0.132 |
All phenotypes |
(AFDN, RIT1) |
2.608 |
0.00819 |
0.109 |
All phenotypes |
(KRAS, PLAAT3) |
2.425 |
0.000882 |
0.0205 |
All phenotypes |
(BRAF, YWHAZ) |
2.216 |
0.0148 |
0.132 |
All phenotypes |
(CD28, PTPN11) |
2.198 |
0.0275 |
0.149 |
All phenotypes |
(KRAS, GRB7) |
2.147 |
0.0246 |
0.143 |
All phenotypes |
(PAK1, RIT1) |
2.101 |
0.022 |
0.138 |
All phenotypes |
(KRAS, ARAF) |
2.060 |
0.0288 |
0.149 |
All phenotypes |
(MET, PTPN11) |
1.976 |
0.0184 |
0.132 |
All phenotypes |
(KRAS, RALGDS) |
1.918 |
0.0137 |
0.132 |
All phenotypes |
(KRAS, RGL1) |
1.862 |
0.0158 |
0.132 |
All phenotypes |
(KRAS, BRAF) |
1.755 |
0.05 |
0.211 |
All phenotypes |
(PPP1R11, PPP1CB) |
1.683 |
0.0484 |
0.211 |
All phenotypes |
(GRB2, PTPN11) |
1.613 |
0.000309 |
0.00957 |
All phenotypes |
(ERBB2, PTPN11) |
1.510 |
0.0174 |
0.132 |
All phenotypes |
(KRAS, NF1) |
1.392 |
0.048 |
0.211 |
All phenotypes |
(KRAS, SOS2) |
1.392 |
0.0222 |
0.138 |
All phenotypes |
(PTPN6, PTPN11) |
1.167 |
0.00127 |
0.0236 |
All phenotypes |
(RRAS2, RGL3) |
1.159 |
0.0402 |
0.197 |
All phenotypes |
(PTPN11, PTPN11) |
0.935 |
0.00638 |
0.0989 |
Noonan syndrome 12 (NS12) [MIM:618624] |
(RRAS2, RGL3) |
1.159 |
0.0402 |
0.0402 |
Noonan syndrome 1 (NS1) [MIM:163950] |
(CD28, PTPN11) |
2.198 |
0.0275 |
0.0504 |
Noonan syndrome 1 (NS1) [MIM:163950] |
(MET, PTPN11) |
1.976 |
0.0184 |
0.0405 |
Noonan syndrome 1 (NS1) [MIM:163950] |
(GRB2, PTPN11) |
1.613 |
0.000309 |
0.0034 |
Noonan syndrome 1 (NS1) [MIM:163950] |
(ERBB2, PTPN11) |
1.510 |
0.0174 |
0.0405 |
Noonan syndrome 1 (NS1) [MIM:163950] |
(PTPN6, PTPN11) |
1.167 |
0.00127 |
0.00697 |
Noonan syndrome 1 (NS1) [MIM:163950] |
(PTPN11, PTPN11) |
0.935 |
0.00638 |
0.0234 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, TRB) |
3.240 |
0.0176 |
0.0912 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, PLAAT3) |
2.425 |
0.000882 |
0.0229 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, GRB7) |
2.147 |
0.0246 |
0.0912 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, ARAF) |
2.060 |
0.0288 |
0.0937 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, RALGDS) |
1.918 |
0.0137 |
0.0912 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, RGL1) |
1.862 |
0.0158 |
0.0912 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, BRAF) |
1.755 |
0.05 |
0.13 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, NF1) |
1.392 |
0.048 |
0.13 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, SOS2) |
1.392 |
0.0222 |
0.0912 |
Noonan syndrome 3 (NS3) [MIM:609942] |
(KRAS, SOS1) |
1.325 |
0.00352 |
0.0457 |
Noonan syndrome 5 (NS5) [MIM:611553] |
(RAF1, SFN) |
3.898 |
1.13e-7 |
1.13e-6 |
Noonan syndrome 5 (NS5) [MIM:611553] |
(RAF1, YWHAZ) |
3.506 |
7.16e-7 |
3.58e-6 |
Noonan syndrome 7 (NS7) [MIM:613706] |
(BRAF, YWHAZ) |
2.216 |
0.0148 |
0.207 |
Noonan syndrome 8 (NS8) [MIM:615355] |
(AFDN, RIT1) |
2.608 |
0.00819 |
0.0409 |
Noonan syndrome 8 (NS8) [MIM:615355] |
(PAK1, RIT1) |
2.101 |
0.022 |
0.0549 |
Noonan syndrome-like disorder with loose anagen hair 2 (NSLH2) [MIM:617506] |
(PPP1R11, PPP1CB) |
1.683 |
0.0484 |
0.341 |
Obesity |
All phenotypes |
(NTRK2, SH2B1) |
5.066 |
0.0299 |
0.209 |
All phenotypes |
(FBXW7, DISC1) |
2.810 |
0.000141 |
0.00177 |
All phenotypes |
(MYC, FBXW7) |
2.665 |
1.58e-5 |
0.000395 |
All phenotypes |
(MORC1, MORC2) |
1.493 |
0.0402 |
0.209 |
All phenotypes |
(MORC2, MORC2) |
1.477 |
0.0418 |
0.209 |
Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012] |
(FBXW7, DISC1) |
2.810 |
0.000141 |
0.000141 |
Developmental delay, hypotonia, and impaired language (DEDHIL) [MIM:620012] |
(MYC, FBXW7) |
2.665 |
1.58e-5 |
3.16e-5 |
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090] |
(MORC1, MORC2) |
1.493 |
0.0402 |
0.0418 |
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN) [MIM:619090] |
(MORC2, MORC2) |
1.477 |
0.0418 |
0.0418 |
Obesity, hyperphagia, and developmental delay (OBHD) [MIM:613886] |
(NTRK2, SH2B1) |
5.066 |
0.0299 |
0.0299 |
Oculodentodigital dysplasia |
Oculodentodigital dysplasia (ODDD) [MIM:164200] |
(GJA1, GJA1) |
0.958 |
0.000356 |
0.000356 |
Oculoectodermal syndrome |
Oculoectodermal syndrome (OES) [MIM:600268] |
(HLA-Cw, KRAS) |
3.240 |
0.0156 |
0.102 |
Oculoectodermal syndrome (OES) [MIM:600268] |
(KRAS, HLA-C) |
3.240 |
0.0156 |
0.102 |
Orofacial cleft |
All phenotypes |
(KDM1A, INSM1) |
4.392 |
0.000108 |
0.000358 |
All phenotypes |
(KDM1A, SNAI1) |
4.307 |
0.000129 |
0.000358 |
All phenotypes |
(KDM1A, H3-4) |
4.227 |
0.000152 |
0.000358 |
All phenotypes |
(KDM1A, ) |
4.010 |
0.000239 |
0.000358 |
All phenotypes |
(KDM1A, H3-5) |
4.010 |
0.000239 |
0.000358 |
All phenotypes |
(KDM1A, H3C12) |
4.010 |
0.000239 |
0.000358 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, INSM1) |
4.392 |
0.000108 |
0.000239 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, SNAI1) |
4.307 |
0.000129 |
0.000239 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, H3-4) |
4.227 |
0.000152 |
0.000239 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, ) |
4.010 |
0.000239 |
0.000239 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, H3-5) |
4.010 |
0.000239 |
0.000239 |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728] |
(KDM1A, H3C12) |
4.010 |
0.000239 |
0.000239 |
Osteogenesis imperfecta |
All phenotypes |
(COL3A1, SPARC) |
3.777 |
0.00532 |
0.0319 |
All phenotypes |
(COL1A1, GP6) |
2.862 |
0.00201 |
0.0241 |
All phenotypes |
(COL1A1, COL9A3) |
1.199 |
0.0255 |
0.0829 |
All phenotypes |
(COL1A1, COL9A1) |
1.175 |
0.0276 |
0.0829 |
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115] |
(COL1A1, FN1) |
4.524 |
0.0435 |
0.0435 |
Osteogenesis imperfecta 17 (OI17) [MIM:616507] |
(COL3A1, SPARC) |
3.777 |
0.00532 |
0.00532 |
Osteogenesis imperfecta 1 (OI1) [MIM:166200] |
(COL1A1, FN1) |
3.787 |
0.000769 |
0.00462 |
Osteogenesis imperfecta 2 (OI2) [MIM:166210] |
(COL1A1, GP6) |
3.386 |
0.000473 |
0.00331 |
Osteoporosis-pseudoglioma syndrome |
Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
(LRP5, SOST) |
2.057 |
0.0339 |
0.0339 |
Ovarian cancer |
Ovarian cancer (OC) [MIM:167000] |
(HLA-A, PIK3CA) |
6.891 |
0.00843 |
0.0379 |
Ovarian cancer (OC) [MIM:167000] |
(HLA-A, CTNNB1) |
5.072 |
0.000884 |
0.00796 |
Ovarian cancer (OC) [MIM:167000] |
(CTNNB1, BTRC) |
4.860 |
0.0341 |
0.0768 |
Ovarian cancer (OC) [MIM:167000] |
(BRCA1, BRIP1) |
3.130 |
0.0165 |
0.0495 |
Ovarian dysgenesis |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(NCOA2, ESR2) |
4.923 |
0.033 |
0.0721 |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(ESR2, NCOA5) |
4.700 |
0.0385 |
0.0721 |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(ESR2, NCOA3) |
4.601 |
0.0412 |
0.0721 |
Ovarian dysgenesis 8 (ODG8) [MIM:618187] |
(NRIP1, ESR2) |
4.601 |
0.0412 |
0.0721 |
PAPA syndrome |
PAPA syndrome (PAPAS) [MIM:604416] |
(PSTPIP1, PTPN22) |
3.779 |
0.00685 |
0.00685 |
PHOAR2-enteropathy syndrome |
PHOAR2-enteropathy syndrome (PHOAR2E) [MIM:614441] |
(HLA-A, SLCO2A1) |
3.629 |
0.00161 |
0.00161 |
Pachyonychia congenita |
All phenotypes |
(KRT6A, LMNA) |
2.032 |
1.89e-5 |
0.000954 |
All phenotypes |
(KRT34, KRT6A) |
1.729 |
0.000113 |
0.000954 |
All phenotypes |
(KRT6A, KRT31) |
1.729 |
0.000113 |
0.000954 |
All phenotypes |
(KRT38, KRT6A) |
1.704 |
0.000131 |
0.000954 |
All phenotypes |
(KRT6A, DES) |
1.704 |
0.000131 |
0.000954 |
All phenotypes |
(KRT6A, KRT35) |
1.704 |
0.000131 |
0.000954 |
All phenotypes |
(KRT6A, KRT40) |
1.680 |
0.000151 |
0.000954 |
All phenotypes |
(KRT6A, KRT17) |
1.668 |
9.42e-5 |
0.000954 |
All phenotypes |
(KRT14, KRT6A) |
1.662 |
0.000648 |
0.00336 |
All phenotypes |
(KRT6A, KRT20) |
1.662 |
0.000648 |
0.00336 |
All phenotypes |
(KRT6A, KRT16) |
1.598 |
0.000146 |
0.000954 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, LMNA) |
2.032 |
1.89e-5 |
0.000227 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT34, KRT6A) |
1.729 |
0.000113 |
0.000258 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT31) |
1.729 |
0.000113 |
0.000258 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT38, KRT6A) |
1.704 |
0.000131 |
0.000258 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, DES) |
1.704 |
0.000131 |
0.000258 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT35) |
1.704 |
0.000131 |
0.000258 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT40) |
1.680 |
0.000151 |
0.000258 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT14, KRT6A) |
1.662 |
0.000648 |
0.000777 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT17) |
1.662 |
0.000648 |
0.000777 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT20) |
1.662 |
0.000648 |
0.000777 |
Pachyonychia congenita 3 (PC3) [MIM:615726] |
(KRT6A, KRT16) |
1.610 |
0.000842 |
0.000919 |
Pancreatitis |
Pancreatitis, hereditary (PCTT) [MIM:167800] |
(PRSS1, TMPRSS15) |
1.390 |
0.00313 |
0.00938 |
Parkinson disease |
All phenotypes |
(LRRK2, CSNK1G3) |
3.358 |
0.00301 |
0.0994 |
All phenotypes |
(YWHAG, LRRK2) |
3.250 |
0.0186 |
0.15 |
All phenotypes |
(YWHAE, LRRK2) |
3.188 |
0.0202 |
0.15 |
All phenotypes |
(YWHAH, LRRK2) |
3.188 |
0.0202 |
0.15 |
All phenotypes |
(YWHAQ, LRRK2) |
3.188 |
0.0202 |
0.15 |
All phenotypes |
(YWHAZ, LRRK2) |
3.188 |
0.0202 |
0.15 |
All phenotypes |
(YWHAB, LRRK2) |
3.129 |
0.0217 |
0.15 |
All phenotypes |
(SNCA, PPIA) |
2.959 |
0.0227 |
0.15 |
All phenotypes |
(MYL9, LRRK2) |
2.551 |
0.014 |
0.15 |
All phenotypes |
(PLA2G6, PLA2G6) |
2.364 |
0.0377 |
0.207 |
All phenotypes |
(LRRK1, LRRK2) |
2.001 |
0.0377 |
0.207 |
All phenotypes |
(LRRK2, LRRK2) |
1.896 |
0.000127 |
0.0084 |
Parkinson disease 14 (PARK14) [MIM:612953] |
(PLA2G6, PLA2G6) |
2.364 |
0.0377 |
0.0377 |
Parkinson disease 1, autosomal dominant (PARK1) [MIM:168601] |
(SNCA, PPIA) |
2.959 |
0.0227 |
0.0682 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(LRRK2, CSNK1G3) |
3.358 |
0.00301 |
0.0256 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(YWHAG, LRRK2) |
3.250 |
0.0186 |
0.0411 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(YWHAE, LRRK2) |
3.188 |
0.0202 |
0.0411 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(YWHAH, LRRK2) |
3.188 |
0.0202 |
0.0411 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(YWHAQ, LRRK2) |
3.188 |
0.0202 |
0.0411 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(YWHAZ, LRRK2) |
3.188 |
0.0202 |
0.0411 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(YWHAB, LRRK2) |
3.129 |
0.0217 |
0.0411 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(MYL9, LRRK2) |
2.551 |
0.014 |
0.0411 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(LRRK1, LRRK2) |
2.001 |
0.0377 |
0.0641 |
Parkinson disease 8 (PARK8) [MIM:607060] |
(LRRK2, LRRK2) |
1.896 |
0.000127 |
0.00216 |
Patterned dystrophy of retinal pigment epithelium |
Macular dystrophy, patterned, 1 (MDPT1) [MIM:169150] |
(PRPH2, ROM1) |
1.865 |
0.0422 |
0.0422 |
Periventricular heterotopia |
All phenotypes |
(UBA52, NEDD4L) |
2.711 |
0.0315 |
0.315 |
Periventricular nodular heterotopia 7 (PVNH7) [MIM:617201] |
(UBA52, NEDD4L) |
2.711 |
0.0315 |
0.0946 |
Peroxisome biogenesis disorder |
All phenotypes |
(PEX1, PEX6) |
1.389 |
0.0107 |
0.0428 |
Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100] |
(PEX1, PEX6) |
2.208 |
0.0179 |
0.0179 |
Peroxisome biogenesis disorder 4A (PBD4A) [MIM:614862] |
(PEX1, PEX6) |
2.403 |
0.0358 |
0.0358 |
Perry syndrome |
Perry syndrome (PERRYS) [MIM:168605] |
(DCTN1, MAPRE3) |
2.470 |
0.047 |
0.113 |
Pfeiffer syndrome |
Pfeiffer syndrome (PS) [MIM:101600] |
(FGF19, FGFR1) |
4.440 |
0.0461 |
0.198 |
Pfeiffer syndrome (PS) [MIM:101600] |
(FGF7, FGFR2) |
1.535 |
0.0439 |
0.198 |
Pheochromocytoma |
Pheochromocytoma (PCC) [MIM:171300] |
(RET, MAPK1) |
4.890 |
0.0337 |
0.484 |
Pheochromocytoma (PCC) [MIM:171300] |
(RET, MAPK3) |
4.756 |
0.037 |
0.484 |
Piebaldism |
Piebald trait (PBT) [MIM:172800] |
(LCK, KIT) |
2.802 |
0.0317 |
0.19 |
Pilomatrixoma |
Pilomatrixoma (PTR) [MIM:132600] |
(CTNNB1, BTRC) |
5.182 |
8.11e-8 |
1.22e-7 |
Pilomatrixoma (PTR) [MIM:132600] |
(CTNNB1, FBXW11) |
5.097 |
7.07e-5 |
7.07e-5 |
Pilomatrixoma (PTR) [MIM:132600] |
(HLA-A, CTNNB1) |
5.072 |
6.11e-13 |
1.83e-12 |
Pitt-Hopkins syndrome |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4, TCF4) |
1.447 |
0.00013 |
0.0039 |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4, ID2) |
1.276 |
0.0209 |
0.209 |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4, ID3) |
1.276 |
0.0209 |
0.209 |
Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
(TCF4, ID1) |
1.165 |
0.0302 |
0.226 |
Pontocerebellar hypoplasia |
All phenotypes |
(EXOSC9, EXOSC3) |
2.692 |
0.00694 |
0.0832 |
All phenotypes |
(TSEN15, TSEN34) |
1.596 |
0.0362 |
0.164 |
Pontocerebellar hypoplasia 2F (PCH2F) [MIM:617026] |
(TSEN15, TSEN34) |
1.596 |
0.0362 |
0.0725 |
Progressive external ophthalmoplegia |
All phenotypes |
(TWNK, TWNK) |
1.537 |
0.00034 |
0.00102 |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3 (PEOA3) [MIM:609286] |
(TWNK, TWNK) |
1.537 |
0.00034 |
0.00034 |
Prostate cancer |
Prostate cancer (PC) [MIM:176807] |
(RNF8, CHEK2) |
2.784 |
5.32e-5 |
0.000213 |
Prostate cancer (PC) [MIM:176807] |
(NBN, CHEK2) |
2.556 |
0.000684 |
0.00137 |
Pseudohypoaldosteronism |
All phenotypes |
(KLHL2, WNK4) |
5.256 |
1.79e-5 |
0.000108 |
All phenotypes |
(COPS2, CUL3) |
3.753 |
0.0055 |
0.0132 |
All phenotypes |
(WNK4, KLHL3) |
3.001 |
2.9e-7 |
3.48e-6 |
All phenotypes |
(WNK3, KLHL3) |
2.142 |
0.000848 |
0.00339 |
All phenotypes |
(KEAP1, KLHL3) |
1.928 |
0.002 |
0.006 |
Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491] |
(WNK4, KLHL3) |
5.408 |
1.31e-5 |
1.79e-5 |
Pseudohypoaldosteronism 2B (PHA2B) [MIM:614491] |
(KLHL2, WNK4) |
5.256 |
1.79e-5 |
1.79e-5 |
Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495] |
(WNK4, KLHL3) |
2.327 |
0.000396 |
0.00238 |
Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495] |
(WNK3, KLHL3) |
2.142 |
0.000848 |
0.00254 |
Pseudohypoaldosteronism 2D (PHA2D) [MIM:614495] |
(KEAP1, KLHL3) |
1.928 |
0.002 |
0.004 |
Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496] |
(COPS2, CUL3) |
3.753 |
0.0055 |
0.0165 |
Pseudohypoparathyroidism |
All phenotypes |
(FZD7, GNAS) |
2.578 |
0.013 |
0.327 |
All phenotypes |
(GNAS, FZD1) |
2.452 |
0.0164 |
0.327 |
All phenotypes |
(OXTR, GNAS) |
1.867 |
0.0465 |
0.327 |
All phenotypes |
(CASR, GNAS) |
1.752 |
0.0275 |
0.327 |
All phenotypes |
(GNAS, NMUR1) |
1.545 |
0.0434 |
0.327 |
Pseudohypoparathyroidism 1A (PHP1A) [MIM:103580] |
(GNAS, ADCY2) |
2.452 |
0.0472 |
0.331 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(FZD7, GNAS) |
5.163 |
0.000779 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, FZD1) |
5.037 |
0.000928 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, C3AR1) |
4.452 |
0.00209 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(OXTR, GNAS) |
4.452 |
0.00209 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, ADGRG4) |
4.230 |
0.00284 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GHRHR) |
4.230 |
0.00284 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, HRH4) |
4.230 |
0.00284 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, CRHR2) |
4.163 |
0.00312 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(TRHR, GNAS) |
4.163 |
0.00312 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADRA1A, GNAS) |
4.098 |
0.00341 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR61) |
4.098 |
0.00341 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(PTH2R, GNAS) |
4.098 |
0.00341 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(EDNRA, GNAS) |
4.037 |
0.00371 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GALR2, GNAS) |
4.037 |
0.00371 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(PTGER2, GNAS) |
4.037 |
0.00371 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(CRHR1, GNAS) |
3.978 |
0.00403 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, OR51E2) |
3.978 |
0.00403 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADGRE5, GNAS) |
3.922 |
0.00435 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADORA2A, GNAS) |
3.922 |
0.00435 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(CASR, GNAS) |
3.922 |
0.00435 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(PTGFR, GNAS) |
3.922 |
0.00435 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR65) |
3.867 |
0.0047 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR68) |
3.867 |
0.0047 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(PRLHR, GNAS) |
3.867 |
0.0047 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(CNR1, GNAS) |
3.815 |
0.00505 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, ADGRD1) |
3.815 |
0.00505 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR161) |
3.815 |
0.00505 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, SUCNR1) |
3.815 |
0.00505 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, ADGRF1) |
3.764 |
0.00542 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, CALCRL) |
3.764 |
0.00542 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GHRHR) |
3.764 |
0.00542 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(HRH2, GNAS) |
3.764 |
0.00542 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(P2RY1, GNAS) |
3.764 |
0.00542 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, NMUR1) |
3.715 |
0.0058 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR139) |
3.622 |
0.0066 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GPR12, GNAS) |
3.622 |
0.0066 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(NMBR, GNAS) |
3.622 |
0.0066 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADORA2B, GNAS) |
3.578 |
0.00702 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GIPR, GNAS) |
3.578 |
0.00702 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPER1) |
3.578 |
0.00702 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR101) |
3.578 |
0.00702 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(MC3R, GNAS) |
3.578 |
0.00702 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(TSHR, GNAS) |
3.578 |
0.00702 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(EDNRB, GNAS) |
3.535 |
0.00745 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GPR6, GNAS) |
3.535 |
0.00745 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(HTR7, GNAS) |
3.535 |
0.00745 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(TACR1, GNAS) |
3.535 |
0.00745 |
0.0135 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, HTR4) |
3.493 |
0.00789 |
0.0136 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, RXFP3) |
3.493 |
0.00789 |
0.0136 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, TAS2R14) |
3.452 |
0.00835 |
0.0136 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(SCTR, GNAS) |
3.452 |
0.00835 |
0.0136 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(VIPR1, GNAS) |
3.452 |
0.00835 |
0.0136 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(PTGIR, GNAS) |
3.413 |
0.00882 |
0.0139 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(TAS2R46, GNAS) |
3.413 |
0.00882 |
0.0139 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(DRD5, GNAS) |
3.374 |
0.0093 |
0.0144 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GRPR, GNAS) |
3.337 |
0.0098 |
0.0148 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR174) |
3.300 |
0.0103 |
0.0148 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, MC1R) |
3.300 |
0.0103 |
0.0148 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(CALCR, GNAS) |
3.264 |
0.0108 |
0.0148 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR52) |
3.264 |
0.0108 |
0.0148 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, NMUR2) |
3.264 |
0.0108 |
0.0148 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(MC5R, GNAS) |
3.264 |
0.0108 |
0.0148 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR21) |
3.230 |
0.0114 |
0.0151 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GPR3, GNAS) |
3.230 |
0.0114 |
0.0151 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, CYSLTR2) |
3.196 |
0.0119 |
0.0156 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(HTR6, GNAS) |
3.163 |
0.0125 |
0.0158 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(MTNR1B, GNAS) |
3.163 |
0.0125 |
0.0158 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADCYAP1R1, GNAS) |
3.098 |
0.0136 |
0.0168 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, PTH1R) |
3.098 |
0.0136 |
0.0168 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, FFAR4) |
3.037 |
0.0148 |
0.0175 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPBAR1) |
3.037 |
0.0148 |
0.0175 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(PTGER4, GNAS) |
3.037 |
0.0148 |
0.0175 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(CCKAR, GNAS) |
3.007 |
0.0155 |
0.0178 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, GPR119) |
3.007 |
0.0155 |
0.0178 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(AVPR2, GNAS) |
2.978 |
0.0161 |
0.0183 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GCGR, GNAS) |
2.950 |
0.0168 |
0.0187 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(MC4R, GNAS) |
2.922 |
0.0174 |
0.0192 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GNAS, TAAR1) |
2.894 |
0.0181 |
0.0197 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(DRD1, GNAS) |
2.691 |
0.024 |
0.0258 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(ADRB2, GNAS) |
2.668 |
0.0248 |
0.0263 |
Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462] |
(GLP1R, GNAS) |
2.556 |
0.0289 |
0.0303 |
Pyridoxine-5'-phosphate oxidase deficiency |
Pyridoxine-5'-phosphate oxidase deficiency (PNPOD) [MIM:610090] |
(PNPO, PNPO) |
1.526 |
0.0419 |
0.0419 |
Pyropoikilocytosis |
Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
(SPTA1, SPTB) |
5.465 |
0.0226 |
0.0453 |
Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
(SPTA1, SPTBN1) |
4.465 |
0.0453 |
0.0453 |
Rabson-Mendenhall syndrome |
Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
(INSR, IRS1) |
2.471 |
0.0492 |
0.225 |
Radioulnar synostosis with amegakaryocytic thrombocytopenia |
Thrombocytopenia 6 (THC6) [MIM:616937] |
(SRC, PTPN23) |
6.235 |
0.0133 |
0.0465 |
Thrombocytopenia 6 (THC6) [MIM:616937] |
(SRC, PTPN1) |
6.013 |
0.0155 |
0.0465 |
Refsum disease |
All phenotypes |
(MEFV, SFN) |
6.412 |
0.0117 |
0.0822 |
All phenotypes |
(RHOA, TRPV4) |
4.268 |
5.21e-8 |
2.19e-6 |
All phenotypes |
(LYN, SRC) |
3.281 |
0.0106 |
0.0822 |
All phenotypes |
(VWF, GP1BA) |
2.929 |
0.00227 |
0.0476 |
All phenotypes |
(CRYAB, HSPB1) |
1.898 |
0.00879 |
0.0822 |
All phenotypes |
(MFN2, MFN1) |
1.508 |
0.00815 |
0.0822 |
All phenotypes |
(MFN2, MFN2) |
1.365 |
0.0138 |
0.083 |
Autoinflammatory disease, systemic, with vasculitis (SAIDV) [MIM:620376] |
(LYN, SRC) |
3.281 |
0.0106 |
0.0212 |
Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260] |
(MFN2, MFN1) |
1.719 |
0.00325 |
0.0057 |
Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260] |
(MFN2, MFN2) |
1.576 |
0.0057 |
0.0057 |
Charcot-Marie-Tooth disease, axonal, 2C (CMT2C) [MIM:606071] |
(RHOA, TRPV4) |
4.268 |
5.21e-8 |
5.21e-8 |
Charcot-Marie-Tooth disease, axonal, 2F (CMT2F) [MIM:606595] |
(CRYAB, HSPB1) |
1.898 |
0.00879 |
0.0615 |
Pyrin-associated autoinflammatory disease (PAAND) [MIM:608068] |
(MEFV, SFN) |
6.412 |
0.0117 |
0.0117 |
Von Willebrand disease, platelet-type (VWDP) [MIM:177820] |
(VWF, GP1BA) |
2.929 |
0.00227 |
0.00453 |
Renal cell carcinoma |
All phenotypes |
(MET, SH2B1) |
4.970 |
3.74e-7 |
1.87e-6 |
All phenotypes |
(SH2B2, MET) |
4.970 |
3.74e-7 |
1.87e-6 |
All phenotypes |
(MET, SH2B3) |
4.844 |
5.74e-7 |
2.15e-6 |
All phenotypes |
(MET, NTRK3) |
3.785 |
0.000161 |
0.000483 |
All phenotypes |
(MET, SYK) |
3.407 |
0.000437 |
0.000945 |
All phenotypes |
(MET, TXK) |
2.800 |
1.23e-7 |
1.85e-6 |
All phenotypes |
(MET, TEC) |
2.444 |
0.000441 |
0.000945 |
All phenotypes |
(MET, BTK) |
2.370 |
0.000581 |
0.00109 |
All phenotypes |
(MET, ITK) |
2.321 |
0.00225 |
0.00375 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, SH2B1) |
4.970 |
3.74e-7 |
1.75e-6 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(SH2B2, MET) |
4.970 |
3.74e-7 |
1.75e-6 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, SH2B3) |
4.844 |
5.74e-7 |
2.01e-6 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, NTRK3) |
3.785 |
0.000161 |
0.000451 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, SYK) |
3.407 |
0.000437 |
0.000882 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, TXK) |
2.800 |
1.23e-7 |
1.73e-6 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, TEC) |
2.444 |
0.000441 |
0.000882 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, BTK) |
2.370 |
0.000581 |
0.00102 |
Renal cell carcinoma papillary (RCCP) [MIM:605074] |
(MET, ITK) |
2.321 |
0.00225 |
0.0035 |
Renal glucosuria |
Renal glucosuria (GLYS) [MIM:233100] |
(SLC5A2, PDZK1IP1) |
5.144 |
0.0283 |
0.0283 |
Retinitis pigmentosa |
All phenotypes |
(ZBTB48, ZNF408) |
6.242 |
0.0132 |
0.0881 |
All phenotypes |
(ZNF408, ZNF331) |
6.242 |
0.0132 |
0.0881 |
All phenotypes |
(ZNF473, ZNF408) |
5.242 |
0.0264 |
0.132 |
All phenotypes |
(ZNF764, ZNF408) |
4.505 |
0.0441 |
0.189 |
All phenotypes |
(PRPF3, PRPF8) |
4.291 |
0.00261 |
0.0318 |
All phenotypes |
(STAT3, STAT2) |
2.380 |
0.0018 |
0.0318 |
All phenotypes |
(SNRNP200, PRPF8) |
1.950 |
0.00318 |
0.0318 |
All phenotypes |
(PRPH2, ROM1) |
1.807 |
0.00127 |
0.0318 |
All phenotypes |
(RP2, ARL3) |
1.701 |
0.026 |
0.132 |
All phenotypes |
(STAT3, STAT3) |
1.483 |
0.0473 |
0.189 |
Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections (HIES1) [MIM:147060] |
(STAT3, STAT2) |
2.380 |
0.0018 |
0.018 |
Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections (HIES1) [MIM:147060] |
(STAT3, STAT3) |
1.483 |
0.0473 |
0.237 |
Retinitis pigmentosa 13 (RP13) [MIM:600059] |
(SNRNP200, PRPF8) |
2.843 |
0.00131 |
0.00131 |
Retinitis pigmentosa 18 (RP18) [MIM:601414] |
(PRPF3, PRPF8) |
4.291 |
0.00261 |
0.00261 |
Retinitis pigmentosa 2 (RP2) [MIM:312600] |
(RP2, ARL3) |
1.701 |
0.026 |
0.026 |
Retinitis pigmentosa 72 (RP72) [MIM:616469] |
(ZBTB48, ZNF408) |
6.242 |
0.0132 |
0.0463 |
Retinitis pigmentosa 72 (RP72) [MIM:616469] |
(ZNF408, ZNF331) |
6.242 |
0.0132 |
0.0463 |
Retinitis pigmentosa 72 (RP72) [MIM:616469] |
(ZNF473, ZNF408) |
5.242 |
0.0264 |
0.0617 |
Retinitis pigmentosa 72 (RP72) [MIM:616469] |
(ZNF764, ZNF408) |
4.505 |
0.0441 |
0.0771 |
Retinitis pigmentosa 7 (RP7) [MIM:608133] |
(PRPH2, ROM1) |
1.807 |
0.00127 |
0.00127 |
Richieri-Costa-Pereira syndrome |
Richieri-Costa-Pereira syndrome (RCPS) [MIM:268305] |
(EIF4A3, UPF3B) |
4.911 |
0.0332 |
0.0665 |
SHORT syndrome |
All phenotypes |
(PDGFRA, PIK3R1) |
4.841 |
0.0346 |
0.103 |
All phenotypes |
(PIK3R1, GRB10) |
4.426 |
0.046 |
0.103 |
All phenotypes |
(PIK3R1, SHC1) |
4.339 |
0.0488 |
0.103 |
All phenotypes |
(PLCG1, PIK3R1) |
4.339 |
0.0488 |
0.103 |
All phenotypes |
(TUBB, TUBB4B) |
2.888 |
0.0183 |
0.103 |
All phenotypes |
(TUBB, TUBB2A) |
2.794 |
0.0208 |
0.103 |
SHORT syndrome (SHORTS) [MIM:269880] |
(PDGFRA, PIK3R1) |
4.841 |
0.0346 |
0.0866 |
SHORT syndrome (SHORTS) [MIM:269880] |
(PIK3R1, GRB10) |
4.426 |
0.046 |
0.0866 |
SHORT syndrome (SHORTS) [MIM:269880] |
(PIK3R1, SHC1) |
4.339 |
0.0488 |
0.0866 |
SHORT syndrome (SHORTS) [MIM:269880] |
(PLCG1, PIK3R1) |
4.339 |
0.0488 |
0.0866 |
Skin creases, congenital symmetric circumferential, 1 (CSCSC1) [MIM:156610] |
(TUBB, TUBB4B) |
2.888 |
0.0183 |
0.0416 |
Skin creases, congenital symmetric circumferential, 1 (CSCSC1) [MIM:156610] |
(TUBB, TUBB2A) |
2.794 |
0.0208 |
0.0416 |
Schimmelpenning-Feuerstein-Mims syndrome |
Schimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM:163200] |
(KRAS, TRBC1) |
4.755 |
0.037 |
0.126 |
Sclerosteosis |
Sclerosteosis 2 (SOST2) [MIM:614305] |
(MUSK, LRP4) |
6.097 |
0.000214 |
0.000214 |
Severe combined immunodeficiency |
All phenotypes |
(B2M, TRA@) |
4.573 |
0.042 |
0.21 |
All phenotypes |
(LCK, ZAP70) |
2.885 |
0.0271 |
0.21 |
All phenotypes |
(IL2RG, IL15) |
1.214 |
0.0402 |
0.21 |
Immunodeficiency 43 (IMD43) [MIM:241600] |
(B2M, TRA@) |
4.573 |
0.042 |
0.042 |
Immunodeficiency 48 (IMD48) [MIM:269840] |
(LCK, ZAP70) |
2.885 |
0.0271 |
0.0541 |
Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
(IL2RG, IL15) |
1.214 |
0.0402 |
0.225 |
Short stature |
All phenotypes |
(C3, CFHR4) |
3.472 |
0.000297 |
0.00233 |
All phenotypes |
(C3, CR2) |
3.448 |
0.000317 |
0.00233 |
All phenotypes |
(C3, CD46) |
2.432 |
0.0166 |
0.0911 |
All phenotypes |
(C3, CFH) |
1.587 |
0.000107 |
0.00233 |
Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925] |
(C3, CFHR4) |
3.472 |
0.000297 |
0.000846 |
Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925] |
(C3, CR2) |
3.448 |
0.000317 |
0.000846 |
Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925] |
(C3, CD46) |
2.997 |
0.0247 |
0.0494 |
Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925] |
(C3, CFH) |
2.548 |
0.00017 |
0.000846 |
Shprintzen-Goldberg craniosynostosis syndrome |
Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212] |
(SKI, SMAD2) |
3.282 |
1.68e-11 |
2.99e-11 |
Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212] |
(SKI, SMAD3) |
3.212 |
2.99e-11 |
2.99e-11 |
Sialuria |
Sialuria (SIALURIA) [MIM:269921] |
(GNE, GNE) |
2.356 |
0.00745 |
0.00745 |
Sick sinus syndrome |
All phenotypes |
(HCN4, HCN4) |
1.599 |
0.036 |
0.108 |
Sick sinus syndrome 2 (SSS2) [MIM:163800] |
(HCN4, HCN4) |
1.599 |
0.036 |
0.036 |
Snijders Blok-Campeau syndrome |
Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205] |
(CHD3, CHD3) |
1.501 |
0.0468 |
0.0468 |
Spastic paraplegia |
All phenotypes |
(SPAST, SPAST) |
0.601 |
0.000868 |
0.00347 |
Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601] |
(SPAST, SPAST) |
0.601 |
0.000868 |
0.000868 |
Spermatogenic failure |
Spermatogenic failure 10 (SPGF10) [MIM:614822] |
(SEPTIN12, SEPTIN1) |
2.408 |
0.0355 |
0.248 |
Spinal muscular atrophy |
All phenotypes |
(RHOA, TRPV4) |
4.491 |
0.0445 |
0.145 |
All phenotypes |
(DYNC1I2, DYNC1H1) |
4.162 |
3.36e-5 |
0.000437 |
All phenotypes |
(SMN2, SMN2) |
2.091 |
0.00451 |
0.0293 |
All phenotypes |
(AFG3L2, AFG3L2) |
1.128 |
0.033 |
0.143 |
Optic atrophy 12 (OPA12) [MIM:618977] |
(AFG3L2, AFG3L2) |
1.128 |
0.033 |
0.033 |
Scapuloperoneal spinal muscular atrophy (SPSMA) [MIM:181405] |
(RHOA, TRPV4) |
4.491 |
0.0445 |
0.0445 |
Spinal muscular atrophy 1 (SMA1) [MIM:253300] |
(SMN2, SMN2) |
2.676 |
0.033 |
0.033 |
Spinal muscular atrophy 3 (SMA3) [MIM:253400] |
(SMN2, SMN2) |
2.091 |
0.0281 |
0.0562 |
Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600] |
(DYNC1I2, DYNC1H1) |
4.162 |
3.36e-5 |
6.72e-5 |
Spinocerebellar ataxia |
All phenotypes |
(ABCB7, ABCB7) |
1.858 |
0.0299 |
0.284 |
All phenotypes |
(AFG3L2, AFG3L2) |
1.184 |
0.000158 |
0.00301 |
Anemia, sideroblastic, spinocerebellar ataxia (ASAT) [MIM:301310] |
(ABCB7, ABCB7) |
1.858 |
0.0299 |
0.0299 |
Spinocerebellar ataxia 28 (SCA28) [MIM:610246] |
(AFG3L2, AFG3L2) |
1.184 |
0.000158 |
0.000158 |
Split-hand/foot malformation |
All phenotypes |
(PPP1R13L, TP63) |
3.757 |
0.00706 |
0.0181 |
All phenotypes |
(PPP1R13B, TP63) |
3.692 |
0.0077 |
0.0181 |
All phenotypes |
(TP53BP2, TP63) |
3.572 |
0.00907 |
0.0181 |
Split-hand/foot malformation 4 (SHFM4) [MIM:605289] |
(PPP1R13L, TP63) |
3.757 |
0.00706 |
0.0121 |
Split-hand/foot malformation 4 (SHFM4) [MIM:605289] |
(PPP1R13B, TP63) |
3.692 |
0.0077 |
0.0121 |
Split-hand/foot malformation 4 (SHFM4) [MIM:605289] |
(TP53BP2, TP63) |
3.572 |
0.00907 |
0.0121 |
Stolerman neurodevelopmental syndrome |
Stolerman neurodevelopmental syndrome (NEDSST) [MIM:618505] |
(KDM6B, H3C12) |
3.161 |
0.0125 |
0.0125 |
Symphalangism |
All phenotypes |
(BMP2, NOG) |
2.244 |
0.000445 |
0.00469 |
All phenotypes |
(BMP7, NOG) |
1.892 |
0.00171 |
0.00685 |
All phenotypes |
(GDF5, NOG) |
1.625 |
0.000782 |
0.00469 |
Symphalangism, proximal 1A (SYM1A) [MIM:185800] |
(BMP2, NOG) |
2.244 |
0.000445 |
0.00178 |
Symphalangism, proximal 1A (SYM1A) [MIM:185800] |
(BMP7, NOG) |
1.892 |
0.00171 |
0.00228 |
Symphalangism, proximal 1A (SYM1A) [MIM:185800] |
(GDF5, NOG) |
1.892 |
0.00171 |
0.00228 |
Tangier disease |
Tangier disease (TGD) [MIM:205400] |
(ABCA1, ABCA12) |
3.561 |
0.0124 |
0.0124 |
Tarsal-carpal coalition syndrome |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
(BMP2, NOG) |
2.829 |
0.00279 |
0.00579 |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
(BMP7, NOG) |
2.477 |
0.00579 |
0.00579 |
Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
(GDF5, NOG) |
2.477 |
0.00579 |
0.00579 |
Temple-Baraitser syndrome |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1, CALM2) |
5.975 |
0.0158 |
0.0239 |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1, KCNB1) |
3.133 |
0.0164 |
0.0239 |
Temple-Baraitser syndrome (TMBTS) [MIM:611816] |
(KCNH1, KCNF1) |
3.068 |
0.018 |
0.0239 |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome |
All phenotypes |
(H2AC17, H4C16) |
1.650 |
0.00682 |
0.0739 |
All phenotypes |
(H4C16, H2AC12) |
1.650 |
0.00682 |
0.0739 |
All phenotypes |
(H4C16, H2AC14) |
1.650 |
0.00682 |
0.0739 |
All phenotypes |
(H2AZ1, H4C16) |
1.593 |
0.0178 |
0.0981 |
All phenotypes |
(H4C16, H2AC1) |
1.593 |
0.0178 |
0.0981 |
All phenotypes |
(NASP, H4C16) |
1.557 |
0.00941 |
0.0739 |
All phenotypes |
(H4C16, DNAJC9) |
1.487 |
0.0241 |
0.11 |
All phenotypes |
(H4C16, H2AC21) |
1.487 |
0.0241 |
0.11 |
All phenotypes |
(H2AC8, H4C16) |
1.387 |
0.0167 |
0.0981 |
All phenotypes |
(H4C16, SUPT16H) |
1.387 |
0.00827 |
0.0739 |
All phenotypes |
(MCM2, H4C16) |
1.109 |
0.00108 |
0.0595 |
All phenotypes |
(H4C16, DAXX) |
0.802 |
0.00322 |
0.0739 |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 1 (TEBIVANED1) [MIM:619758] |
(H4C16, HJURP) |
2.672 |
0.0332 |
0.295 |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 1 (TEBIVANED1) [MIM:619758] |
(MCM2, H4C16) |
1.350 |
0.0237 |
0.295 |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950] |
(H4C16, RBBP7) |
1.972 |
0.0307 |
0.798 |
Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950] |
(H4C16, SUPT16H) |
1.695 |
0.0188 |
0.798 |
Thanatophoric dysplasia |
All phenotypes |
(FGFR3, FGFR3) |
2.084 |
0.000395 |
0.00276 |
Thanatophoric dysplasia 1 (TD1) [MIM:187600] |
(FGF1, FGFR3) |
2.425 |
0.0489 |
0.151 |
Thanatophoric dysplasia 1 (TD1) [MIM:187600] |
(FGFR3, FGFR3) |
2.044 |
0.00168 |
0.0118 |
Thrombocythemia |
Thrombocythemia 3 (THCYT3) [MIM:614521] |
(JAK2, JAK2) |
3.021 |
0.0152 |
0.0152 |
Thrombocytopenia |
All phenotypes |
(THPO, MPL) |
2.322 |
0.000478 |
0.00191 |
All phenotypes |
(RAP1B, RASGRP2) |
2.144 |
0.00262 |
0.00524 |
Amegakaryocytic thrombocytopenia, congenital, 1 (CAMT1) [MIM:604498] |
(THPO, MPL) |
2.702 |
0.00861 |
0.00861 |
Amegakaryocytic thrombocytopenia, congenital, 2 (CAMT2) [MIM:620481] |
(THPO, MPL) |
2.029 |
0.0147 |
0.0147 |
Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies (THC11) [MIM:620654] |
(RAP1B, RASGRP2) |
2.144 |
0.00262 |
0.00785 |
Thyroid dyshormonogenesis |
All phenotypes |
(THRB, NCOA2) |
1.513 |
0.0289 |
0.26 |
Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570] |
(THRB, NCOA2) |
1.604 |
0.0225 |
0.18 |
Tooth agenesis, selective |
Tooth agenesis, selective, X-linked, 1 (STHAGX1) [MIM:313500] |
(EDA, EDAR) |
1.968 |
0.011 |
0.022 |
Treacher Collins syndrome |
All phenotypes |
(POLR1C, POLR1G) |
4.109 |
0.00336 |
0.0202 |
Treacher Collins syndrome 3 (TCS3) [MIM:248390] |
(POLR1C, POLR1G) |
4.109 |
0.00336 |
0.00336 |
Trichothiodystrophy |
All phenotypes |
(ERCC2, GTF2H2C_2) |
2.663 |
0.000777 |
0.00466 |
All phenotypes |
(ERCC2, GTF2H2) |
2.341 |
0.00656 |
0.0197 |
Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675] |
(ERCC2, GTF2H2C_2) |
2.663 |
0.000777 |
0.00233 |
Trichothiodystrophy 1, photosensitive (TTD1) [MIM:601675] |
(ERCC2, GTF2H2) |
2.341 |
0.00656 |
0.00983 |
Usher syndrome |
Usher syndrome 1D/F (USH1DF) [MIM:601067] |
(CDH23, USH1C) |
5.485 |
0.0223 |
0.0223 |
Verheij syndrome |
Verheij syndrome (VRJS) [MIM:615583] |
(EWSR1, PUF60) |
5.053 |
0.0301 |
0.0602 |
Verheij syndrome (VRJS) [MIM:615583] |
(RNPS1, PUF60) |
5.053 |
0.0301 |
0.0602 |
Vissers-Bodmer syndrome |
Vissers-Bodmer syndrome (VIBOS) [MIM:619033] |
(CNOT1, ZFP36) |
3.898 |
0.0076 |
0.0124 |
Vissers-Bodmer syndrome (VIBOS) [MIM:619033] |
(CNOT1, CNOT9) |
2.773 |
0.00824 |
0.0124 |
Von Hippel-Lindau disease |
Von Hippel-Lindau disease (VHLD) [MIM:193300] |
(VHL, ELOC) |
0.515 |
0.00574 |
0.149 |
Von Willebrand disease |
All phenotypes |
(VWF, GP1BA) |
2.271 |
0.00933 |
0.028 |
Von Willebrand disease 2 (VWD2) [MIM:613554] |
(VWF, GP1BA) |
2.458 |
0.00587 |
0.0176 |
Waardenburg syndrome |
Waardenburg syndrome 1 (WS1) [MIM:193500] |
(POU3F2, PAX3) |
1.171 |
0.0275 |
0.055 |
Weaver syndrome |
Weaver syndrome (WVS) [MIM:277590] |
(EZH2, SKIC8) |
4.315 |
0.00434 |
0.0174 |
Weaver syndrome (WVS) [MIM:277590] |
(EZH2, JARID2) |
3.508 |
0.000287 |
0.0023 |
Weaver syndrome (WVS) [MIM:277590] |
(EED, EZH2) |
1.303 |
0.0366 |
0.0975 |
White-Kernohan syndrome |
White-Kernohan syndrome (WHIKERS) [MIM:619426] |
(STK19, DDB1) |
5.570 |
0.000655 |
0.00393 |
White-Kernohan syndrome (WHIKERS) [MIM:619426] |
(DDB1, DCAF16) |
2.869 |
0.0256 |
0.0384 |
White-Kernohan syndrome (WHIKERS) [MIM:619426] |
(DDB1, DDB2) |
2.833 |
0.0043 |
0.0106 |
White-Kernohan syndrome (WHIKERS) [MIM:619426] |
(DDB1, DCAF1) |
2.729 |
0.0053 |
0.0106 |
White-Kernohan syndrome (WHIKERS) [MIM:619426] |
(DDB1, CRBN) |
2.373 |
0.0489 |
0.0587 |
Wilms tumor |
All phenotypes |
(DICER1, DICER1) |
5.712 |
0.000364 |
0.000728 |
Global developmental delay, lung cysts, overgrowth, and Wilms tumor (GLOW) [MIM:618272] |
(DICER1, DICER1) |
5.712 |
0.000364 |
0.000364 |
Xeroderma pigmentosum |
All phenotypes |
(ERCC2, GTF2H1) |
1.302 |
0.0087 |
0.087 |
Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
(ERCC2, GTF2H1) |
1.302 |
0.0087 |
0.0348 |
[Show all]
(**) All phenotypes refers to the union of mutations related to any phenotype of the same disease.
|